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Abstract 
Adequate maternal behaviour offers the best chance for the offspring to survive to maturity. 
This pro-social behaviour is known to be regulated by the nonapeptide arginine-vasopressin 
(AVP) amongst other peptidergic and non-peptidergic systems in rodents as well as in 
humans. Most research regarding the AVP system in maternal behaviour has focussed on the 
peptide itself and its V1a receptor (V1aR), and revealed a pivotal involvement in the 
regulation of different aspects of maternal behaviour. In addition, the involvement of AVP 
and its V1aR was investigated in the animal model of rats selected for extremes in anxiety-
related behaviour. Highly anxious dams (HAB) have a single nucleotide polymorphism in the 
AVP promoter-region, resulting in increased expression and release of AVP. Regarding the 
phenotype, HAB dams show a hyper-protective mothering style in contrast to dams selected 
for low anxiety-related behaviour (LAB), which only provide a low amount of maternal 
behaviour. Since the maternal phenotype of HAB and LAB dams can be partly reversed by 
blockade or infusion of V1aR or synthetic AVP, respectively, these rats provide a good model 
to observe the behavioural consequences after pharmacological manipulation of the AVP 
system on maternal behaviour. 
The influence of V1b receptors (V1bR) on mediating maternal behaviour has only been 
investigated in a single study in V1bR knockout mice to date. This study showed that V1bR 
knockout dams show decreased maternal aggression compared to wildtype dams. 
Therefore, I aimed to investigate in more detail the role of central V1bR on the maternal 
repertoire via acute central application of V1bR agonist and antagonist during lactation in 
non-selected rats (Chapter 2) as well as in the animal model of rats selected for extremes in 
anxiety-related behaviour (Chapter 3). Although the V1bR is widely distributed within the 
brain, I aimed to investigate the involvement of the receptor subtype in brain-regions known 
to be involved in maternal behaviour, including the medial preoptic area (MPOA), the bed 
nucleus of the stria terminalis (BNST) and the paraventricular nucleus (PVN) via acute local 
infusion of V1bR antagonist. In addition, I determined whether endogenous V1bR protein 
and/or mRNA expression differ in lactation within these brain regions (Chapter 4 -5). 
Further, in a pilot study co-expression of AVP and gonadotropin-releasing hormone (GnRH) 
immune-reactivity in the organum vasculosum of the lamina terminalis (OVLT) in lactating 
rats was observed. Since mice with a 30 % decrease of GnRH neurons show impaired pup 
retrieval, and the co-localization suggests an interaction with the AVP system known to be 
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involved in maternal behaviour, I was interested in the influence of the GnRH and the 
interconnected kisspeptin system in the regulation of maternal behaviour in rodents 
(Chapter 6). 
To investigate my aims I used a variety of cellular, molecular and behavioural approaches 
like quantitative real-time PCR, western blotting, central or local acute pharmacological 
manipulation of V1bR, GnRH receptors or kisspeptin receptors followed by observations of 
maternal care, maternal motivation to retrieve pups, maternal aggression and anxiety-
related behaviour. 
In this thesis I showed that central blockade of V1bR in non-selected rats impaired maternal 
care but did not affect maternal motivation, maternal aggression or anxiety-related 
behaviour. V1bR manipulation in HAB and LAB dams had no effect on any maternal 
behaviour. When investigating the role of V1bR in specific brain regions, I could show that 
blockade of V1bR within the MPOA increased maternal motivation whereas within the BNST 
maternal aggression, more precisely pup-directed behaviour, was decreased. Additionally, 
V1bR blockade in both brain regions decreased nursing, but only under stress conditions. 
Interestingly, in the PVN only V1aR, but not V1bR blockade decreased nursing under non-
stress conditions in addition to maternal anxiety.  
Thus, both V1R subtypes seem to be involved in the regulation of maternal behaviour in a 
brain region-dependent and context-specific manner, thereby acting exclusively, as 
complement or as counterpart of the other receptor subtype. Interestingly, this was not 
associated with alterations in mRNA or protein expression in any brain-region, suggesting 
that either transport of the receptor-subtype to the membrane, signal transduction or 
agonist sensitivity may be altered in lactation, which remains to be investigated. 
Regarding the involvement of GnRH and kisspeptin in the regulation of maternal behaviour, 
blocking GnRH decreased maternal aggression, whereas kisspeptin receptor (GPR54) 
blockade resulted in impaired maternal care, in a dose-dependent manner. These results 
provide evidence, that the GnRH and kisspeptin system are not only involved in 
reproduction, but also in various aspects of maternal behaviour. Further investigation of 
their role, especially in maternal brain circuits, is essentially required. 
In conclusion, the presence of V1bR in brain regions involved in maternal behaviour are 
mandatory in lactating rodents to show adequate maternal behaviour, especially in stressful 
situations. Further, maternal behaviour is regulated by a variety of hormones acting centrally 
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within the brain like oxytocin and AVP, whereby hormones like GnRH and kisspeptin, 
thought to be mainly responsible in reproduction also influence maternal behaviour.  
Taken all these results into account I could provide further knowledge of the impact of 
central hormonal systems on the complexity of regulatory mechanism in maternal 
behaviour. 
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Zusammenfassung 
Adäquates mütterliches Verhalten ermöglicht den Nachkommen die bestmögliche Chance 
bis zum Erwachsenenalter zu überleben. Dieses prosoziale Verhalten wird sowohl im Nager 
als auch im Menschen, unter anderem durch das Nonapeptid Arginin-Vasopressin (AVP), 
reguliert. 
Im Zusammenhang mit mütterlichem Verhalten lag der Forschungsschwerpunkt bezüglich 
des AVP-Systems bis jetzt auf dem Peptid selbst, sowie seinem im Gehirn exprimierten V1a 
Rezeptor (V1aR). Beide sind ein essentieller Bestandteil in der Regulierung von 
verschiedenen mütterlichen Verhaltensweisen. Des Weiteren wurde der Einfluss von AVP 
und seinem V1aR im Tiermodell für Ratten, die auf die Extreme im Angstverhalten selektiert 
sind, untersucht. Rattenmütter mit einem hohen Maß an Angstverhalten (HAB) haben einen 
Einzelnukleotid-Polymorphismus (single nucleotide polymorphism, engl.) in der AVP 
Promoter-Region, der zu einer erhöhten AVP Expression und Ausschüttung führt. Bezüglich 
des Phänotypen, kennzeichnen sich HAB-Mütter durch ein Übermaß an Fürsorge, im 
Gegensatz zu Rattenmüttern die auf niedriges Angstverhalten selektiert sind (LAB). Diese 
zeigen nur ein geringes Maß an mütterlichen Verhaltensweisen. Da der mütterliche 
Phänotyp der HAB und LAB Ratten durch eine Blockade von V1aR bzw. eine Injektion von 
synthetischem AVP verändert werden kann, eignet sich dieses Tiermodell besonders gut, um 
die Auswirkungen pharmakologischer Manipulationen des AVP Systems auf mütterliches 
Verhalten zu beobachten. 
Der Einfluss von V1b Rezeptoren (V1bR) auf mütterliches Verhalten wurde bis jetzt nur in 
einer einzigen Studie untersucht. Diese zeigt, dass V1bR Knockout-Mäuse im Vergleich zu 
Wildtyp-Mäusen eine verringerte mütterliche Aggression zeigen.  
Aufgrund dieser unzureichenden Studienlage war es ein Ziel meiner Arbeit, den Einfluss der 
zentralen V1bR auf die unterschiedlichen mütterlichen Verhaltensweisen während der 
Laktation in nicht-selektierten Ratten (Kapitel 2), sowie im Tiermodell für Ratten, die auf die 
Extreme im Angstverhalten selektiert sind (Kapitel 3), mit Hilfe akuter zentraler 
Verabreichung eines V1bR Agonisten sowie Antagonisten genauer zu untersuchen. Obwohl 
der V1bR weitflächig im Gehirn exprimiert wird, war es ein weiteres Ziel meiner Arbeit den 
Einfluss des Rezeptors auf mütterliches Verhalten, mit Hilfe von akuten lokalen Injektionen 
eines V1bR Antagonisten in das mediale präoptische Areal (MPOA), in den bed nucleus der 
Stria terminalis (BNST) und in den paraventrikulären Nukleus (PVN), zu untersuchen. Diese 
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Gehirnregionen sind nachweislich an der Regulation von mütterlichem Verhalten beteiligt. 
Des Weiteren, habe ich erforscht, ob sich die Menge an endogenem V1bR Protein und/oder 
die mRNA Expression in diesen Gehirnregionen während der Laktation unterscheiden 
(Kapitel 4 und 5). 
Auf Basis einer Pilotstudie wurde außerdem im organum vasculosum der lamina terminalis 
(OVLT) laktierender Ratten eine Koexpression von AVP und des Gonadotropin-releasing 
Hormons (GnRH) beobachtet. Da Mäuse mit 30 %iger Reduzierung von GnRH Neuronen ein 
vermindertes Einsammeln ihres Nachwuchses zeigen, und die Kolokalisation einen 
Zusammenhang mit dem AVP System, das nachweislich mütterliches Verhalten beeinflusst, 
vermuten lässt, war ich ausserdem am Einfluss des GnRH- und des eng verbundenen 
Kisspeptin-Systems auf mütterliches Verhalten im Nager interessiert (Kapitel 6). 
Zur Untersuchung meiner Ziele habe ich eine Reihe an zellulären, molekularen sowie 
verhaltensbasierten Methoden angewendet, wie z.B. quantitative real-time PCR, Western 
Blot, zentrale oder lokale akute pharmakologische Manipulation von V1bR, GnRH- oder 
Kisspeptin-Rezeptoren, gefolgt von Verhaltensbeobachtungen (mütterliche Fürsorge, 
mütterliche Motivation zum Einsammeln der Jungen, mütterliche Aggression und 
Angstverhalten). 
In meiner Arbeit konnte ich zeigen, dass die zentrale Blockade von V1bR in nicht-selektierten 
Ratten zu einer verringerten mütterlichen Fürsorge führt, ohne dabei die mütterliche 
Motivation, mütterliche Aggression oder das Angstverhalten zu beeinflussen. Die 
Manipulation von V1bR in laktierenden HAB und LAB Ratten hatte keine Auswirkungen auf 
etwaige mütterliche Verhaltensweisen. Eine gehirnregionspezifische Blockade von V1bR in 
der MPOA führte zu einer gesteigerten mütterlichen Motivation zum Einsammeln der 
Jungen, während die Blockade im BNST die mütterliche Aggression, genaugenommen die 
Aufmerksamkeit, die dem Nachwuchs während des Aggressionstests entgegengebracht 
wurde, verringert war. Zusätzlich führte die V1bR Blockade in beiden Gehirnregionen zu 
einem verminderten Säugeverhalten, jedoch ausschließlich unter Stressbedingungen. 
Interessanterweise veranlasste im PVN nur die Blockade von V1aR, jedoch nicht von V1bR, 
ein niedrigeres Säugeverhalten unter stressfreien Bedingungen, sowie ein geringeres 
Angstverhalten. 
Daraus lässt sich folgern, dass beide V1R-Subtypen in einer gehirnregions- sowie 
kontextspezifischen Art und Weise an der Regulation von mütterlichem Verhalten beteiligt 
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sind. Das resultierende Verhalten erfolgt daher aus der Wirkungsweise eines einzelnen 
Rezeptorsubtypen, dem Zusammen- oder aber auch dem Gegenspiel beider 
Rezeptorsubtypen. Allerdings standen die Verhaltensänderungen nicht im Zusammenhang 
mit der mRNA- oder Protein-Expression. Dies lässt eine Anpassung im Transport des 
Rezeptors zur Zellmembran, in der Signalweiterleitung oder in der Sensibilität des Agonisten 
vermuten, was untersucht werden muss. 
Hinsichtlich des Einflusses von GnRH und Kisspeptin auf mütterliches Verhalten führte die 
Blockade von GnRH zu verminderter mütterlicher Aggression, während die Blockade von 
Kisspeptin Rezeptoren (GPR54) dosisabhängig zu einer verringerten mütterlichen Fürsorge 
führte. Diese Ergebnisse zeigen deutlich, dass sowohl das GnRH- als auch das Kisspeptin-
System nicht nur in der Fortpflanzung, sondern auch in verschiedenen Aspekten von 
mütterlichem Verhalten eine Rolle spielen. Die weiterführende Erforschung beider Systeme, 
insbesondere im Zusammenhang mit mütterlichen Verhaltensweisen, ist von großem 
Interesse. 
Es ergibt sich die Schlussfolgerung, dass die V1bR in Gehirnregionen, die mütterliches 
Verhalten modulieren, zwingend notwendig sind, um angemessenes mütterliches Verhalten 
vor allem unter Stressbedingungen zu garantieren. Des Weiteren wird mütterliches 
Verhalten von zahlreichen Hormonen im Gehirn, wie Oxytocin und AVP, reguliert, wobei 
aber auch Hormone wie GnRH und Kisspeptin, die bis jetzt hauptsächlich dem 
Fortpflanzungsverhalten zugesprochen wurden, mütterliches Verhalten beeinflussen. 
Somit konnte ich mit meiner Arbeit das Wissen über den Einfluss zentraler Hormonsysteme 
auf die Regulation komplexer Mechanismen, die mütterliches Verhalten regulieren, 
erweitern. 
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Chapter 1 
General Introduction 
 
One of the most important objectives in the life cycle of humans and other mammalian 
species is reproduction and the successful rearing of the young. The latter is promoted by 
parental behaviour, which was defined by Numan and Insel as “any behaviour of a member 
of a species towards a reproductively immature conspecific that increases the probability 
that the recipient will survive to maturity” (for review see Numan and Insel, 2003). About 90 
% of species show uniparental care, with the mother taking care for the offspring which is 
due to the fact that in mammals only the females provide milk. This is essential for the young 
as they would die without the nutrition. In preparation for motherhood the female 
undergoes numerous physiological, cellular and molecular adaptations to be prepared for 
the upcoming birth, lactation and defence of the young against potential threats. These 
changes occur as a direct consequence of both hormonal and non-hormonal alterations that 
occur throughout the peripartum period. All the more remarkable as in most mammalian 
species females are not maternal per se I want to give insight in these changes that lead to 
maternal behaviour in more detail. Due to the fact that these mechanisms are most studied 
in laboratory rodents, the following descriptions refer to rats unless otherwise stated. 
 
1.1 Maternal Behaviour 
1.1.2 Non-hormonal and hormonal basis of maternal behaviour in rats 
Nulliparous rodent females naturally avoid pups (Fleming and Rosenblatt, 1974; Rosenblatt, 
1967) or even show infanticide (Mennella and Moltz, 1989). Interestingly, these virgins show 
less infanticide after a distinct co-habituation period with the actual mother of the test pups; 
after a co-habituation period of 5 to 10 consecutive days 55 % of nulliparous female exhibit 
pup killing, whereas after 20 days of co-habituation only 9 % show infanticide (Mennella and 
Moltz, 1989). Also the co-habituation of nulliparous rats with foster pups over a period of 4 
to 7 days, leads to tolerance of the pups, which is followed by spontaneous maternal 
interest, expressed as increased licking of the pups, before retrieving them to a nest and 
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crouching over them (Fleming and Rosenblatt, 1974; Rosenblatt, 1967; Stern, 1983). This 
process is known as “sensitization” and occurring as a response to pup stimuli. 
In contrast to virgins, primiparous female rats show spontaneous maternal behaviour 
starting around 3.5 hours before parturition by licking (foster) pups, retrieving them to a 
nest site and crouching over them to provide milk (Mayer and Rosenblatt, 1984). Such 
preterm maternal interest in pregnant rats was linked to the hormonal changes, 
concomitant to non-hormonal adaptations, occurring during the peripartum period and 
inducing maternal behaviour. 
The steroid hormones oestradiol and progesterone - together with lactogenic hormones like 
prolactin (PRL) and placental lactogens (see below) - are the major factors implicated in the 
regulation of maternal behaviour in rats (Bridges et al., 1996; Grattan et al., 2001; Southard 
and Talamantes, 1991). Thereby, oestradiol levels are low during the first trimester, before 
they start rising on pregnancy day (PD) 10 and peak at a level, 3- to 4-fold higher than at the 
start of pregnancy, from day 15 until the day of parturition in rats (see Figure 1). In contrast, 
progesterone is already high during the first two weeks of pregnancy and declines with a 
robust drop (to 1/6 of magnitude) during the last days of gestation. Finally, a reversal of the 
oestradiol-to-progesterone ratio occurs leading from long progesterone dominance to a 
short oestradiol dominance (for reviews see Bridges, 2014; Numan and Insel, 2003). 
 
 
Figure 1 Relative levels of oestradiol and 
progesterone in blood plasma throughout 
pregnancy in rats. 
The percentage of the maximum value 
detected during pregnancy is shown. 
Adapted from Numan, 2003. 
 
 
Lactogenic hormones are secreted throughout pregnancy and are either derived from the 
anterior pituitary (PRL) or from the placenta (placental lactogens e.g. placental lactogen I 
and II) (Grattan, 2001). PRL is released in two daily surges within the first half of pregnancy 
and on the last day of pregnancy, whereas during the second half of pregnancy plasma levels 
of placental lactogens increase (Cohick et al., 1996; Southard and Talamantes, 1991). The 
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dominance of oestradiol, together with the drop of progesterone and increase of PRL at the 
end of pregnancy are important hormonal adaptations which prime the neural circuits 
within the medial preoptic area (MPOA) and the bed nucleus of the stria terminalis (BNST) 
among others. These brain regions are also termed “maternal circuits” and facilitate the 
appropriate onset of maternal behaviour (Bridges and Ronsheim, 1990; Bridges et al., 1997, 
1996). 
Besides PRL, the neuropeptides oxytocin (OXT) and arginine-vasopressin (AVP) are released 
within this maternal circuits around parturition, facilitating the adequate onset of maternal 
behaviour (Numan et al., 1977; Pedersen and Prange, 1979; Pedersen et al., 1994, 1982). 
The OXT system also adapts during pregnancy and lactation in order to decrease stress 
responsiveness of the HPA axis (Slattery and Neumann, 2008), i.e. with elevated OXT release 
within the hypothalamus in response to a stressor (Bosch et al., 2004). In addition, changes 
in sizing and branching patterns of dendritic trees within the supraoptic (SON) and 
paraventricular nuclei (PVN), alterations of electrophysiological properties and changes in 
the synthetic and secretory activity of oxitocinergic neurons take place (for review see 
Neumann, 2003). All these adaptations provide a dynamic OXT system, which is highly 
responsive to stimuli in the context of reproduction, i.e. labour and suckling of the pups, but 
attenuated in response to pharmacological, emotional or physical stressors (for reviews see 
Neumann, 2003; Slattery and Neumann, 2008). 
Similar adaptations during the peripartum period occur within the AVP system, described in 
more detail below (Chapter 1.8). Before going into detail with the AVP system, I will 
introduce the distinct maternal parameters, which can be observed in lactating laboratory 
rodents, and will especially refer to brain regions, which are involved in the modulation of 
maternal behaviour. 
 
1.1.3 Maternal care and “brain circuitry” 
Rodent mothers show a variety of distinct behaviours towards their pups to provide them 
with milk, warmth and protection against potential threats (for review see Bosch and 
Neumann, 2012). This care provided by the mother, i.e. maternal care, is one of the most 
important pro-social behaviours displayed by mammalian mothers and helps to raise the 
litter to maturity (for review see Bosch, 2011). Therefore, nest-building is an active, 
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voluntary aspect of maternal behaviour initiated by the dam and mediated via oestradiol, 
PRL, OXT and dopamine within the MPOA in rodents (for review see Numan and Insel, 2003). 
By licking and grooming their pups, rat mothers enable them to urinate and defecate. 
Further, it positively influences the social and emotional development of the offspring (Caldji 
et al., 1998; Champagne, 2008). This behaviour occurs very frequently during the first weeks 
of life, declining with the growth of the pups and their move to independence (for review 
see Numan and Insel, 2003). Another important parameter is nursing, which can be 
subdivided into various distinct nursing postures. The dams show blanket posture to keep 
the pups warm and safe while lying in a flat position above them. Furthermore, dams will 
also lay on their side or back during nursing, especially when the pups grow older. 
Sometimes dams also hover over their litter by resting on their hind limbs while being 
engaged in licking the pups or mouthing them. The most intense nursing position is termed 
arched back nursing (ABN; Figure 2), the only active nursing posture with the dam crouching 
over the pups in a quiescent kyphosis (Stern and Johnson, 1990). Depending on the angle of 
her back, one can distinguish between low crouch with a flat or slightly arched back, or high 
crouch with an intensely arched back and splayed legs (Stern, 1996), thereby ensuring the 
best possibility for all young (12 on average in Wistar rats (Rosen et al., 1987)) to have access 
to the 12 nipples (for review see Numan and Insel, 2003). 
 
  
Figure 2 Lactating rat engaged in arched back nursing (ABN). 
Dam showing ABN in either low crouch (left) or high crouch (right) position during quiescent kyphosis. 
 
Kyphosis can be seen as a reflex, which is induced by ventral stimulation caused by the 
nuzzling, rooting pups searching for the nipples (for review see Numan and Insel, 2003). 
Maintenance of this behaviour, including its relatively long upright crouch durations, 
depends of the suckling stimulus of the pups, which itself is not essential for the initiation of 
kyphosis (Stern and Johnson, 1990; Stern, 1991). 
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The tactile stimulus from the pups provides positive afferent input to the MPOA/BNST 
region, which facilitates maternal behaviour. Neurons within the dorsolateral MPOA and the 
ventral BNST (vBNST) form a functional system, called “maternal super-region” (for reviews 
see Bosch and Neumann, 2012; Numan and Insel, 2003), and are important for the 
regulation of maternal behaviour in rats (Numan and Numan, 1996). These neurons express 
oestrogen receptors, which bind oestradiol and lactogenic hormones, thereby facilitating the 
onset of maternal behaviour in rats (see above)(Bakowska and Morrell, 1997; Numan and 
Insel, 2003; Pfaff and Keiner, 1973). Further, the maternal super-region receives input from 
the medial amygdala, which is the relay site of olfactory information from the pups, and thus 
leading to a fear/avoidance response of pups in virgins or an attraction/approach circuit in 
dams (for reviews see Numan and Insel, 2003; Numan and Woodside, 2010). Another brain 
region projecting to the “maternal super-region” is the PVN (Ingram and Moos, 1992). The 
PVN is known to be important for the onset, but not the maintenance of established 
maternal care (Consiglio, 1996; Insel and Harbaugh, 1989; Numan and Corodimas, 1985). In 
addition, it is the main source of oxitocinergic, but also vasopressinergic projections to other 
brain regions (de Vries and Buijs, 1983). As both the OXT and the AVP system are increased 
in the peripartum period (see Chapter 1.8), they implicate a role in the regulation of 
maternal behaviour (Bosch and Neumann, 2008; Bosch et al., 2010; Neumann et al., 1993, 
2000; for review see Bosch and Neumann, 2012). 
 
1.1.4 Pup retrieval and “brain circuitry” 
During the period when pups depend on their mother, dams show retrieval behaviour if a 
pup is lying outside the nest. This describes mouthing the pups and carrying them back to 
the nest if they got scattered or if they are transported to a new nesting site. Pup retrieval is 
thought to reflect the dam’s motivation to retrieve the offspring to a single nesting-site and 
is described as a voluntary, proactive and goal-directed appetitive response of the mother 
(for review see Numan and Insel, 2003). As motivation is referred to an internal process that 
regulates changes in responsiveness to a constant stimulus, pup cues evoke this response in 
mothers. A study focussing on the brain regions involved in mediating maternal motivation 
found that lesions of the MPOA disrupts pup retrieval (Kalinichev et al., 2000). Further, the 
processing of information occurs via dopaminergic neurons projecting from the 
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MPOA/vBNST to the nucleus accumbens (NAc) (Numan and Numan, 1996) both directly and 
indirectly via synapses in the ventral tegmental area (for review see Numan and Insel, 2003). 
More specifically, lesion of the dorsolateral connections of the MPOA/vBNST by knife-cuts 
extinguishes pup retrieval (Numan et al., 1990). These findings provide insight in brain 
regions important in maternal motivation to retrieve pups, which are regulated via the 
neuropeptides OXT and AVP within the MPOA (Bosch and Neumann, 2008; Bosch et al., 
2010; Meddle et al., 2007)(see below for more details). 
 
1.1.5 Maternal aggression and “brain circuitry” 
Another adaptation occurring in the postpartum female is increased maternal aggression. 
This behaviour is not directed towards the pups (Peters et al., 1991), but against any 
potential threat, which could harm the offspring, like conspecifics.  
Maternal aggression can be distinguished from other forms of aggression, like predator 
aggression, territorial aggression, intermale aggression, defensive aggression or competitive 
aggression as the trigger to attack the opponent is a different one (Blanchard et al., 2003; 
Moyer, 1968). This can also be seen by the fact that lactating females show higher 
aggression towards a male intruder than non-lactating females (Erskine et al., 1980, 1978a). 
Maternal aggression first occurs at the end of pregnancy, vanishes at parturition and peaks 
during the first week of lactation before declining afterwards (Caughey et al., 2011). During 
this time the dam shows a variety of offensive and defensive aggressive behaviours when 
confronted with an opponent (Bosch et al., 2005; Erskine et al., 1978a; for review see 
Lonstein and Gammie, 2002). In the laboratory, this can be tested in the maternal defence 
test (Neumann et al., 2001). The lactating mother, as resident, is confronted with an 
unfamiliar virgin female or male intruder, ideally about 10 % smaller than the resident (to act 
as an stressor but to prohibit a dominance over the resident; for review see Bosch, 2013). 
This encounter leads to a defensive reaction of the intruder followed by aggressive 
behaviours of the residents (Blanchard et al., 2001; Haney et al., 1989). Aggressive 
behaviours shown by the resident include offensive behaviours like attacks, which are 
normally directed towards the neck or the back of an intruder, sometimes paired with bites. 
Further, the dam displays threat behaviours, e.g. pushing the intruder from the side termed 
“lateral threat”, or standing with all four paws on top of the intruder, termed “keep down” 
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(Figure 3). Also boxing the intruder in an “offensive upright” position and “aggressive 
grooming” of the intruder are considered threat behaviours. Species-specific cues lead to 
termination of aggression, i.e. defensive behaviour in rats. Thus, as soon as the intruder 
shows submissive behaviour, the residents’ attacks and threats decrease/stop. 
 
   
Figure 3 Lactating dam engaged in threat behaviours during the maternal defence test. 
Resident dam showing lateral threat (left), keep down (middle) and offensive upright (right) against a virgin 
female intruder (marked with black stripes). 
 
A variety of extrinsic and intrinsic factors contribute to the occurrence of maternal 
aggression (for review see Bosch, 2013). The main extrinsic factor is the offspring; the 
presence of the pups is essential for the initiation of maternal aggression (Gandelman and 
Simon, 1980). Short-term removal (4 to 5 hours) of the young decreases, but does not 
suppress, maternal aggression, whereas 24 hours or more do so (Erskine et al., 1978a; 
Ferreira and Hansen, 1986; for review see Lonstein and Gammie, 2002). Importantly, it is not 
the suckling stimulus per se, but the ventral somato-sensory stimulation (Stern and Kolunie, 
1993) and olfactory cues (Ferreira and Hansen, 1986; for review see Lonstein and Gammie, 
2002) from the pups, which are important for the onset and the maintenance of maternal 
aggression. 
Another main extrinsic factor is the intruder, which acts as a potential threat to the offspring 
and, therefore, is a critical threat which evokes maternal aggression in lactating rats to 
protect the offspring from infanticide (for review see Bosch, 2013). Depending on the age 
and size of the intruders, the mothers attack smaller intruders up to 80 %, whereas larger 
males receive only 30 % attacks (Erskine et al., 1978b; Flannelly and Flannelly, 1985). Also 
the sex of the intruder plays a role, with females being attacked more often than males 
(Haney et al., 1989); independent of their reproductive status (Neumann et al., 2001). 
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In addition to these factors, intrinsic factors also influence aggressive behaviour in lactating 
mothers. On the last days before parturition, aggression already increases, which depends 
on rising oestrogen, but not dropping progesterone, levels (Mayer and Rosenblatt, 1987; for 
review see Lonstein and Gammie, 2002). Adaptations in neuropeptidergic AVP (see below 
Chapter 1.8) and OXT systems during the peripartum period play a crucial role in the 
modulation of maternal aggression. In response to the maternal defence test, OXT release is 
increased within the PVN, central amygdala (CeA), BNST and lateral septum (LS), whereas 
increased neuronal activity and OXT receptor binding is found within the BNST and LS 
compared to non-aggressive controls immediately after the end of the test, lasting up to 45 
min (Caughey et al., 2011; Gammie and Nelson, 2001; for review see Bosch, 2013). 
Noteworthy, adaptations in the neuropeptide systems, i.e. increased OXT release in the LS in 
response to the maternal defence test strongly depends on the rat line used with Sprague 
Dawleys, but not Wistar, dams showing the effect (Bosch et al., 2004; for review see Bosch, 
2013). 
 
1.1.6 Maternal anxiety and “brain circuitry” 
The decreased anxiety in postpartum females is important to allow the dam to protect the 
offspring at the nest site (for review see Numan and Insel, 2003). A reduction in anxiety 
occurs directly after parturition and continues until mid-lactation, while being more anxious 
in late pregnancy, compared to virgin rats (Neumann et al., 2000; for review see Lonstein, 
2007). In order to achieve this hypoanxious state the dam must be able to assess the 
stressful stimulus or scenario and adequately cope with it (for review see Neumann et al., 
2010). Similar to maternal aggression, it is pup contact and not the suckling stimulus per se 
that facilitates this adaptation (Lonstein, 2005). Thus, dams separated 4 hours or more from 
their pups show no reduction in anxiety (Lonstein, 2005). Further, changes in the PRL, OXT 
and AVP systems are involved in the regulation of anxiety during lactation. For example, 
increased levels of central PRL (Torner et al., 2002), as well as of central OXT (Neumann et 
al., 2000; for review see Bosch, 2011), act anxiolytically, whereas central AVP exerts an 
anxiogenic action (Bosch and Neumann, 2008) during the postpartum period.  
Regarding the fact that dams are less anxious but highly aggressive during the first week 
postpartum, the increased expression of maternal aggression and protection of the offspring 
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may require a concomitant reduction in anxiety when facing the intruder (Hansen et al., 
1985; Lonstein, 2005). The brain regions and circuitries involved in the regulation of anxiety 
in lactating rats are still not completely understood but studies suggest an involvement of 
the periaqueductal gray (Lonstein et al., 1998) as well as the extended amygdala (Davis and 
Shi, 1999). Indeed, OXT receptor (Figueira et al., 2008) and γ-amino butyric acid (GABA)a 
receptor (Miller et al., 2010) antagonism in the ventrocaudal PAG increases anxiety-related 
behaviour in lactating rats. But also pharmacological blockade of V1aR within the BNST 
tended to decrease anxiety on the elevated plus maze (EPM) in lactating dams, suggesting an 
involvement of this part of the extended amygdala in the regulation of anxiety-related 
behaviour in rat dams (Bosch et al., 2010). Further, the corticotropin-releasing factor (CRF) 
system is known to be involved in the regulation of anxiety in the peripartum period, with 
central CRF receptor blockade eliciting an anxiolytic effect (Klampfl et al., 2013). In more 
detail, antagonism of the CRF receptors within the medial-posterior part of the BNST 
(mpBNST) leads to anxiolysis (Klampfl et al., 2014). Also the noradrenergic system is involved 
in the regulation of anxiety by releasing noradrenalin into the BNST in response to aversive 
stimuli. In lactating female rats this response is blunted by disinhibiting GABAergic output 
cells as response to pup contact, resulting in attenuated anxiety (Smith et al., 2013; for 
review see Lonstein, 2007). 
Although other neurotransmitter systems are implicated in the regulation of maternal 
anxiety and the other maternal parameters, the main interest in my thesis is the impact of 
the AVP system on maternal behaviour; therefore, I will focus on AVP in the remainder. 
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1.2 The brain AVP system 
In the last decades AVP has not only been linked to the regulation of the hypothalamo-
pituitary-adrenal (HPA) axis and anxiety, but also to the facilitation of a wide range of social 
behaviours including pair bonding, parental care and aggression in rodents. 
 
1.2.1 AVP 
AVP was firstly isolated and synthesized in 1953, together with OXT (for review see 
Ottenhausen et al., 2015). Both are nonapeptides forming a ring structure, linked by a 
disulphide bridge connecting two cysteines. AVP differs only in two amino acids at position 3 
and 8 from OXT; AVP contains phenylalanine instead of isoleucine in the ring and arginine 
instead of leucine in the side branch (Figure 4). 
 
 
Figure 4 Molecular structure of the nonapeptides vasopressin and oxytocin 
The peptides only differ in two out of nine amino acids (highlighted in blue) formed to ring structure by a 
disulphide bridge (S-S). 
Arg = arginine, Asn = asparagine, Cys = cysteine, Gln = glutamine, Gly = glycine, Ile = isoleucine, Leu = leucine, 
NH2 = amidogen, Phe = phenylalanine, Pro = proline, Tyr = tyrosine. 
 
Both hormones are products of several enzymatic cleavage steps. In case of AVP, the 
primary protein precursor preprovasopressin is cleaved into a signal peptide and 
provasopressin. After translation and several modification steps, provasopressin is further 
cleaved into the active nonapeptide itself, neurophysin II protein and the copeptin 
glycopeptide (Gainer, 1983; Russell et al., 1980; Sachs et al., 1969). Neurophysin II ensures 
the proper targeting, packing and storage of AVP before release into the bloodstream 
(Ginsburg and Ireland, 1966). The exact function of the copeptin remains unknown although 
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it is a stable biomarker for pathologies linked to AVP like stress, diabetes, heart failure and 
myocardial infarction in human diagnostics (Bolignano et al., 2014; Pozsonyi et al., 2015; 
Reinstadler et al., 2015; Urwyler et al., 2015; Wannamethee et al., 2015; for review see 
Yilman et al., 2015). 
The cleavage process takes place within the Golgi complex of neurone cell bodies in the 
hypothalamic SON and PVN, where neurosecretory granules containing the prohormone are 
formed. The cleavage products pass down nerve axons to be stored in the posterior 
pituitary, where they are released from nerve terminals after stimulation into the blood 
(Brownstein et al., 1980) but also centrally from cell bodies and dendrites of magnocellular 
neurons of the SON (Ludwig, 1998). In addition, AVP is also synthesized centrally within the 
suprachiasmatic nucleus (SCN), the olfactory bulb and the LS, among others. In the brain, 
AVP mediates a wide range of behaviours linked to social behaviours (see Chapter 1.7), 
emotionality, learning and memory but also circadian rhythms (Laycock et al., 2010). 
Further, its importance in HPA axis regulation in response to stress is generally accepted 
(Aguilera et al., 2008). Thereby, AVP exerts its effect on all three different levels of the HPA 
axis, the hypothalamus, the pituitary as well as the adrenals (for review see Zelena et al., 
2015). Whereas former studies in AVP-deficient Brattleboro rats supported the theory of 
AVP being the predominant regulator of the HPA axis response during chronic stress 
(Aguilera et al., 2008, 1994), recent studies also hint to a role of AVP after acute stressor 
exposure (Makara et al., 2012; for review see Zelena et al., 2015). On the level of the 
hypothalamus an increased AVP mRNA concentration was observed within the PVN during 
chronic stress (Aguilera et al., 1994). In addition, AVP was found to compensate for CRF 
effects in HPA axis regulation (for review see Scott and Dinan, 2002). Interestingly, the 
response of the HPA axis to stressors is attenuated in human, but also in rodent, mothers 
towards the end of pregnancy and in lactation (Heinrichs et al., 2001; Neumann et al., 2000, 
1998a). Instead, these females show a basal hyper-corticism (Brunton and Russell, 2003; 
Neumann et al., 1998a), enhanced sensitivity of the pituitary to AVP (Toufexis et al., 1999) 
and a down-regulation in the brain CRF system (Klampfl et al., 2013; Neumann et al., 1998b; 
Walker et al., 2001) among other factors involved in the change in stress sensitivity (Slattery 
and Neumann, 2008). 
Besides central and neurohypophysial functions, AVP is synthesized in the periphery, i.e. 
within the sympathetic ganglia, the adrenals, ovaries and testis among others (Laycock et al., 
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2010). Indeed AVP was originally known as antidiuretic hormone, leading to increased blood 
pressure and water permeability in renal nephrons. In addition, AVP was found to play a role 
in thermoregulation (Richmond, 2003) and in cardiac function (Wasilewski et al., 2015). 
 
1.2.2 AVP receptors 
AVP mediates its action via three receptors, the V1a, V1b (formerly V3) and the V2 subtypes. 
Whereas the V1 receptor subtypes are mostly found both centrally and peripherally, the V2 
receptor is distributed exclusively in the periphery; mainly within the kidney. There, V2 
receptors in the collecting ducts and the loop of Henle are responsible for free water 
reabsorption (for reviews see Laycock and Hanoune, 1998; Verbalis, 2009). The main focus in 
this thesis is on the V1 receptors, which I want to further describe in the following. 
V1a receptors (V1aR) are mainly distributed in the central nervous system, where they have 
been identified within the hippocampus, BNST and PVN among others (Figure 5).  
V1b receptors (V1bR) are mainly found within the adenohypophysis on corticotroph cells, 
where they mediate adrenocorticotropic hormone (ACTH) secretion, especially under 
chronic stress conditions (Volpi et al., 2004a, 2004b). Within the brain the receptor-subtype 
is distributed throughout brain regions like the hippocampus, thalamus, MPOA and 
amygdala (Hernando et al., 2001; Lolait et al., 1995) among others (Figure 5). 
Both V1 receptors are G-protein coupled receptors (GPCRs) of the 1b family. Thus, they have 
a similar basic structure, which consists of seven transmembrane helices, connected by 
three intracellular and three extracellular loops, with two cysteine residues forming a 
disulfide bridge (for review see Bockaert and Pin, 1999). 
The primary signalling pathway linked to the receptors has been well-characterised: Gq/G11 
for both V1 receptors (Laycock et al., 2010; Thibonnier et al., 1997; Wange et al., 1991). 
In detail, the Gαq protein activates phospholipase C, which results in the hydrolysis of 
phosphatidylinsositol-4,5-bisphosphate into two 2nd messengers (Kirk et al., 1981; Michell et 
al., 1979); namely inositol triphosphate (IP3) and diacylglycerol (Laycock et al., 2010). IP3 can 
diffuse into the cytosol and bind to calcium channels in the plasma membrane of the 
endoplasmatic reticulum, followed by the release of calcium from its intracellular storage or 
via calcium dependent channels (Dayanithi et al., 2000; Levy et al., 1990). In return, in the 
presence of calcium, diacylglycerol can activate protein kinase C which than phosphorylates 
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further protein substrates. Additionally, the released calcium can bind to calmodulin, which 
activates calcium/calmodulin-dependent kinases (Laycock et al., 2010). These kinases have 
the ability to phosphorylate cyclic adenosine monophosphate response element binding 
protein (CREB), which stimulates the expression of genes by recruiting a coactivator, thus 
resulting in new protein synthesis.  
Regarding the V1bR, the signalling pathway is similar to that of V1aR. In addition to coupling 
to a Gq/G11 protein, V1bR have also been found to recruit Gs and Gi proteins, but only in 
transfected cells, rendering the physiological importance of such mechanisms unclear 
(Birnbaumer, 2000; Laycock et al., 2010; Thibonnier et al., 2001). 
 
 
Figure 5 Distribution of V1 receptors in the rat brain 
Adapted from (Griebel et al., 2005) 
Acc = nucleus accumbens, AON = anterior olfactory nucleus, AP = area postrema, Astr = amygdalostriatal area, 
AthN = anteroventral thalamic nucleus, BlA = basolateral amygdala, BNST = bed nucleus of the stria terminalis, 
CA1 = hippocampal field CA1, CA2 = hippocampal field CA2, CA3 = hippocampal field CA3, CeA = central 
amygdala, CingCx = cingulate cortex, CoA = cortical amygdaloid nucleus, Cpu = caudate/putamen, DBB = 
diagonal band of Broca, DG = dentate Gyrus, FrCx = frontal cortex, FStr = fundus striati, Hab = medial habenula, 
HyN = hypoglossal nucleus, IO = inferior olive, LS = lateral septum, ME = median eminence, MeA = median 
amygdala, MFB = medial forebrain bundle, MM = medial mammillary nucleus, MPA = medial preoptic area, NST 
= nucleus of the solitary tract, OT = olfactory tubercle, Ovasc = organum vasculosum laminae terminalis, Pa = 
paraventricular hypothalamic nucleus, ParCx = parietal cortex, Pe = periventricular hypothalamic nucleus, PG = 
pineal gland, Pit = pituitary gland, SCN = suprachiasmatic nucleus, SFN = septofimbrial nucleus, SFO = 
subfornical organ, SON = supraoptic nucleus, St = stigmoid nucleus, TSN = triangular septal nucleus, tt = taenia 
tecta, Tz = trapezoid body, VCN = ventral cochlear nucleus 
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Under physiological conditions, V1 receptors are thought to be expressed in a steady state 
within the membrane. Thus, the combination of receptor synthesis, proteolytic degradation, 
internalisation and recycling back to the membrane occurs until binding of the hormone or 
an analogue (Bowen-Pidgeon et al., 2001; Fishman et al., 1985; Koshimizu et al., 2012; 
Laycock et al., 2010). This cycle was indeed shown to be true for V1aR, being primarily 
located in the plasma membrane (Innamorati et al., 2001). A very recent study on the V1bR 
showed an adapted mechanism for the receptor-subtype in cell culture (Kashiwazaki et al., 
2015); a high number of V1bR within the cytoplasm, as well as an agonist-dependent 
mechanism of V1bR internalization was found. Thus, the binding affinity, receptor 
expression and internalization of V1bR is different to V1aR, which seems to be necessary 
during stress conditions to deal with the augmented AVP release (Kashiwazaki et al., 2015). 
 
1.2.3 The central AVP system in social behaviours 
AVP and its V1 receptors have been implicated in various social behaviours (Bosch and 
Neumann, 2008; Insel and Young, 2001; Landgraf et al., 1995). In male prairie voles, AVP is 
responsible for the pair bond formation; inhibition of AVP actions by blocking V1aR within 
the ventral pallidum of male prairie voles can lead to a suppression of pair bond formation 
(Barrett et al., 2013; Pitkow et al., 2001; Winslow et al., 1993; for review see Young and 
Wang, 2004). In addition, a recent study showed a link between epigenetic regulation of the 
V1aR gene in the retrosplenial cortex of prairie voles (which is linked to spatial memory) in 
relation to sexual fidelity trade-offs, i.e. if males stay closer to home and the partner, being 
more faithful (high V1aR expression) or if they enter neighboring territories to mate with 
additional females (low V1aR expression)(Okhovat et al., 2015). 
The role of AVP in social recognition was not only proved in prairie voles, but also in mice 
and rats (for review see Bielsky and Young, 2004). Antagonism of the V1aR in rats leads to 
social recognition deficits, and further studies evaluated primarily the septum to be the brain 
region mediating this effect (Engelmann and Landgraf, 1994; Engelmann et al., 1994; Everts 
and Koolhaas, 1997). V1aR downregulation via antisense oligodeoxynucleotides in the 
mediolateral septum of male rats leads to the inability to discriminate between a known and 
a novel conspecific (Landgraf et al., 1995). Further, the facilitatory role of AVP in intermale 
aggression is widely studied (Ferris, 2005; for review see Neumann et al., 2010). Orally 
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administered V1aR (Ferris et al., 2006) or V1bR antagonist (Blanchard et al., 2005) decreased 
aggression in a resident-intruder test in male Syrian hamsters. A study by Wersinger et al. in 
V1bR knockout mice found, that these mice show reduced attack behaviour without deficits 
in predatory or defensive aggression (Wersinger et al., 2007). Thus, both V1aR and V1bR 
seem to be important for the coupling of social context to the display of the appropriate 
aggressive behaviour. 
AVP is also found to mediate parental behaviour in voles, rats, and mice (Bosch and 
Neumann, 2010, 2008; Bosch et al., 2010; Kessler et al., 2011; Wang et al., 1994). Due to the 
main focus on maternal behaviour in my thesis I want to introduce this pro-social behaviour 
in context with AVP in the following. 
 
1.2.4 The central AVP system in maternal and anxiety-related behaviour 
The AVP system in rats is activated around parturition when AVP mRNA expression (Landgraf 
et al., 1991; Walker et al., 2001) and AVP-ir (Caldwell et al., 1987) are increased. After birth, 
AVP is important for the onset (Pedersen et al., 1994, 1982) as well as the maintenance of 
maternal care in rodents (Bosch and Neumann, 2008; Bosch et al., 2010; Kessler et al., 2011). 
Further, increased AVP release during mother-pup interactions within the MPOA and BNST is 
observed in lactation (Bosch et al., 2010). 
Besides AVP itself, the brain V1aR adapt during the peripartum period. This takes the form of 
increased V1aR binding in brain areas important for the expression of maternal care in 
lactating rats compared to virgins (Bosch and Neumann, 2008; Bosch et al., 2010). In 
addition, activation or up-regulation of the V1aR facilitates maternal care, especially in brain 
regions like the MPOA and the BNST. In contrast, blockade or down-regulation of the V1aR 
via an receptor subtype-specific antagonist or antisense oligodeoxynucleotides decreases 
maternal care (Bosch and Neumann, 2008). Besides maternal care, V1aR are also involved in 
maternal motivation as down-regulation of V1aR within the MPOA decreases pup retrieval 
(Bosch and Neumann, 2008). Further, activation of V1aR results in increased maternal 
aggression in rat dams (Bosch and Neumann, 2010; Bosch et al., 2010; for review see Bosch 
and Neumann, 2012). The other way around, maternal aggression also causes increased 
V1aR-binding in the MeA in mid-lactation compared to parturition, but decreased V1aR-
binding in the PVN or CeA in early or late lactation compared to parturition, respevtively 
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(Caughey et al., 2011). The AVP system is also implicated in the regulation of maternal 
anxiety; infusion of synthetic AVP was shown to be anxiogenic whereas blockade of V1aR act 
anxiolytic on the EPM (Bosch and Neumann, 2008). 
As indicated above, the V1bR has only scarcely been investigated in relation with maternal 
behaviour to date. A single study showed decreased attack behaviour in V1bR knockout mice 
when confronted with an unfamiliar male intruder (Wersinger et al., 2007). 
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1.3 Animal model for extremes in anxiety-related behaviour 
Given the detrimental effects of postpartum mood disorders on both mothers and the 
offspring, investigating the underlying pathophysiology in animal models appears a 
beneficial approach. 
In 1993, the breeding of two rat lines for extremes in anxiety-related behaviour was started 
out of unselected Wistar rats (Liebsch et al., 1998). The most and least anxious rats, 
validated on the EPM at the age of 10 weeks, are re-bred within the same phenotype for 
following generations (avoiding sibling pairing). After several generations, rats showing a 
stable high anxiety-related behaviour (HAB) or low anxiety-related behaviour (LAB) 
phenotype on the EPM have established. In contrast to non-selected for anxiety-related 
behaviour (NAB) rats, which spent around 25-35 % on the open arms of the EPM, HABs spent 
less than 10 %, LABs more than 40 % on the open arms of the EPM, independent of sex 
(Neumann et al., 2011). The highly anxious phenotype of HAB males (Murgatroyd et al., 
2004) as well as females (Bosch and Neumann, 2008; Neumann et al., 2005) was found to 
rely on a single nucleotide polymorphism in the AVP promoter region (Murgatroyd et al., 
2004; for review see Landgraf et al., 2007), leading to increased AVP synthesis and release 
within the PVN (Keck et al., 2002; Wigger et al., 2004). This leads to increased AVP mRNA 
expression within the PVN (Bosch and Neumann, 2008; Bosch et al., 2006; Keck et al., 2002; 
Wigger et al., 2004), the BNST and the medial amygdala (Bosch and Neumann, 2010) 
compared to NAB and LAB rats. In addition, female HAB rats show increased CRF mRNA 
within the PVN compared to LAB rats (Bosch et al., 2006), which might also contribute to the 
hyper-anxious phenotype. 
The HAB and LAB phenotype has been stable over years (Beiderbeck et al., 2012; Bosch and 
Neumann, 2008; Landgraf and Wigger, 2002; Liebsch et al., 1998) and also between several 
laboratories (Salomé et al., 2002) thereby providing an ideal animal model for the 
investigation of the neurochemical basis of behaviour (Neumann et al., 2011).  
However, HAB rats do not only differ in their anxiety phenotype, but also in their stress-
coping strategy and depressive-like behaviour. In detail, HAB rats are characterized by a 
hyper-responsive HPA axis activity (Landgraf et al., 1999) and a more passive stress-coping 
strategy (Keck et al., 2003; Neumann et al., 2005), which is indicative of higher depressive-
like behaviour (Landgraf and Wigger, 2002). Thus, HABs show more floating in the forced 
swim test, increased risk assessment, and less exploration in a novel environment compared 
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to LAB rats (Bosch et al., 2006; Liebsch et al., 1998; Neumann et al., 2005; Ohl et al., 2001; 
Slattery and Neumann, 2010). 
Regarding social behaviours, the two breeding lines differ in their aggressive behaviour and 
also in maternal behaviour. In virgin females, HABs have been found to be more aggressive 
in the female intruder test compared to LABs or NABs (de Jong et al., 2014). In lactating 
females, HAB dams are more aggressive in the maternal defence test (Neumann et al., 2001) 
compared to LABs (Bosch et al., 2005; for review see Bosch, 2013). In contrast to HAB and 
LAB males, only HAB dams show higher aggression compared to NABs (and also to LABs), as 
seen by decreased attack latency, an increased number of attacks and threat behaviour (for 
review see Bosch, 2011). Importantly, HAB and LAB dams have not been described to attack 
vulnerable body parts of the intruder as this was seen in males (Beiderbeck et al., 2012). 
Interestingly, a correlation between the intensity of maternal behaviour and the dam’s 
innate anxiety was found in the HAB/LAB breeding lines (for review see Bosch, 2011).  
HAB dams are highly maternal compared to LAB dams (Bosch and Neumann, 2008; Bosch et 
al., 2010, 2006, 2005; Neumann et al., 2005); the high innate anxiety of HAB dams leads to a 
more protective mothering style, i.e. leaving the nest less often and showing more ABN as 
well as total nursing (Bosch and Neumann, 2008; Bosch et al., 2006; Neumann et al., 2005). 
Further, HAB dams retrieve their pups faster to the nest and also retrieve more pups in a 
novel environment (for review see Bosch, 2011), even under challenging conditions, for 
instance pups are located behind a metal curtain or the dams need to cross an unpleasant 
floor surface (Neumann et al., 2005).  
With the different anxiety and maternal phenotypes relying on the adaptation in the AVP 
system, studies in lactating HAB/LAB females help to understand the involvement of the 
neuropeptide AVP in the regulation of maternal behaviour. 
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1.4 The gonadotropin-releasing hormone (GnRH) and kisspeptin system in 
maternal behaviour 
In addition to OXT, PRL and AVP mediating maternal behaviour, also other neuropeptide 
systems like the GnRH system influence reproductive behaviour, e.g. the onset of puberty 
and mating behaviour (Yoon et al., 2005). The main function of GnRH is to facilitate the 
action of the hypothalamo-pituitary-gonadal (HPG) axis as it mediates sexual and 
reproductive behaviour by releasing steroids into the blood stream (Ellis, 2013). In detail, 
GnRH is synthesized from neurons in the hypothalamus and released at the median 
eminence into the hypophyseal portal system. At the pituitary level, GnRH facilitates the 
release of luteinising hormone (LH) and follicle stimulating hormone (FSH), which stimulate 
the testes or ovaries for steroid production, respectively. 
GnRH is released in pulses before binding to its receptor, GnRH receptor type I (shortly 
referred to as GnRH receptor), which is present in both humans and rats (Millar, 2005). 
Interestingly, GnRH neurons have been found in many of the brain areas described above in 
connection to maternal behaviour including the MPOA, the amygdala, and the arcuate 
nucleus (ARC; Bosch and Neumann, 2010; Bosch et al., 2010; Ehret et al., 1993; Moss and 
Foreman, 1976; Numan and Insel, 2003; Pi and Grattan, 1999; Yoon et al., 2005). However, 
there is only one study to date describing a role of GnRH in maternal behaviour. In detail, 
transgenic mice with a 30 % reduction in GnRH neurons have severe impairments not only in 
reproduction and parturition (Tsai et al., 2005), but also fail to retrieve and nurse their pups 
appropriately (Brooks et al., 2012). 
A pilot study performed in transgenic rats expressing an AVP-enhanced green fluorescent 
protein (eGFP) fusion gene (Ueta et al., 2005) showed increased AVP immunoreactivity (ir) 
within the organum vasculosum of the lamina terminalis (OVLT) of lactating dams compared 
to virgins (Y. Ueta, V. Grinevich, O. Bosch, unpublished observation). Interestingly, when 
staining the same region for GnRH expression, and creating an overlay, a co-expression of 
AVP and GnRH seems to exist (Figure 6), suggesting that both systems may interact or 
oppose each others effects. 
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Figure 6 Expression of AVP and 
GnRH-ir in the organum vasculosum 
of the lamina terminalis (OVLT) of a 
lactating AVP-eGFP reporter rat. 
Single stainings for eGFP signal 
(upper left), AVP (VP; upper right) 
and GnRH (lower left) in the OVLT of 
a lactating rat. The overlay (lower 
right) shows a co-expression of AVP- 
and GnRH-positive cells. 
 
 
Furthermore, in non-transgenic ovariectomized, hormonally primed rats priming induced an 
increased AVP-ir within the OVLT compared to control rats (Figure 7). These preliminary 
results further strengthen the implication of GnRH in mediating maternal behaviour. 
 
 
Figure 7 AVP immunoreactivity 
within the organum vasculosum 
of the lamina terminalis of 
primed female rats 
Ovariectomized, hormone-treated 
virgin rats show increased AVP-
immunoreactivity (ir) compared 
to control rats. 
3v: third ventricle, VP-IR: AVP-ir 
 
In addition to the overlap with the AVP system, GnRH interacts with the kisspeptin system. 
Kisspeptin has been shown to stimulate GnRH neurons to release the neuropeptide into the 
plasma (Guerriero et al., 2012; Han et al., 2005; Liu et al., 2008). Kisspeptin neurons are also 
innervated by GnRH neurons, thus being a potential target for a role in maternal behaviour 
G e n e r a l  Introduction  27 
(Han et al., 2005; Kalló et al., 2013; Liu et al., 2008). Thus, co-expression of GnRH and AVP 
neurons within the OVLT of lactating rats may also be triggered by the kisspeptin system. 
Interestingly, kisspeptin was not investigated in the context of maternal behaviour so far. It 
is known to mainly influence reproduction and especially integrates signals about the 
metabolic status to the reproductive axis (for review see d’Anglemont de Tassigny and 
Colledge, 2010). 
Taken together, GnRH and kisspeptin represent strong candidates to promote maternal 
behaviour besides the neuropeptides OXT and AVP. 
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1.5 Aim of the thesis 
Given the outlined knowledge on peripartum adaptations occurring in preparation for birth 
and lactation, the critical involvement of the different components of the AVP system in 
maternal behaviour in rats is obvious. Although AVP and its V1aR are highly studied, the 
contribution of V1bR is only poorly investigated so far. In addition, the GnRH and kisspeptin 
system seems to be potentially linked to play a role in maternal behaviour, but is hardly 
investigated in this context at all. 
Therefore, the aim of my thesis was: 
1. To outline the involvement of brain V1bR on different aspects of maternal behaviour 
in lactating Wistar rats. 
2. To investigate the distinct role of V1bR in the maternal super-region, i.e. the MPOA 
and the BNST in the regulation of maternal behaviour. 
3. To assess the effects of both, V1aR and V1bR antagonism in the PVN on maternal 
behaviour. 
4. To determine a potential role of the GnRH as well as the kisspeptin system in 
maternal behaviour of lactating Wistar rats. 
5. To study the involvement of V1bR in maternal behaviour of lactating HAB and LAB 
dams. 
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Chapter 2 
Central V1b Receptor Antagonism in Lactating Rats:  
Impairment of Maternal Care But Not of Maternal Aggression 
 
Authors’ contribution: 
Doris Bayerl: experimental design, performance of experiments, data analysis, first 
draft of manuscript 
Stefanie Klampfl: performance of experiments, revision of manuscript 
Oliver Bosch: experimental design, performance of experiments, revision of 
manuscript 
 
Taken and partly adapted from: Bayerl DS, Klampfl SM, Bosch OJ (2014) Central V1b receptor 
antagonism in lactating rats: impairment of maternal care but not of maternal aggression. J 
Neuroendocrinol 26(12):918-26. 
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2.1 Abstract 
Maternal behaviour in rodents is mediated by the central OXT and AVP systems, amongst 
others. The role of AVP, acting via the V1aR, on maternal care and maternal aggression has 
recently been described. However, a potential involvement of the V1bR in maternal 
behaviour has only been demonstrated in knockout mice. 
The present study aimed to examine the effects of central pharmacological manipulation of 
the V1bR on maternal behaviour in lactating Wistar rats. On PD 18, female rats were 
implanted with a guide cannula targeting the lateral ventricle. After parturition, dams 
received an acute central infusion of a specific V1bR agonist (d[Leu4,Lys8]VP) or V1bR 
antagonist (SSR149415) once daily, followed by observations of maternal care [lactation day 
(LD) 1], maternal motivation in the pup retrieval test (PRT; LD 2), anxiety-related behaviour 
on the EPM (LD 3) and maternal aggression in the maternal defence test followed by 
maternal care monitoring (LD 4). 
Our data demonstrate that, under non-stress conditions, the V1bR antagonist decreased the 
occurrence of both nursing and mother–pup interaction, whereas the V1bR agonist did not 
affect either parameter. Under stress conditions (i.e. after the maternal defence test), 
mother–pup interaction was decreased by infusion of the V1bR antagonist. During the 
maternal defence test, neither treatment affected aggressive or non-aggressive behaviour. 
Finally, neither treatment altered maternal motivation or anxiety.  
In conclusion, central V1bR antagonism modulates aspects of maternal care but not of 
maternal aggression or maternal motivation in lactating rats. These findings further extend 
our knowledge on the AVP system as a vital mediator of maternal behaviour. 
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2.2 Introduction 
Maternal behaviour is crucial for the well-being and development of the offspring, as well as 
for protection against potential threats (e.g. infanticide by conspecifics) (for reviews see 
Bosch and Neumann, 2012; Numan and Insel, 2003). In addition to the neuropeptide OXT, 
the closely-related AVP has also been shown to mediate maternal care and maternal 
aggression in lactating rats (for review see Bosch and Neumann, 2012). The majority of these 
effects have been linked to activation of the V1aR (for reviews see Bosch and Neumann, 
2012; Bosch, 2013) but not of the V1bR. 
Around parturition, the brain AVP system in rats becomes activated, as indicated by 
increased AVP mRNA expression (Landgraf et al., 1991; Walker et al., 2001) and AVP-ir 
(Caldwell et al., 1987). During mother–pup interactions, the release of AVP is increased 
within the MPOA and the BNST (Bosch et al., 2010), which are brain areas that are 
importantly involved in mediating maternal behaviour (Bosch et al., 2010; for reviews see 
Bosch and Neumann, 2012; Bosch, 2011; Numan and Insel, 2003). AVP facilitates the onset 
(Pedersen et al., 1994, 1982), as well as the maintenance, of maternal care in both rats 
(Bosch and Neumann, 2008; Bosch et al., 2010) and mice (Kessler et al., 2011). Furthermore, 
V1aR binding is increased in brain areas important for the expression of maternal care in rat 
dams compared to virgins (Bosch and Neumann, 2008; Bosch et al., 2010). Moreover, V1aR 
activation promotes maternal aggression in lactating rats (Bosch and Neumann, 2010; Bosch 
et al., 2010; for review see Bosch and Neumann, 2012). However, whether the V1bR plays a 
role in maternal care and/or maternal aggression has not been studied so far. 
The V1bR was initially found in the adenohypophysis on the surface of corticotroph cells, 
which mediate ACTH secretion (Koshimizu et al., 2012). Here, the main function of the V1bR 
is regulation of hypothalamic-pituitary-adrenal axis activity at the pituitary level, under both 
resting and stress conditions (Tanoue et al., 2004). In the brain, the V1bR is expressed in 
various regions of the hypothalamus and limbic system (Laycock et al., 2010). Some of these 
regions have been implicated in the regulation of maternal care and maternal aggression, 
such as the BNST and the MPOA, as described above (Caughey et al., 2011; for review see 
Bosch, 2013). Interestingly, maternal aggression is reduced in lactating V1bR knockout mice 
(Wersinger et al., 2007), which indicates a potential involvement of the V1bR in mediating 
maternal behaviour. However, compensatory mechanisms may underlie the observed 
phenotype, such as OXT acting on the V1bR (Koshimizu et al., 2012), meaning that a 
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pharmacological approach is necessary to determine the role of the V1bR in maternal 
behaviour. In addition to the BNST and MPOA, the V1bR is also found in the septum and the 
amygdala (Hernando et al., 2001), which play an active role not only in maternal behaviour, 
but also in anxiety-related behaviour. Indeed, the V1bR antagonist SSR149415 increases the 
time mice spend on the open arms of the EPM, which is indicative of an anxiolytic effect 
(Griebel et al., 2002). 
In the present study, we aimed to characterise the role of the central V1bR in maternal and 
anxiety-related behaviour in lactating rats via bidirectional pharmacological manipulation. 
One day after parturition (i.e. LD 1), dams received once daily acute intracerebroventricular 
(icv) infusions of vehicle (VEH), a specific V1bR agonist (d[Leu4, Lys8]VP), or a specific V1bR 
antagonist (SSR149415) for four consecutive days. Maternal care was monitored under non-
stress conditions (LD 1), as well as after an acute psychosocial stressor, namely the maternal 
defence test (LD 4). Moreover, maternal motivation in the PRT (LD 2), maternal aggression 
during the maternal defence test (LD 4) and anxiety-related behaviour on the EPM (LD 3) 
were assessed. 
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2.3 Material and methods 
2.3.1 Animals 
All rats were maintained under a 12 : 12 h light/dark cycle (lights on 07.00 h) at 22 ± 1 °C and 
55 ± 5% relative humidity, with free access to water and standard rat chow. 
Virgin female Wistar rats (12–14 weeks, 220–250 g; Charles River, Sulzfeld, Germany) were 
mated with sexually experienced stud Wistar males and pregnancy was confirmed the next 
day by the presence of sperm in vaginal smears [assigned as PD 1]. Rats were housed in 
groups of three to four until PD 18, when they underwent surgery. Subsequently, they were 
single-housed in plexiglass observation cages (38 x 22 x 35 cm³) to ensure undisturbed 
parturition. Prior to (PD 16–17) and after (PD 19–21) surgery, rats were handled twice daily 
to familiarise them with the infusion procedure and to minimise stress-related behavioural 
reactions (Neumann et al., 1998a). All of the rats gave birth on PD 22 or 23. On the day of 
parturition, offspring were culled to eight pups of mixed sexes. At the same time, half of the 
bedding was replaced with new bedding to avoid any disturbance of the mother during the 
experiment. Virgin female Wistar rats (10 weeks, 180–220 g; Charles River) at random stages 
of their oestrous cycle were used as intruders in the maternal defence test. They were kept 
group-housed in a separate room until the behavioural testing to avoid olfactory recognition. 
All experiments were conducted in accordance with the European Communities Council 
Directive (86/609/EEC) and were approved by the local government of the Oberpfalz, 
Bavaria. 
 
2.3.2 Implantation of an icv guide cannula 
On PD 18, female rats were implanted with a stainless steel guide cannula (21 G, length 12 
mm), 2 mm above the right lateral ventricle (1.0 mm posterior, 1.6 mm lateral to bregma, 
2.0 mm ventral) (Paxinos and Watson, 1998) under semi-sterile conditions. Briefly, rats were 
anaesthetised with the inhalation narcotic isoflurane (Baxter Germany GmbH, 
Unterschleißheim, Germany) and placed on a thermo pad (32 °C) to minimise core body 
temperature loss. The guide cannula was fixed with dental cement (Kallocryl, Speiko, 
Münster, Germany) to two stainless steel screws, which were inserted into the skull. The 
cannula was closed with a stainless steel dummy cannula of the same length as the guide 
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cannula. At the end of the surgery, rats received 0.12 ml of the antibiotic Enrofloxacin 
(Baytril 2.5%; Bayer Vital GmbH, Leverkusen, Germany) subcutaneously to prevent 
inflammation. 
 
2.3.3 Infusion of receptor-specific V1bR agonist or V1bR antagonist 
Starting on LD 1, dams received daily one acute infusion of VEH (5 µl; Ringer’s solution + 5% 
dimethyl sulphoxide), the receptor-specific V1bR agonist d[Leu4,Lys8]VP (50 ng/5 µl) (Pena 
et al., 2007a) or the receptor-specific V1bR antagonist SSR149415 (500 ng/5 µl) (Serradeil-Le 
Gal et al., 2002) 10 min prior to behavioural testing. The dose of the V1bR antagonist was 
based on previous studies (Salomé et al., 2006; Stemmelin et al., 2005), whereas the dose of 
the V1bR agonist matched one-tenth of the V1bR antagonist. The treatments were 
administered over 20 s via a 10-µl Hamilton syringe connected to an injection system 
consisting of an infusion cannula (25 G, length 14 mm, i.e. 2 mm exceeding the guide 
cannula) on a polyethylene tube 20 cm in length. 
 
2.3.4 Experimental schedule 
The experimental schedule is presented in Figure 8.  
 
 
Figure 8 Experimental schedule.  
PD, pregnancy day; LD, lactation day; EPM, elevated plus maze. Dotted lines represent PD19 until PD21. 
 
On LD 1, maternal care was observed in the home cage under ‘non-stress’ conditions before 
and immediately after treatment infusion at 10.00 h for 1 h, as well as in the afternoon 
between 15.00 h and 16.00 h. On LD 4, maternal care was monitored for 1 h in the morning 
before moving the rats to the maternal defence test room, as well as 1 h immediately after 
termination of the maternal defence test, which served as an acute psychosocial stressor for 
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the lactating mother (‘stress’ conditions) (Neumann et al., 2001). To distinguish LD 4, on 
which the stress of the maternal defence test was included, from LD 1, we use the term 
‘non-stress’ conditions for LD 1, although we are aware of the minimal amount of stress 
associated with the infusion procedure. Additionally, dams were tested for maternal 
motivation in the PRT on LD 2, for anxiety-related behaviour on the EPM on LD 3 and for 
maternal aggression in the maternal defence test on LD 4 (for details, see below). 
Importantly, the dams were moved to separate rooms and given 1 h for habituation before 
treatment infusion and testing. All tests were performed in the light cycle between 09.00 h 
and 12.00 h. 
 
2.3.5 Behavioural tests 
2.3.5.1 Maternal care observation in the home cage 
Maternal care was observed in the home cage according to an established protocol (Bosch 
and Neumann, 2008; Klampfl et al., 2013). In detail, the behaviour of the mother was 
monitored every 2 min for approximately 10 s at 30-min intervals. The behaviours scored 
were nursing including ABN as the only active nursing posture of the mother (Stern and 
Johnson, 1990) and blanket posture (i.e. lying passively on top of the pups) (for review see 
Bosch, 2011), as well as mother–pup interaction, which includes all nursing postures, 
licking/grooming the pups and carrying the pups. 
 
2.3.5.2 Maternal motivation in the PRT 
In the PRT, dams were tested for their motivation to retrieve their own eight pups in a novel 
environment (van Leengoed et al., 1987) according to an established protocol (Bosch and 
Neumann, 2008; Neumann et al., 2005). Naturally, the motivation to retrieve the pups 
during this early phase of lactation is very high (for review see Bosch, 2011). One hour prior 
to testing, pups were separated from their mothers at the time when dams were transferred 
to the experimental room. During the separation period, pups were kept on a thermo pad 
(32 °C) in a different room than the dams. Subsequently, pups were brought to the 
experimental room and distributed in a white plastic box (54 x 34 x 32 cm³) prepared with a 
handful of bedding from the home cage. Ten minutes after infusion of the treatment, the 
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dam was placed in the middle of the box and the time of retrieval and number of retrieved 
pups was scored during the 15-min test period. After termination of the test, the dam was 
placed back into her home cage together with her pups. 
 
2.3.5.3 Maternal aggression in the maternal defence test 
In the maternal defence test, the dams (residents) received their respective treatment 
infusion 10 min prior to introducing a virgin female rat (intruder) into their home cage in the 
presence of the pups (Bosch et al., 2005; Neumann et al., 2001; for review see Bosch, 2013). 
During the 10-min testing period, the behaviour was video-taped for subsequent analysis by 
an experienced observer blind to the treatment. The behaviours scored were attacks and 
threat behaviours, which consist of offensive upright (the dam stands in an upright position 
in front of the intruder), keep down (the mother keeping the intruder down with her front 
paws), lateral threat (the mother engages to push the intruder aside by approaching laterally 
with her whole body) and aggressive grooming (for review see Bosch, 2013). Further, non-
aggressive behaviours were scored, including sniffing the intruder, exploration of the cage, 
maternal care, eating/drinking and self-grooming.  
One resident did not show any aggressive behaviour and was excluded from the statistical 
analysis. All other residents showed attacks and keep down behaviour, whereas two 
residents from the VEH group did not show any lateral threat behaviour. 
After termination of the test, the virgin intruders were removed from the residents’ home 
cage. Intruders were used only once per day, as well as only twice during the experiment, 
with at least 1 day in between for recovery. 
 
2.3.5.4 Anxiety-related behaviour on the EPM 
Anxiety-related behaviour was tested on the EPM as described previously (Bosch and 
Neumann, 2008; Liebsch et al., 1998; Pellow et al., 1985). Briefly, the plus-shaped maze 
consisted of two open arms (50 x 10 cm²; 90 lux) and two closed arms (50 x 10 cm²; height of 
walls: 30 cm; 10 lux) connected by a neutral zone (10 x 10 cm²; 65 lux) and was elevated 80 
cm over the floor. This test is based on the rats’ aversion of open areas combined with their 
exploratory drive, which results in an approach–avoidance conflict behaviour (Handley and 
McBlane, 1993; Pellow et al., 1985). Ten minutes after infusion of the treatment, the dams 
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were placed in the neutral zone facing a closed arm and were allowed to freely explore the 
maze for 5 min. Behaviours were scored live by an observer who was blind to treatment via 
a camera located above the EPM. The percentage of time spent on the open arms (time on 
the open arms versus all arms) and the percentage of entries into the open arms (entries 
into the open arms versus all arms) were counted as measures of anxiety-related behaviour, 
whereas the number of closed arm entries accounted for locomotion (Neumann et al., 
2000). 
 
2.3.6 Verification of guide cannula placement 
At the end of the experiments, rats were sacrificed with CO2 and infused with 5 µl of ink 
with an infusion cannula via the implanted guide cannula. Brains were removed and cut with 
a razor blade at the implantation site of the cannula. If the ventricles were coloured blue, 
the cannula placement was considered as correct. 
 
2.3.7 Statistical analysis 
Statistical tests were performed using SPSS, version 20 (IBM, Ehningen, Germany). Only rats 
with correctly implanted cannula were included in the statistical analysis. 
Maternal care and maternal motivation were analysed using a two-way ANOVA for repeated 
measures (factors: treatment x time). Maternal aggression, number of retrieved pups and 
anxiety-related behaviour were analysed using a one-way ANOVA (factor: treatment). The 
ANOVAs were followed by Sidak post-hoc correction if main effects were found.  
Data are presented as the mean + SEM. p < 0.05 was considered statistically significant. 
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2.4 Results 
2.4.1 Maternal care was reduced by V1bR antagonism under non-stress conditions 
On LD 1 under non-stress conditions, ABN significantly differed over time (two-way ANOVA 
for repeated measures, factor time: F2,36 = 4.786; p = 0.014; Figure 9A) but not depending on 
treatment, nor was there a treatment x time interaction. The post-hoc test revealed that 
V1bR antagonist-treated mothers showed increased ABN at t +60 min compared to t +30 
min (p = 0.028). 
 
 
Figure 9 Effects of V1b receptor (V1bR) manipulation on maternal care under non-stress conditions.  
The scored behaviours were arched back nursing (ABN; A), blanket nursing posture (blanket; B), as well as the 
sum of all nursing postures (nursing; C) and of all mother–pup interactions (D). The behaviours were observed 
before (basal) and for 60 min (t +30 min and t +60 min) after icv infusion of vehicle (VEH) (5 µl; Ringer’s 
solution + 5% dimethyl sulphoxide), V1bR agonist d[Leu4,Lys8]VP (V1bR-ago; 50 ng/5 µl) or V1bR antagonist 
SSR149415 (V1bR-A; 500 ng/5 µl).  
Data are presented as the mean + SEM (n = 7 per group). *p < 0.05 versus previous sample. 
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Blanket nursing differed over time (two-way ANOVA for repeated measures, factor time: 
F2,36 = 4.786; p = 0.014; Figure 9B) but was not affected by treatment, nor did we find a 
treatment x time interaction. The post-hoc test revealed a decrease at t +30 min compared 
to pre-injection (p = 0.008) in the V1bR antagonist-treated dams only. 
Nursing behaviour significantly differed over time (two-way ANOVA for repeated measures; 
factor time: F2,36 = 5.558; p = 0.008; Figure 9C) but was not affected by treatment, nor was 
there a treatment x time interaction. At t +30 min, the post-hoc test showed decreased 
nursing in the V1bR antagonist-treated dams compared to pre-injection (p = 0.008) and 
increased nursing at t +60 min compared to t +30 min (p = 0.05). The infusion did not 
influence nursing in the other groups. 
Mother–pup interaction significantly differed over time depending on treatment (two-way 
ANOVA for repeated measures; factor treatment x time: F4,36 = 2.651; p = 0.049; Figure 9D). 
In detail, the post-hoc test showed that, after injection of the V1bR antagonist, mother–pup 
interaction was significantly lower at t +30 min compared to pre-injection (p = 0.001). At  
t +60 min, it increased compared to t +30 min (p = 0.006) and therefore was no longer 
different from basal values. The infusion did not change mother–pup interaction in the other 
groups. 
We did not detect changes in any other pup-directed behaviour, and maternal care 
observation in the afternoon did not reveal any differences (data not shown). Furthermore, 
V1bR agonist injection did not alter any behaviour. 
 
2.4.2 Maternal care was altered by V1bR antagonism and agonism under stress 
conditions 
On LD 4 under stress conditions, the combination of treatment with the maternal defence 
test revealed a significant effect on ABN over time (two-way ANOVA for repeated measures, 
factor time: F2,36 = 13.242; p < 0.001; Figure 10A) but no effect of treatment. Statistical 
analysis did not show a treatment x time interaction. The treatment/maternal defence test 
combination did not affect the occurrence of ABN directly after infusion at t +30 min but was 
increased at t +60 min in the VEH- and the V1bR antagonist-treated mothers compared to 
the previous time-point. 
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However, blanket nursing significantly changed over time (two-way ANOVA for repeated 
measures, factor time: F2,36 = 23.342; p < 0.001; Figure 10B) but not depending on treatment. 
Statistical analysis did not show a treatment x time interaction. The post-hoc test revealed 
that after treatment/maternal defence test blanket nursing is reduced at t +30 min in V1bR 
antagonist- (p = 0.037) and V1bR agonist- (p = 0.015) but not in the VEH-treated mothers. 
The amount of blanket nursing increased in both V1bR-manipulated groups at t +60 min 
compared to the previous time-point (V1bR antagonist: p = 0.009, V1bR agonist: p = 0.004). 
 
 
Figure 10 Effects of V1b receptor (V1bR) manipulation on maternal care under stress conditions.  
The scored behaviours were arched back nursing (ABN; A), blanket nursing posture (blanket; B), as well as the 
sum of all nursing postures (nursing; C) and of all mother–pup interactions (D). The behaviours were observed 
before (basal) and for 60 min (t +30 min and t +60 min) immediately after the combined icv infusion and 
maternal defence test (for details, see Section 2.3.5.3). Dams received a 5 µl icv infusion of vehicle (VEH), 
V1bR agonist (V1bR-ago) or V1bR antagonist (V1bR-A) (for details, see Figure 9) 10 min prior to the maternal 
defence test.  
Data are presented as the mean + SEM (n = 7 per group). *p < 0.05; (*)p = 0.06 versus previous sample. 
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Nursing significantly changed over time (two-way ANOVA for repeated measures, factor 
time: F2,38 = 36.722; p < 0.001; Figure 10C) but not depending on treatment. There was no 
significant treatment x time interaction. The post-hoc test revealed that after treatment/ 
maternal defence test at t +30 min nursing decreased (V1bR antagonist: p = 0.01; V1bR 
agonist: p = 0.003) or tended to decrease (VEH: p = 0.066) compared to basal values. At t +60 
min, nursing increased again compared to t +30 min in all treatment groups (VEH: p = 0.016; 
V1bR antagonist: p = 0.002; V1bR agonist: p = 0.001). 
The occurrence of a mother–pup interaction significantly differed between the groups over 
time (two-way ANOVA for repeated measures, factor time: F2,36 = 36.035; p < 0.001; Figure 
10D) but not depending on treatment. Statistical analysis did not show a treatment x time 
interaction. The post-hoc test revealed that mother–pup interaction was significantly 
reduced after treatment/maternal defence test at t +30 min in V1bR antagonist- (p = 0.001) 
and V1bR agonist- (p = 0.004) but not in the VEH-treated dams. The occurrence of a mother–
pup interaction returned to pre-stress values at t +60 min (VEH: p = 0.036; V1bR antagonist: 
p = 0.001; V1bR agonist: p = 0.001) compared to t +30 min.  
We did not detect any other changes in pup-directed behaviour after treatment/maternal 
defence test (data not shown). 
 
2.4.3 Maternal motivation was not affected by V1bR manipulation 
Maternal motivation as measured by number of retrieved pups in the PRT on LD 2 increased 
over time (two-way ANOVA for repeated measures, factor time: F14,266 = 15.34; p < 0.001; 
Figure 11) but was not altered by any treatment. Statistical analysis did not show a 
treatment x time interaction.  
 
 
Figure 11 Effects of V1b receptor (V1bR) manipulation on 
maternal motivation in the pup retrieval test.  
Following a 60-min separation, pups were distributed in a 
new cage and the retrieval of pups was recorded (for 
details, see Section 2.3.5.2). The dams received a 5 µl icv 
infusion of vehicle (VEH), V1bR agonist (V1bR-ago) or V1bR 
antagonist (V1bR-A) (for details, see Figure 9) 10 min prior 
to the test.  
Data are presented as the mean + SEM (n = 7–8 per group). 
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There was no difference in the latency to initiate pup retrieval (VEH: 590 ± 120 s, V1bR 
antagonist: 450 ± 128 s, V1bR agonist: 577 ± 98 s), nor in the total number of retrieved pups 
(VEH: 2.6 ± 1.0, V1bR antagonist: 3.4 ± 1.2, V1bR agonist: 3.6 ± 1.2). 
 
2.4.4 Maternal aggression was not altered by V1bR manipulation 
During the maternal defence test on LD 4, the number of attacks, as well as the occurrence 
of threat behaviours (keep down, lateral threat; Figure 12), did not differ between the 
groups.  
Furthermore, no effects of treatment were seen in the occurrence of offensive upright 
posture or aggressive grooming (data not shown). Other aggressive, as well as non-
aggressive, behaviours (exploration, sniffing, self-grooming, maternal care, eating/drinking) 
did not differ between the groups (data not shown). 
 
 
Figure 12 Effects of V1b receptor (V1bR) manipulation on maternal aggression in the maternal defence test. 
Lactating mothers (residents) were exposed to virgin female rats (intruders) in the presence of their pups for 
10 min. The number of attacks (left) and the time spent on the threat behaviours keep down (middle) and 
lateral threats (right) are shown. The dams received a 5 µl icv infusion of vehicle (VEH), V1bR agonist (V1bR-
ago) or V1bR antagonist (V1bR-A) (for details, see Figure 9) 10 min prior to the test.  
Data are presented as mean + SEM (n = 5–7 per group). 
 
 
2.4.5 Anxiety-related behaviour was not altered by V1bR manipulation 
None of the treatments altered anxiety-related behaviour on LD 3 as measured as 
percentage of time spent on the open arms (VEH: 47.1 ± 6.6; V1bR antagonist: 59.3 ± 6.3; 
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V1bR agonist: 46.4 ± 9.9) or percentage of entries into the open arms of the EPM (VEH: 50.7 
± 4.4; V1bR antagonist: 50.2 ± 4.4; V1bR agonist: 47.4 ± 4.6). Furthermore, the number of 
closed arm entries as a measure of locomotion was not affected by any treatment (VEH: 9.5 
± 1.4; V1bR antagonist: 11.0 ± 1.4; V1bR agonist: 10.4 ± 1.3). 
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2.5 Discussion 
In the present study, we demonstrate that central V1bR play a critical role in the mediation 
of maternal care but probably not maternal aggression. Under both non-stress and stress 
conditions, central blockade of the V1bR reduced the occurrence of nursing and mother–pup 
interactions. By contrast, neither manipulation altered maternal motivation, maternal 
aggression or anxiety-related behaviour.  
In the peripartum period, AVP system activity is up-regulated in the maternal brain. In 
lactating rats, AVP mRNA expression and/or AVP-ir in the PVN (Bosch et al., 2007; Caldwell et 
al., 1987; Walker et al., 2001) and AVP release within distinct brain regions are increased 
(Bosch and Neumann, 2012; Landgraf et al., 1991). These adaptations are necessary to 
provide adequate maternal behaviour (Caldwell et al., 1987; Landgraf et al., 1991; Walker et 
al., 2001). An involvement of AVP in the regulation of maternal-like behaviour was first 
suggested by Pedersen et al. (Pedersen et al., 1982), who demonstrated that an acute icv 
AVP infusion in ovariectomized, steroid-primed virgin female rats is capable of inducing pup 
retrieval and promotes maternal care, as indicated by crouching over the pups as well as 
licking/grooming. They extended their finding to V1aR in the MPOA, where local infusion of a 
specific V1aR antagonist in parturient rats delays the onset of maternal care (Pedersen et al., 
1994). Furthermore, our group demonstrated a peptide-specific involvement of the brain 
AVP system both centrally and locally within the MPOA in maternal care (Bosch and 
Neumann, 2008). This result confirmed that such effects are mediated directly via the V1aR, 
rather than an off-target effect via the OXT receptor (Pedersen et al., 1994). For example, 
maternal care is impaired after local down-regulation of V1aR expression via antisense 
oligodeoxynucleotide infusion, and improved after local V1aR up-regulation via an adeno-
associated viral vector within the MPOA (Bosch and Neumann, 2008). Regarding maternal 
aggression, central (for review see Bosch and Neumann, 2012) or local manipulations in the 
CeA (Bosch and Neumann, 2010) or BNST (Bosch et al., 2010) could demonstrate that such 
pup-defence behaviour is impaired after blocking V1aR. By contrast, V1aR blockade during 
late lactation in multiparous Sprague–Dawley rats revealed an increased attack duration 
(Nephew et al., 2010) suggesting that parity may be important for the role of the V1aR in 
such behaviours. However, there are almost no data available on a potential role of the 
V1bR in the regulation of maternal care and maternal aggression. 
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V1bR are widely distributed in the brain, and have been identified in the hypothalamus and 
numerous limbic areas in male rats (Hernando et al., 2001) where V1bR are assumed to 
mediate social behaviour (Lolait et al., 1995; Wersinger et al., 2002; for review see 
Stevenson and Caldwell, 2012). Importantly, some of these brain regions form part of the 
maternal brain circuitry, such as the PVN, BNST and MPOA (for reviews see Bosch and 
Neumann, 2012; Numan and Insel, 2003). To date, only one study has examined the role of 
central V1bR in maternal behaviour (Wersinger et al., 2007). Wersinger et al. demonstrated 
that female V1bR knockout mice are less maternally aggressive than wild-type mice 
(Wersinger et al., 2007). However, compensatory mechanisms involving, for example, the 
OXT system (Koshimizu et al., 2012) are likely to determine the phenotype of the V1bR 
knockout mice. Therefore, and as a result of the importance of the AVP system for the 
behavioural expression of maternal behaviour, we aimed to investigate the role of central 
V1bR in maternal care and maternal aggression of lactating Wistar rats using a 
pharmacological approach. 
In the present study, we could show that maternal care was reduced by central blockade of 
V1bR under non-stress conditions. More specifically, blanket nursing, total nursing and 
mother–pup interactions were significantly reduced after acute V1bR blockade.  
These findings are similar to the observation that central V1aR antagonism impairs ABN 
(Bosch and Neumann, 2008). These studies suggest a crucial but subtly different role for 
both V1R subtypes in the regulation of maternal care. Additionally, we investigated the 
effects of a psychosocial stressor, the maternal defence test (Neumann et al., 2001), in 
combination with central V1bR manipulation on maternal care. Exposure to the maternal 
defence test is known to reduce maternal care immediately after termination of the test 
(Klampfl et al., 2013). Indeed, when comparing the pre-stressor exposure with the 30 min 
immediately after the combined treatment/maternal defence test, we found that central 
administration of the V1bR antagonist reduced the amount of blanket nursing, total nursing 
and mother–pup interaction. A similar trend was also observed in the VEH group. Therefore, 
inhibition of V1bR under stress conditions may prohibit adequate stress coping, which leads 
to decreased mother–pup interaction. Moreover, these dams returned to pre-stress levels of 
nursing and interaction with their pups 60 min after termination of the maternal defence 
test. This could be explained by the short half-life of the V1bR antagonist SSR149415, which 
is active for at least 30 min when administered i.v. in rats (Oost et al., 2011). Although we 
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used a different route of administration and central half-life might not be identical with 
peripheral half-life, the duration of central actions (at least on maternal care) might be 
restricted to a similar time frame.  
In addition to its vital effects on maternal care, the brain AVP system is also involved in the 
regulation of maternal aggression (for review see Bosch, 2013). AVP release within the CeA is 
increased during the maternal defence test in dams showing high levels of maternal 
aggression (Bosch and Neumann, 2010). In confirmation, blockade of V1aR within the CeA 
reduces the aggression level in these dams, whereas V1aR activation increases such 
behaviour in low aggressive dams (Bosch and Neumann, 2010) (additional details are 
provided elsewhere (for review see Bosch, 2013, 2011)). Furthermore, similar effects were 
found within the BNST, where V1aR blockade decreases maternal aggression in lactating rats 
compared to VEH-treated mothers (Bosch et al., 2010). By contrast, we did not find 
significant changes in aggressive behaviour via central V1bR activation or blockade, 
suggesting no (or at most a minor) role of V1bR in mediating pup defence. Interestingly, 
there is evidence for the involvement of V1bR in aggressive behaviour from studies in 
lactating V1bR knockout mice; such dams show less attacks, as well as a longer attack 
latency, towards a male conspecific compared to wild-type mice (Wersinger et al., 2007). In 
male Syrian hamsters, orally administered V1bR antagonist reduces aggression in a resident–
intruder paradigm (Blanchard et al., 2005). However, these studies reflect aggression either 
in knockout mice or in males, which cannot be compared to maternal aggression in rats 
because the genetic background and the reason for attacking the opponent are different 
(Blanchard et al., 2003; for reviews see Bosch, 2013; Neumann et al., 2010). 
Similar to maternal aggression, we did not find any effect of treatment on maternal 
motivation in the PRT. However, this does not exclude a role for V1bR in maternal 
motivation. For example, central blocking of V1aR does not change pup retrieval, whereas 
local reduction of MPOA V1aR expression via antisense reduces pup retrieval (Bosch and 
Neumann, 2008). Hence, the lack of behavioural effects not only on maternal motivation, 
but also on maternal aggression might be a result of the icv approach; the V1bR antagonist 
and V1bR agonist might not have reached brain regions involved in the tested maternal 
behaviours in sufficient amounts, highlighting the need to perform studies with various 
doses tested for their behavioural relevance. Furthermore, treatments infused locally act in 
a highly restricted area, whereas icv infused drugs diffuse almost throughout the entire 
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brain, thereby acting on various brain regions, which might influence the behaviour in 
opposing directions. Consequently, the behavioural outcome reflects the integration of all 
the effects in those brain regions, which might mimic a lack of behavioural changes (for 
review see Bosch, 2013, 2011). 
In the present study, no differences were found in anxiety-related behaviour on the EPM. 
However, systemic administration of the V1bR antagonist, SSR149415, has been described to 
result in an anxiolytic phenotype (Griebel et al., 2005). This discrepancy appears to depend 
on the animal model, route of administration, experimental design and also on the targeted 
brain area because previous studies were conducted in males and via local or oral 
administration (Griebel et al., 2002; Litvin et al., 2011; Salomé et al., 2006; Serradeil-Le Gal 
et al., 2002; Stemmelin et al., 2005). For example, in male Sprague–Dawley rats, SSR149415 
acts anxiolytically when applied orally (Griebel et al., 2002; Serradeil-Le Gal et al., 2002) or 
infused into the basolateral amygdala (Salomé et al., 2006) but not into the LS (Stemmelin et 
al., 2005). These findings suggest that SSR149415 needs to be applied peripherally to act on 
the pituitary V1bR, thereby affecting the stress axis and acting anxiolytically (Shimazaki et al., 
2006), or locally into a specific brain region (Salomé et al., 2006). 
Because this is one of the first behavioural studies using both the V1bR antagonist 
SSR149415 (Serradeil-Le Gal et al., 2002) and V1bR agonist d[Leu4, Lys8]VP (Pena et al., 
2007a), it is important to note that both treatments are highly specific for the V1bR in rats 
(Griebel et al., 2002; Pena et al., 2007a, 2007b; Serradeil-Le Gal et al., 2002) (see also a study 
on human cell culture (Griffante et al., 2005)). This is of particular interest because blocking 
or activating the V1bR might influence other neuropeptide systems, which may underlie the 
observed outcomes. For example, if V1bR are insufficiently expressed or knocked out, 
thereby resembling receptor inhibition, OXT receptors can partly take over the stress-
induced ACTH release (Nakamura et al., 2008). Furthermore, studies in V1bR knockout mice 
suggest that OXT can act on V1bR (Koshimizu et al., 2012). Because OXT is a major regulator 
of maternal behaviour (for review see Bosch and Neumann, 2012), these studies show a 
partial incorporation of other receptors with AVP, which could also be the case in the 
present study. This strongly suggests that central V1bR manipulation might not be 
sufficiently specific to assess the role of this receptor in all aspects of maternal behaviour. 
Therefore, the role of this system needs further investigation with respect to local 
manipulations of V1bR in lactating rats. 
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In conclusion, this is the first study to demonstrate a role for V1bR in lactating rats with 
respect to maternal care, further emphasizing the importance of the brain AVP system in the 
regulation of maternal behaviour. V1bR antagonism reduced various parameters of maternal 
care but not of maternal aggression, suggesting an exclusive role of V1bR in direct mother–
pup interaction. Interestingly, the behavioural effects after V1bR manipulation were not as 
prominent as they were after V1aR activation/inhibition (Bosch and Neumann, 2008). 
Furthermore, studies investigating local manipulations of the V1bR in specific brain areas 
crucially involved in mediating maternal behaviour are warranted. 
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Chapter 3 
Maternal behaviour in two breeding lines for extremes in anxiety – 
past and present observations in HAB/LAB dams  
with special focus on V1b receptors 
 
Doris Bayerl: experimental design, performance of experiments, data analysis 
Stefanie Klampfl: performance of experiments 
Oliver Bosch: experimental design, performance of experiments 
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3.1 Abstract 
The animal model of extremes in trait anxiety is commonly used to investigate 
neurobiological mechanisms of anxiety disorders and depression not only in males, but also 
in females. In lactating HAB and LAB rats studies provide evidence for increased maternal 
behaviour in hyper-anxious HAB compared to hypo-anxious LAB dams, which is connected to 
the elevated AVP expression and release in HAB dams. Blockade of the V1aR within HAB 
dams lead to an impairment of maternal behaviour. To investigate the involvement of V1bR 
in both breeding lines, we infused lactating HAB and LAB dams acutely icv with specific V1bR 
agonist and antagonist and observed subsequent maternal behaviour. Overall, no effect of 
treatment was detected in any group on any maternal behaviour. Maternal care, pup 
retrieval and maternal anxiety were higher in HAB dams compared to LAB dams, as 
described before. Surprisingly, maternal aggression was not higher in HAB dams, but equal in 
both breeding lines, with elevated threat behaviour in LAB dams.  
Follow-up studies investigating maternal behaviour in non-manipulated HAB and LAB dams 
of subsequent generations show a shift in maternal aggression, with LAB dams becoming 
hyper-aggressive, even showing forms of abnormal aggression. Maternal care, pup retrieval 
and maternal anxiety were not changed. Potential changes in AVP and V1aR remain to be 
investigated. 
In summary, V1bR seem not to be involved in the regulation of maternal behaviour in rats 
bred for extremes in trait anxiety; although site specific manipulations should be performed 
to confirm this. In addition, the maternal aggression phenotype of LAB dams changed in 
subsequent breedings over the last 3 years, now exceeding the aggression level of HAB 
dams. 
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3.2 Introduction 
The successful rearing of offspring strongly depends on the mothers’ amount of care giving, 
i.e. nursing and protection of her young. Especially in mothers suffering of postpartum 
depression or anxiety disorders, insufficient attention and a loss of interest towards the 
offspring is commonly observed. Among 10 – 22 % of mothers experience postpartum 
depression whereas postpartum anxiety disorders have an incidence of 5 – 12 %. These 
forms of postpartum mood disorders are hard to distinguish as they have most symptoms in 
common. Postpartum anxiety disorder is mainly diagnosed by a hyper-protective mothering-
style, also called “helicopter-parenting” (for review see Hillerer et al., 2014). 
This over-protective mothering style is characteristic in the HAB rat breeding line. The 
counterpart, LAB dams provide only low levels of maternal behaviour. These different 
phenotypes are referred to differences in the AVP system. The highly anxious phenotype of 
the HAB rats is based on an a single nucleotide polymorphism (SNP) in the AVP promoter 
region (Murgatroyd et al., 2004; for review see Landgraf et al., 2007), leading to increased 
AVP synthesis and release within the PVN (Keck et al., 2002; Wigger et al., 2004). This results 
in increased AVP mRNA expression within the PVN (Bosch and Neumann, 2008; Bosch et al., 
2006; Keck et al., 2002; Wigger et al., 2004), the BNST and the medial amygdala (Bosch and 
Neumann, 2010) of male and female HAB rats compared to NAB and LAB rats. Thus, both 
breeding lines serve as animal models to investigate the neuronal basis of dysregulation in 
neuropeptides and the resulting maternal behaviour.  
Regarding maternal behaviour, the hyper-anxious HAB rats differ in almost all aspects from 
hypo-anxious LAB dams (Bosch and Neumann, 2008; Bosch, 2011; Bosch et al., 2010, 2006, 
2005; Neumann et al., 2005). Despite their hyper-anxiety, HAB dams, show higher amount of 
maternal care, which is reflected by increased ABN and total nursing compared to LAB dams 
(Bosch and Neumann, 2008; Bosch et al., 2006; Neumann et al., 2005). In the conventional 
PRT (see 3.2.5.2), HAB dams retrieve their scattered pups faster and also generally retrieve 
more pups compared to LAB dams (Neumann et al., 2005; for review see Bosch, 2011). Due 
to the hyper-protective mothering style of HAB dams, an aggressive phenotype in the 
maternal defence test is described by a decreased attack latency, an increased number of 
attacks and more threat behaviour compared to LAB dams (Bosch et al., 2005; for review see 
Bosch, 2013, 2011). Noteworthy, LAB dams were even shown to be less aggressive than NAB 
dams, similar to what was seen in maternal care (for review see Bosch and Neumann, 2012; 
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Bosch, 2011). This is in contrast to males, where both breeding lines are more aggressive 
than NAB males, LAB males even showing “abnormal” forms of aggression, e.g. attacking 
vulnerable body parts of the intruder (Beiderbeck et al., 2012). 
Taking all these differences of HAB/LAB dams together, a correlation between the intensity 
of maternal behaviour and the dam’s innate anxiety was found in each breeding line (for 
review see Bosch, 2011). 
Maternal behaviour is known to be mediated, at least in part, via AVP and its two distinct 
brain receptors, the V1aR and the V1bR (Bayerl et al., 2016, 2014; for review see Bosch and 
Neumann, 2012, 2008). Due to the increased AVP system in HAB rats, targeting the V1R in 
lactating dams is of special interest. In earlier studies an involvement of the V1aR was 
already demonstrated, as central infusion of a V1aR antagonist decreases the high levels of 
maternal care in HAB dams. In addition, central administration of synthetic AVP in less 
maternal LAB dams increases ABN (Bosch and Neumann, 2008). The level of maternal 
aggression was found to be correlated with AVP release within the amygdala in HAB, but not 
in LAB dams, i.e. AVP release increased during the maternal defence test in HAB dams only 
(Bosch and Neumann, 2010). However, local administration of a V1aR antagonist within the 
CeA decreases maternal aggression in HAB dams, whereas local synthetic AVP in LAB dams 
increases their aggressive behaviour towards an virgin female intruder (Bosch and Neumann, 
2010). 
So far, an involvement of V1bR in the differences of maternal behaviour in HAB and LAB 
dams was not investigated. Due to our results obtained from icv manipulated NAB dams 
(Chapter 2), an involvement of V1bR in the modulation of maternal behaviour was proved. 
Therefore, our aim was to determine the effects of central V1bR manipulation on maternal 
behaviour in lactating HAB/LAB dams, predicting effects on maternal care, especially by 
using V1bR antagonist in HAB dams and V1bR agonist in LAB dams. As we found similar 
aggression levels within the VEH-treated HAB and LAB dams, we analyzed data of maternal 
defence tests in non-manipulated dams of subsequent generations to observe the potential 
changes in maternal behaviour, with special focus on maternal aggression, over the past 
three years. 
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3.3 Material & Methods 
3.3.1 Animals 
Virgin female HAB and LAB rats of our own breeding (12–14 weeks, 220–250 g; University of 
Regensburg, Regensburg, Germany) were mated with sexually experienced NAB stud Wistar 
males and pregnancy was confirmed the next day by the presence of sperm in vaginal 
smears (assigned as PD 1). Rats were housed in groups of three to four until PD 18, when 
rats underwent surgery. On PD 18, rats were single-housed in plexiglass observation cages 
(38 x 22 x 35 cm³) to ensure undisturbed parturition. All of the rats gave birth on PD 22 or 
23. On the day of parturition, offspring were culled to eight pups of mixed sexes. At the 
same time, half of the bedding was replaced with new bedding to avoid any disturbance of 
the mother during the experiment.  
Virgin female Wistar rats (10 weeks, 180–220 g; Charles River) at random stages of their 
oestrous cycle were used as intruders in the maternal defence test. They were kept group-
housed in a separate room until the behavioural testing to avoid olfactory recognition.  
All rats were maintained under a 12:12 h light/dark cycle (lights on 07.00 h) at 22 ± 1 °C and 
55 ± 5% relative humidity, with free access to water and standard rat chow 
All experiments were conducted in accordance with the European Communities Council 
Directive (86/609/EEC) and were approved by the local government of the Oberpfalz, 
Bavaria. 
 
3.3.2 Implantation of an icv guide cannula 
On PD 18, female rats were implanted with a stainless steel guide cannula (21 G, length 12 
mm), 2 mm above the right lateral ventricle (1.0 mm posterior, 1.6 mm lateral to bregma, 
2.0 mm ventral) (Paxinos and Watson, 1998) under semi-sterile conditions under isoflurane 
(Baxter Germany GmbH, Unterschleißheim, Germany) inhalation anaesthesia as described 
before (Bayerl et al., 2014; Klampfl et al., 2013)(also see 2.3.2). To prevent inflammation, 
rats received 0.12 ml of the antibiotic Enrofloxacin (Baytril 2.5%; Bayer Vital GmbH, 
Leverkusen, Germany) subcutaneously at the end of surgery. 
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3.3.3 Infusion of receptor-specific V1bR agonist or V1bR antagonist 
Prior to (PD 16–17) and after (PD 19–21) surgery, rats were handled twice daily to familiarise 
them with the infusion procedure (Neumann et al., 1998a) Starting on LD 1, dams received 
one acute infusion of VEH (5 µl; Ringer’s solution + 5% dimethyl sulphoxide), the receptor-
specific V1bR agonist d[Leu4,Lys8]VP (50 ng/5 µl) (Pena et al., 2007a) or the receptor-specific 
V1bR antagonist SSR149415 (500 ng/5 µl) (Serradeil-Le Gal et al., 2002) on each 
experimental day 10 min prior to behavioural testing (Bayerl et al., 2014). The treatments 
were administered over 20 s via a 10-µl Hamilton syringe connected to an injection system 
consisting of an infusion cannula (25 G, length 14 mm, i.e. 2 mm exceeding the guide 
cannula) on a polyethylene tube 20 cm in length. 
 
3.3.4 Experimental schedule 
The experimental schedule was equivalent to testing V1bR agonist and antagonist in non-
selected Wistar rats (see Chapter 2). Briefly, on LD 1, maternal care was observed in the 
home cage under ‘non-stress’ conditions before and immediately after treatment infusion. 
On LD 4, maternal care was monitored for 1 h in the morning before moving the rats to the 
maternal defence test room, as well as 1 h immediately after termination of the maternal 
defence test, which served as an acute psychosocial stressor for the lactating mother 
(‘stress’ conditions) (Neumann et al., 2001). To distinguish LD 4, on which the stress of the 
maternal defence test was included, from LD 1, we use the term ‘non-stress’ conditions for 
LD 1, although we are aware of the minimal amount of stress associated with the infusion 
procedure. Additionally, on LD 2 the dam’s maternal motivation was tested in the PRT. 
Anxiety-related behaviour on the EPM was assessed on LD 3 and maternal aggression in the 
maternal defence test was measured on LD 4. All tests were performed in the light cycle 
between 09.00 h and 12.00 h. 
 
3.3.5 Behavioural tests 
3.3.5.1 Maternal care observation in the home cage 
Maternal care was observed in the home cage according to an established protocol (Bayerl 
et al., 2014; Bosch and Neumann, 2008). In detail, the behaviour of the mother was 
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monitored every 2 min for approximately 10 s at 30-min intervals. The behaviours scored 
were nursing including ABN (high crouch posture + low crouch posture) as the only active 
nursing posture of the mother (Stern and Johnson, 1990) and blanket posture (i.e. lying 
passively on top of the pups) (for review see Bosch, 2011), as well as mother–pup 
interaction, which includes all nursing postures, licking/grooming the pups and carrying the 
pups. 
 
3.3.5.2 Maternal motivation in the PRT 
In the modified PRT (also see 4.3.5.2 and (Bayerl et al., 2016)), dams were tested for their 
motivation to retrieve their own eight pups in a novel environment (van Leengoed et al., 
1987) according to an established protocol (Bosch and Neumann, 2008; Neumann et al., 
2005). Naturally, the motivation to retrieve the pups during this early phase of lactation is 
very high (for review see Bosch, 2011).  
In the afternoon of LD 2, dams were provided in their homecage with a potential nesting 
site, i.e. a red Perspex plastic house (13 x 17 x 11 cm³, opening 6 x 8.5 cm²; PLEXIGLAS® GS 
Rot 3C33, ThyssenKrupp Plastics GmbH, Regensburg, Germany; transparency: 13 %), which 
they were allowed to explore and to familiarize with for 150 min. On LD 3, pups were 
separated from their mothers one hour prior to testing, at the time when the red house was 
re-introduced and dams were transferred to the experimental room. During the separation 
period, pups were kept on a thermo pad (32 °C) in a different room than the dams. 
Subsequently, pups were brought to the experimental room and distributed in a black plastic 
box (54 x 34 x 60 cm³) prepared with a handful of bedding from the home cage. Ten minutes 
after infusion of the treatment, the house and subsequently the dam was placed in the box 
(t0) and the time of retrieval and number of retrieved pups was scored during the 15-min 
test period. After termination of the test, the dam was placed back into her home cage 
together with her pups. 
 
3.3.5.3 Maternal aggression in the maternal defence test 
The dams were transported to the test room 60 min before testing. The dams (residents) 
received their respective treatment infusion 10 min prior to introducing a virgin female rat 
(intruder) into their home cage in the presence of the pups (Bosch et al., 2005; Neumann et 
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al., 2001; for review see Bosch, 2013). Intruders were used only once per day as well as only 
twice during the experiment with at least one day in between for recovery. During the 10-
min testing period, aggressive behaviours, i.e. attacks and threat behaviours, which consist 
of offensive upright (the dam stands in an upright position in front of the intruder), keep 
down (the mother keeping the intruder down with her front paws), lateral threat (the 
mother engages to push the intruder aside by approaching laterally with her whole body) 
and aggressive grooming (for review see Bosch, 2013), were scored. Further, non-aggressive 
behaviours, including sniffing the intruder, exploration of the cage, maternal care, 
eating/drinking and self-grooming were assessed. After termination of the test, the virgin 
intruders were removed from the residents’ home cage. 
 
Due to the results of the maternal defence test (see below, Chapter 3.4.1.5.), we further 
controlled for maternal behaviour in HAB and LAB dams of subsequent breedings. These 
dams were observed under non-manipulated conditions, i.e. rats did not undergo surgery 
but were tested under the same experimental conditions as described above. 
 
3.3.5.4 Anxiety-related behaviour on the EPM 
Anxiety-related behaviour was tested on the EPM (Liebsch et al., 1998; Pellow et al., 1985) 
as described before (Bayerl et al., 2014; Bosch et al., 2010; Neumann et al., 2000). Briefly, 
the dams were transported to the separate EPM room 60 min prior to the test to allow 
habituation. The substances were infused 10 min before starting the test, when the dams 
were placed in the neutral zone of the EPM facing a closed arm and were allowed to freely 
explore the maze for 5 min. The percentage of time spent on the open arms (time on the 
open arms versus all arms) was taken as indicator for anxiety-related behaviour whereas the 
number of closed arm entries reflected locomotion (Neumann et al., 2000). Behaviours were 
scored live by an observer who was blind to treatment via a camera located above the EPM. 
 
3.3.6 Verification of guide cannula placement 
At the end of the experiments, rats were sacrificed with CO2 and those being implanted with 
icv guide cannula were infused with 5 µl of ink. Brains were removed and cut with a razor 
blade at the implantation site of the cannula. If the ventricles were coloured blue, the 
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cannula placement was considered correctly, and only those rats were included in statistical 
analysis. 
 
3.3.7 Statistical analysis 
Statistical tests were performed using SPSS, version 20 (IBM, Ehningen, Germany). 
For manipulated rats, maternal care and maternal motivation were analysed using a three-
way ANOVA for repeated measures (factors: breeding line x treatment x time). In cases 
where we a priori predicted specific outcomes, planned comparisons of specific contrasts 
within a breeding line were also performed (two-way ANOVA for repeated measures; 
factors: time x treatment). 
Maternal aggression and anxiety-related behaviour were analysed using a two-way ANOVA 
(factors: breeding line x treatment).  
For non-manipulated rats, maternal motivation was analysed using a two-way ANOVA for 
repeated measures (factors: breeding line x time). Maternal care, maternal aggression and 
anxiety-related behaviour were analysed using independent t-tests. If data were not 
distributed normally (Kolmogorov-Smirnov Test), a Mann-Whitney-U test was performed. 
The ANOVAs were followed by Sidak post-hoc correction if main effects were found. Data 
are presented as the mean + SEM. p < 0.05 was considered statistically significant. 
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3.4 Results 
3.4.1 V1bR manipulation in lactating HAB/LAB dams of generation #47 
3.4.1.1 Effects of V1bR agonism and antagonism on maternal care under non-stress 
conditions 
ABN differed significantly between breeding lines (three-way ANOVA for repeated measures; 
F1,32 = 42.15, p < 0.001; Figure 13A), but not depending on treatment or on time; no 
interactions were found. Planned comparisons, analyzing potential treatment effects in each 
breeding line separately revealed a time effect in LABs only (F4,72 = 2.72, p = 0.036); no 
treatment effect or time x treatment interaction was found. 
Splitting ABN in its two crouching behaviours, high crouch differed between breeding lines 
(F1,32 = 17.50, p < 0.001; Figure 13B), but not depending on treatment or on time; no 
interactions were found. Planned comparisons, analyzing potential treatment effects in each 
breeding line separately did not reveal any further differences. 
Low crouch also differed depending on breeding line (F1,32 = 42.54, p < 0.001) and over time 
(F4,128 = 3.06, p = 0.019), but not depending on treatment; no interactions were found (not 
shown). Planned comparisons, analyzing potential treatment effects in each breeding line 
separately revealed a time effect in LABs only (F4,72 = 4.27, p = 0.004); no treatment effect or 
time x treatment interaction was found. 
Blanket differed over time (F4,128 = 4.83, p = 0.001; Figure 13C), but not depending on 
breeding line or on treatment; no interactions were found. Planned comparisons, analyzing 
potential treatment effects in each breeding line separately revealed a time effect in LABs 
only (F4,72 = 4.60, p = 0.002); no treatment effect or time x treatment interaction was found. 
Nursing differed significantly depending on breeding line (F1,32 = 7.07, p = 0.012; Figure 13D) 
and over time (F4,128 = 6.62, p < 0.001), but not depending on treatment; no interactions 
were found. Planned comparisons, analyzing potential treatment effects in each breeding 
line separately revealed a time effect in LABs only (F4,72 = 5.94, p < 0.001); no treatment 
effect or time x treatment interaction was found. 
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Figure 13 Effects of V1b receptor (V1bR) manipulation in HAB and LAB dams on maternal care under non-
stress conditions.  
The behaviours shown are arched back nursing (ABN; A), high crouch (B), blanket nursing posture (blanket; C), 
as well as the sum of all nursing postures (nursing; D). The behaviours were observed before (basal) and for 
120 min in 30 min intervals after icv infusion of vehicle (VEH) (5 µl; Ringer’s solution + 5% dimethyl 
sulphoxide), V1bR agonist d[Leu4,Lys8]VP (V1bR-ago; 50 ng/5 µl) or V1bR antagonist SSR149415 (V1bR-A; 500 
ng/5 µl). 
Data are presented as the mean + SEM (n = 4 - 8). 
 
 
3.4.1.2 Effects of V1bR agonism and antagonism on maternal care under stress 
conditions 
ABN differed significantly under stress conditions between breeding lines (three-way ANOVA 
for repeated measures; F1,22 = 9.98, p = 0.005; Figure 14A) and over time (F2,44 = 6.04, p = 
0.005), but not depending on treatment; no interactions were found. Planned comparisons, 
analyzing potential treatment effects in each breeding line separately revealed a time effect 
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by trend in HABs only (F2,14 = 3.67, p = 0.052); no treatment effect or time x treatment 
interaction was found. 
Splitting ABN in its two crouching behaviours, high crouch differed between breeding lines 
(F1,22 = 7.35, p = 0.013; Figure 14B) and over time (F2,44 = 4.06, p = 0.024), but not depending 
on treatment; no interactions were found. Planned comparisons, analyzing potential 
treatment effects in each breeding line separately did not reveal any further differences 
Low crouch also differed between breeding lines (F1,22 = 9.14, p = 0.006) and over time (F2,44 
= 8.49, p = 0.001), but not depending on treatment; no interactions were found. Planned 
comparisons, analyzing potential treatment effects in each breeding line separately revealed 
a time effect in HABs only (F2,14 = 4.35, p = 0.034); no treatment effect or time x treatment 
interaction was found (not shown).  
Blanket differed between breeding lines (F1,22 = 4.96, p = 0.037; Figure 14C) and over time 
(F2,44 = 17.65, p < 0.001), but not depending on treatment; no interactions were found. 
Planned comparisons, analyzing potential treatment effects in each breeding line separately 
revealed a time effect in both breeding lines (HAB: F2,14 = 7.66, p = 0.006; LAB: F2,30 = 12.11, p 
< 0.001); no treatment effect or time x treatment interaction was found in any breeding line. 
Nursing differed significantly between breeding lines (F1,22 = 12.19, p = 0.002; Figure 14D) 
and over time (F2,44 = 19.82, p < 0.001), but not depending on treatment; no interactions 
were found. Planned comparisons, analyzing potential treatment effects in each breeding 
line separately revealed a time effect in both breeding lines (HAB: F2,14 = 15.12, p < 0.001; 
LAB: F2,30 = 9.51, p = 0.001); no treatment effect or time x treatment interaction was found in 
any breeding line. 
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Figure 14 Effects of V1b receptor (V1bR) manipulation in HAB and LAB dams on maternal care under stress 
conditions.  
The behaviours shown are arched back nursing (ABN; A), high crouch (B), blanket nursing posture (blanket; C), 
as well as the sum of all nursing postures (nursing; D). The behaviours were observed before (basal) and for 60 
min (t +30 min and t +60 min) immediately after the combined icv infusion and maternal defence test (for 
details, see Section 3.3.5.3). Dams received a 5 µl icv infusion of vehicle (VEH), V1bR agonist (V1bR-ago) or 
V1bR antagonist (V1bR-A) (for details, see Figure 13) 10 min prior to the maternal defence test.  
Data are presented as the mean + SEM (n = 3 - 7). 
 
 
3.4.1.3 Effects of V1bR agonism and antagonism on maternal motivation 
Maternal motivation measured in the modified PRT on LD 2 differed over time (three-way 
ANOVA for repeated measures; F15,435 = 102.29, p < 0.001), but not depending on breeding 
line or treatment; a time x breeding line interaction was found (F15,435 = 7.26, p < 0.001). No 
further interactions were analyzed (not shown). 
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Focussing on the VEH groups only (due to a missing treatment effect), retrieval behaviour 
differed over time (two-way ANOVA for repeated measures; F15,135 = 51.49, p < 0.001; Figure 
15), but not depending on the breeding line; a significant time x breeding line interaction 
was found (F15,135 = 6.27, p < 0.001). In detail, HAB dams retrieved significantly more pups 
from t10 onwards, whereas LAB dams already retrieved more pups from t7 onwards, 
compared to t0. 
 
 
Figure 15 Maternal motivation to retrieve pups of HAB and LAB dams (VEH groups) in the pup retrieval test.  
Following a 60-min separation, pups were distributed in the testing arena and the retrieval of pups was 
recorded (for details, see Section 3.3.5.2). 
Data are presented as the mean + SEM (n = 4 - 8). 
 
 
3.4.1.4 Effects of V1bR agonism and antagonism on maternal aggression 
Aggressive and non-aggressive behaviours were not influenced by any treatment during the 
maternal defence test in any breeding line.  
Depending on breeding line, differences were found in the latency for the first attack (two-
way ANOVA; F1,26 = 21.21, p < 0.001), keep down (F1,26 = 4.48, p = 0.046), lateral threat (F1,26 
= 14.72, p = 0.001), aggressive grooming (F1,26 = 9.24, p = 0.006) and sniffing (F1,26 = 11.18, p 
= 0.003) independent of treatment; no time x treatment interaction was found. 
Focussing on the VEH groups only (due to a missing treatment effect), separate statistics 
showed an increase in number of attacks by trend in LAB dams compared to HAB dams (t6 = -
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2.48, p = 0.067; Figure 16A). Further, significantly increased lateral threat behaviour was 
found in LAB dams compared to HAB dams (independent t-test; t6 = -2.46, p = 0.049; Figure 
16B). 
 
 
Figure 16 Effects of V1b receptor (V1bR) manipulation in HAB and LAB dams on maternal aggression in the 
maternal defence test. 
Lactating mothers (residents) were exposed to virgin female rats (intruders) in the presence of their pups for 
10 min. The number of attacks (A), the time spent on showing lateral threats (B) as well as the time spent on 
attacks plus threat behaviour as reflected in the sum of all aggressive behaviours (C) is shown. Additionally, 
sniffing the intruder was measured (D). The dams received a 5 µl icv infusion of vehicle (VEH), V1bR agonist 
(V1bR-ago) or V1bR antagonist (V1bR-A) (for details, see Figure 13) 10 min prior to the test.  
Data are presented as mean + SEM (n = 3 - 7). $ p ≤ 0.05, ($) = 0.067 vs. HAB VEH in separate statistics. 
 
 
3.4.1.5 Effects of V1bR agonism and antagonism on maternal anxiety 
Anxiety-related behaviour on the EPM differed depending on breeding line (three-way 
ANOVA; F1,31 = 24.94, p < 0.001; see Table 1), but was not affected by treatment; no 
breeding line x treatment interaction was found.  
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Locomotion did not differ between the breeding lines or depending on treatment; no 
breeding line x treatment interaction was found. 
 
Table 1 Effect of central V1bR manipulation in HAB and LAB dams on maternal anxiety  
 treatment dams [n] % time on open arm  closed arm entries [n] 
      HAB VEH 5 11.6 ± 1.9  7.0 ± 1.8 
 agonist 4   7.9 ± 1.5  6.8 ± 1.2 
 antagonist 5 18.9 ± 5.8  8.0 ± 1.3 
      
LAB VEH 5 48.9 ± 7.4  7.2 ± 0.7 
 agonist 8 36.9 ± 7.4  6.1 ± 0.9 
 antagonist 5 40.1 ± 9.5  6.6 ± 0.8 
Data are presented as mean ± SEM. 
 
 
3.4.2 Maternal behaviour in non-manipulated HAB/LAB dams of generation #50 
Maternal care was observed one hour in the morning on LD 1. We found that HAB and LAB 
dams differed significantly in their nursing behaviour. HAB dams showed more ABN 
compared to LAB dams (t39 = 4.14, p < 0.001; Figure 17A). Dividing ABN in high crouch and 
low crouch, both nursing positions are increased in HAB compared to LAB dams (high 
crouch: U = 67.5, W = 320.5, Z = -3.85, p < 0.001; Figure 17B; low crouch: t39 = 2.61, p = 
0.013; Figure 17C). Blanket nursing did not differ between the breeding lines (Figure 17D). 
Total nursing was higher in HAB compared to LAB dams (t39 = 3.05, p = 0.004; Figure 17E). 
 
Maternal motivation in the conventional PRT was higher in HAB dams compared to LAB 
dams. When testing the dams in the modified PRT, LAB dams improved their retrieval 
behaviour, what makes them indistinguishable from HAB dams (see Chapter 4). 
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Figure 17 Maternal care under non-stress conditions in non-manipulated HAB and LAB dams of generation 
#50.  
The behaviours shown are arched back nursing (ABN; A), high crouch (B), low crouch (C), blanket nursing 
posture (blanket; D), as well as the sum of all nursing postures (nursing; E). The behaviours were observed for 
60 min in the morning (for details see Section 3.3.5.1). 
Data are presented as the mean + SEM (n = 19 – 22 per group). * p ≤ 0.05 versus HAB. 
 
 
Due to the fact that rats were also involved in another subsequent experiment which is not 
part of this thesis, only a smaller cohort of HAB and LAB dams underwent maternal 
aggression testing. Therefore the rat numbers differ in the maternal defence test 
substantially from those above. 
Maternal aggression was higher in LAB dams compared to HAB dams (sum aggressive: t13 = 
2.80, p = 0.015; Figure 18).  
 
LAB dams showed more attacks (t13 = -2.35, p = 0.063), duration of attack behaviour (t13 = -
2.73, p = 0.041: Figure 18A) and threat behaviours like keep down (t13 = -3.34, p = 0.021; 
Figure 18B), lateral threat (t13 = -2.61, p = 0.022; Figure 18C) and offensive upright (t13 = -
2.75, p = 0.039; Figure 18D) compared to HAB dams. Further, time sniffing the intruder was 
decreased in LABs compared to HABs (t13 = 4.18, p = 0.001). No further differences in any 
other aggressive or non-aggressive behaviour were found between breeding lines. 
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Figure 18 Maternal aggression in non-manipulated HAB and LAB dams of generation #50 in the maternal 
defence test. 
Lactating mothers (residents) were exposed to virgin female rats (intruders) in the presence of their pups for 
10 min. The number of attacks (A) as well as the time spent with the threat behaviours keep down (B), lateral 
threat (C) and offensive upright (D) are shown.  
Data are presented as mean + SEM (n = 6 – 9 per group). * p ≤ 0.05 versus HAB 
 
 
Maternal anxiety was higher in HAB dams compared to LAB dams by spending less time on 
the open arm (t39 = -8.71, p < 0.001; Figure 19 left) and showing less locomotion (t39 = -3.08, 
p = 0.004; Figure 19 right). 
 
 
Figure 19 Anxiety-related behaviour in HAB and 
LAB dams of generation #50 on the EPM 
Time spent on the open arms (left) and 
locomotion reflected by closed arm entries 
(right) of HAB and LAB dams. 
Data are presented as the mean + SEM (n = 19 – 
22 per group). * p ≤ 0.05 versus HAB. 
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3.4.3 Maternal behaviour in non-manipulated HAB/LAB dams of generation #51 
Maternal care was observed one hour in the morning on LD 1. We found that HAB and LAB 
dams differed significantly in their nursing behaviour. Although ABN did not differ between 
the breeding lines (Figure 20A), HAB dams showed more high crouch compared to LAB dams 
(t12 = 3.15, p = 0.008; Figure 20B). Low crouch did not differ between HAB and LAB dams 
(Figure 20C). Blanket nursing was higher in LAB compared to HAB dams (t12 = -2.70, p = 
0.023; Figure 20D). Total nursing did not differ between the breeding lines (Figure 20E). 
 
 
Figure 20 Maternal care under non-stress conditions in non-manipulated HAB and LAB dams of generation 
#51.  
The behaviours shown are arched back nursing (ABN; A), high crouch (B), low crouch (C), blanket nursing 
posture (blanket; D), as well as the sum of all nursing postures (nursing; E). The behaviours were observed for 
60 min in the morning (for details see Section 3.3.5.1). 
Data are presented as the mean + SEM (n = 6 – 8 per group). * p ≤ 0.05 versus HAB. 
 
Maternal aggression was not analyzed in the dams of this breeding as maternal defence 
tests in LABs have to be interrupted after a maximum of three minutes due to abnormal high 
aggression of the dams towards the intruders resulting in serious injuries of the intruders 
(attacks of vulnerable body parts). 
 
Maternal anxiety was higher in HAB dams compared to LAB dams by spending more time on 
the open arm (t12 = -5.11, p < 0.001; Figure 21 left). Locomotion did not differ between 
breeding lines (see Figure 21 right).  
C h a p t e r  3  68 
 
Figure 21 Anxiety-related behaviour in HAB 
and LAB dams of breeding #51 on the EPM 
Time spent on the open arms (left) and 
locomotion reflected by closed arm entries 
(right) of HAB and LAB dams. 
Data are presented as the mean + SEM (n = 6 - 
8). 
 
Analysis of breeding EPM data compared to experimental EPM data showed significant 
differences between HAB and LAB rats under different reproductive stages (Supplementary 
Figure S1). Thus LAB rats showed significantly decreased % time on the open arm in the 
experimental EPM compared to the breeding EPM (independent t-test; t14 = 3.12, p = 0.013), 
whereas no differences between the two tests were found in HAB rats. Comparing HAB and 
LAB rats in each test separately, the two breeding lines differ in the breeding EPM (t12 = -
24.96, p < 0.001) as well as in the experimental EPM (t12 = -5.11, p < 0.001), with HAB rats 
being more anxious compared to LAB rats. 
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3.5 Discussion 
Central manipulation of V1bR in lactating HAB and LAB rats did not show any effect on 
maternal behaviour, unlike to lactating NAB rats (Chapter 2). In line with previous studies, 
LAB dams improved their retrieval behaviour up to levels of HAB dams in the modified PRT 
as shown before (Chapter 4). Surprisingly, the aggressive phenotype of the dams was not as 
expected in this experiment. LAB dams had equivalent levels of aggressive behaviours 
compared to HAB dams, threat behaviour of LAB dams even exceeded the amount of HAB 
dam’s threats. Nevertheless, we found the typical HAB phenotype described by elevated 
maternal care and maternal anxiety. With subsequent breeding, LAB dams showed an 
abnormal aggressive phenotype, leading to serious injuries of the intruders. Therefore, 
HAB/LAB rats do not provide a good tool for investigations of postpartum adaptations and 
dysregulations any longer. 
Various studied have shown the involvement of AVP and its V1 receptors in the regulation of 
maternal behaviour in rats and mice (Chapter 2, 4 and 5)(Bayerl et al., 2014; Bosch and 
Neumann, 2010, 2008; Wersinger et al., 2007). The differences in the HAB/LAB phenotype 
have been proven to rely, at least in part, on increased levels of AVP in HAB rats. The hyper-
maternal phenotype of HAB dams has been shown to be stable over years, with only mild 
fluctuations in the last generation (#51). In more detail, high crouch was still shown in a 
higher frequency in HAB dams, whereas low crouch levels appeared to be equal. This 
difference may depend on environmental conditions. High crouch position reflects a highly 
sensitive maternal behaviour as barely perceptible changes (at least for humans) may not 
disrupt, but decrease the quality of ABN, by performing low instead of high crouch (personal 
observations SMK, OJB, DSB). Further, noise disturbance during the behavioural 
observations, which may not be audible for researchers, may interfere with high crouch, as 
rats have better, and wider frequency range of hearing than humans (Lauer et al., 2009; 
Milligan et al., 1993). 
In contrast to a stable maternal phenotype of HAB dams, regarding increased ABN, pup 
retrieval and maternal anxiety (Bosch and Neumann, 2010, 2008; Kruszynski et al., 1980) 
compared to LAB dams, we found changes in maternal aggression in our study. 
Maternal aggression not only serves to protect the offspring of potential threats but also 
comes along with high energy costs and health risks (for reviews see Bosch and Neumann, 
2012; Numan and Insel, 2003). Therefore, defensive behaviour can be seen by the 
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subordinate, which helps to reduce injuries or killing (Blanchard et al., 2003). Further, 
defensive behaviours of the intruder lead to a limitation of attacks by the resident, 
supported by vibrissae-contact between the opponents (Blanchard and Blanchard, 1977). 
With subsequent breeding, LAB dams seem to ignore defensive behaviours of the intruders, 
resulting in serious attacks and bites on vulnerable body parts like the nose, anogenital 
region, and belly. These observations on changed frequency and type of aggression are 
similar to what was seen in LAB males already several years ago (Beiderbeck et al., 2012). 
Normally, residents attack the back or flanks of an intruder rat, according to species-specific 
rules (Blanchard et al., 2003). Aggression that exceeds a distinct level or species-specific 
pattern is called escalated, pathological or abnormal aggression (Takahashi and Miczek, 
2014). This abnormal aggression differs quantitatively (decreased attack latency, higher 
number and duration of attacks and threat behaviour) as well as qualitatively (attacks of high 
intensity towards vulnerable body parts, like head and throat, of the intruder) from normal 
aggression levels (for review see Haller and Kruk, 2006). 
Most likely, the reason of this abnormal aggression is due to selective breeding over years.  
Selective breeding is described to lead to a stabilisation of traits (for review see Neumann et 
al., 2010). However, aggression in females, especially maternal aggression, was not assessed 
in all HAB/LAB generations (in contrast to anxiety as phenotype readout parameter), 
therefore, it may have increased over the last generations. This shift to heightened 
aggression was also seen in HAB and LAB males, with LAB males showing abnormal 
aggression (for review see Neumann et al., 2010). 
In addition, beside the SNP for AVP, further neuropeptide systems involved in the regulation 
of aggression, i.e. the serotonin system (De Almeida et al., 2005; Ferris, 1996), may have 
adapted over years with subsequent breeding. To investigate possible adaptations a genetic 
screening of the AVP plus other neurotransmitter systems would provide the next step.  
Another reason for abnormal aggressive behaviour may be the loss or impairment of 
receiving social cues and behavioural control. According to this hypothesis, LAB males show 
a decreased neuronal activation (c-fos) of the LS (Beiderbeck et al., 2007; Veenema et al., 
2007), which is associated with increased aggression as seen in mice (for review see Haller 
and Kruk, 2006). Further, the LS is known to regulate anxiety and social recognition also in 
females (Engelmann et al., 1996; Sheehan et al., 2004). This might explain the higher amount 
of aggression that LAB dams display due to impaired recognition of social cues. Studies 
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investigating the neuronal activation in lactating HAB and LAB dams during maternal 
aggression, may shed light on a possible involvement of brain regions important for 
behavioural control, like the LS, the prefrontal cortex or the amygdala (for review see Haller 
and Kruk, 2006). 
In addition, we observed decreased sniffing in LAB dams of generation #50 compared to HAB 
dams. This is in line with observations in male LABs, which also show less social investigation 
of conspecifics (Ohl et al., 2001; for review see Lukas and Neumann, 2013) but increased 
aggression also in situations without a potential threat, i.e. towards a female or 
anaesthetized rat (Beiderbeck et al., 2012; de Boer et al., 2003). However, data on social 
investigation in virgin females during the FIT does not reflect a difference between HAB and 
LAB rats (de Jong et al., 2014). Both strains show decreased sniffing compared to NAB 
females in adolescence as well as in adulthood. However, social investigation includes not 
only sniffing, but also approach behaviour. Data on social investigation and/or sniffing in 
non-manipulated lactating females during the maternal defence test are incomplete/ 
scarcely reported over generations. Therefore, future assessment of social investigation with 
special focus on sniffing in following generation of HAB and LAB rats can provide further 
insight in the ability of the breeding lines in receiving social cues properly. A lack in this 
ability could explain the abnormal levels of aggression in LAB dams towards an intruder in 
the maternal defence test.  
Regarding the changes in maternal aggression, one also has to take seasonal fluctuations 
into account. Seasonal variations even under constant laboratory conditions in (inter-male) 
aggression have been observed before (de Boer et al., 2003). In our laboratory we also 
observe decreased (male) aggression during winter, compared to autumn and summer (for 
review see Neumann et al., 2010). These observations are in line with human studies, 
showing the lowest level of aggression during winter compared to other seasons (Miczek et 
al., 2002). Testing of generation #47 and #50 took place in spring, whereas experiments with 
generation #51 were performed in autumn. The increased aggression levels of generation 
#51 are in contrast to iterature; therefore our results cannot be referred to annual 
fluctuations, as a steadily increasing aggression was observed instead. Thus, changes due to 
other factors are more likely. 
Interestingly, when comparing data of the EPM testing of rats used as virgins (breeding EPM) 
with the data of the dams (experimental EPM) of breeding #51, LAB dams show higher 
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anxiety in the latter, whereas anxiety in HAB rats is unchanged. This stands in contrast to 
anxiolytic effects, which are described in general in lactation (for reviews see Neumann et 
al., 2010; Numan and Insel, 2003). Due to the fact that LAB rats already show very little 
anxiety, a further drop might not be possible. But interestingly, also in HAB females the 
anxiolytic effect of lactation is missing, which could not be due to a floor effect. It might be 
that changes in maternal aggression are concomitant to these changes in maternal anxiety 
or vice versa, as a correlation of both behaviours have been shown in HAB and LAB rats 
before (for review see Bosch, 2011). 
Interestingly, V1bR antagonism was ineffective in both breeding lines. This stands in contrast 
to the findings in NAB dams, where V1bR blockade decreased maternal care under non-
stress as well as under stress conditions (Chapter 2). The lack of an effect in HAB/LAB dams 
might be due to changes in the AVP system and the resulting phenotype. Low levels of 
maternal care in LAB rats might hinder further decrease of nursing and mother-pup 
interaction after V1bR blockade. Chronic administration of the V1bR agonist/antagonist 
and/or local manipulation, i.e. within the PVN might help to rule out potential effects of the 
V1R subtype. 
The change in aggression was rather suprising, as other maternal parameters were not 
affected. Due to observed changes in maternal aggression focusing especially on the 
abnormal aggressive behaviour in LAB dams, we decided to halt the use of HAB/LAB dams as 
animal model for investigating maternal behaviour. Studies investigating the influence of 
V1bR in maternal behaviour were conducted in Wistar rats instead (see Chapter 4 & 5).  
Nevertheless, female HAB/LAB rats show a stable phenotype in anxiety- and depressive like 
behaviour, providing a good animal model for further investigations of neurobiological 
maladaptations in mood disorders, leading to anxiety or depression. 
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Chapter 4 
Antagonism of V1b receptors promotes maternal motivation to 
retrieve pups in the MPOA and impairs pup-directed behaviour 
during maternal defence in the mpBNST of lactating rats. 
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Inga Neumann: revision of manuscript 
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manuscript 
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4.1 Abstract 
Recent studies using V1bR knockout mice or central pharmacological manipulations in 
lactating rats highlighted the influence of this receptor for maternal behavior. However, its 
role in specific brain sites known to be important for maternal behavior has not been 
investigated to date. In the present study, we reveal that V1bR mRNA (quantitative real-time 
PCR; qPCR) and protein levels (Western Blot) within either the MPOA or the mpBNST did not 
differ between virgin and lactating rats. Furthermore, we characterized the effects of V1bR 
blockade via bilateral injections of the receptor subtype-specific antagonist SSR149415 
within the MPOA or the mpBNST on maternal behavior (maternal care under non-stress and 
stress conditions, maternal motivation to retrieve pups in a novel environment, maternal 
aggression) and anxiety-related behavior in lactating rats. Blocking V1bR within the MPOA 
increased pup retrieval, whereas within the mpBNST it decreased pup-directed behavior, 
specifically licking / grooming the pups, during the maternal defense test. In addition, 
immediately after termination of the maternal defense test, V1bR antagonism in both brain 
regions reduced nursing, particularly ABN. Anxiety-related behavior was not affected by 
V1bR antagonism in either brain region. In conclusion our data indicate that V1bR 
antagonism significantly modulates different aspects of maternal behavior in a brain region-
dependent manner. 
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4.2 Introduction 
Maternal behavior serves to increase the probability that the offspring survive to maturity 
(for review see Numan and Insel, 2003). This behavior is comprised of different activities 
directed towards the young like nursing, licking / grooming, retrieving the pups into the nest 
but also defending them from any potential threat. Numerous studies have shown the 
importance of AVP and its V1aR in the regulation of maternal behavior of rats (Bosch and 
Neumann, 2008; Nephew and Bridges, 2008; for review see Bosch and Neumann, 2012). 
Shortly before parturition, the activity/expression of AVP and V1aR is up-regulated (Bosch et 
al., 2007; Caldwell et al., 1987; Caughey et al., 2011; Landgraf et al., 1991) in preparation for 
the forthcoming challenge of motherhood. This up-regulation continues into lactation (Bosch 
and Neumann, 2008; Van Tol et al., 1988; Walker et al., 2001), where the AVP system 
facilitates maternal behavior as demonstrated by central (Pedersen and Prange, 1979; 
Pedersen et al., 1982) and local manipulations within the MPOA (Bosch and Neumann, 2008; 
Pedersen et al., 1994) and the BNST (Bosch et al., 2010). Both brain regions are important 
regulators of maternal behavior and form the so-called maternal “super-region” (for review 
see Numan and Insel, 2003). Specifically, the MPOA plays a distinct role in maternal 
motivation as measured by pup retrieval behavior (Kalinichev et al., 2000; Neumann et al., 
2005; Numan, 1990; Pedersen et al., 1994) whereas the BNST is involved in maternal 
aggression (Bosch et al., 2010; Consiglio et al., 2005; Klampfl et al., 2014). Accordingly, in the 
MPOA and BNST endogenous AVP release increases during mother-pup interaction (Bosch et 
al., 2010). Inhibition of the V1aR in the MPOA of the lactating mother via local infusion of a 
V1aR antagonist or receptor down-regulation by antisense oligodeoxynucleotides decreases 
pup retrieval (Bosch and Neumann, 2008; Pedersen et al., 1994). Blocking V1aR within the 
BNST decreases aggression against a virgin female intruder rat during the maternal defense 
test without affecting maternal care (Bosch et al., 2010).  
To date, most studies investigating the function of the AVP system in maternal behavior 
have focused on the V1aR. Considering the expression of the second brain V1 receptor, the 
V1bR, in the maternal super-region (Hernando et al., 2001), it is very likely that the effects of 
AVP on maternal behavior are brought about by the two different AVP receptor subtypes. 
However, studies investigating the role of V1bR have been hindered due to a lack of specific 
pharmacological tools. An initial study in V1bR knockout mice demonstrated reduced 
maternal aggression in knockout compared to wild-type mothers (Wersinger et al., 2007). 
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Recently, using the receptor subtype-specific V1bR antagonist SSR149415 (Serradeil-Le Gal 
et al., 2002), we revealed that in Wistar rats central blockade of the receptor reduced 
nursing and mother-pup interaction, whereas it did not affect pup retrieval or maternal 
aggression (Bayerl et al., 2014). 
In the present study, we investigated the role of V1bR in various aspects of maternal 
behavior in more detail by focusing on the two maternal brain regions MPOA and BNST. 
Firstly, we assessed whether lactation is associated with altered V1bR mRNA (experiment 1) 
and/or protein level (experiment 2) by comparing lactating and virgin rats. Secondly, we 
studied the behavioral effects of acute local infusion of the V1bR antagonist SSR149415 
within the MPOA (experiment 3) or mpBNST (experiment 4) on maternal care under basal 
condition (non-stress) and following exposure to the maternal defense test (stress 
condition), as well as on maternal motivation to retrieve pups, maternal aggression and 
anxiety-related behavior. 
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4.3 Material and Methods 
4.3.1 Animals 
Female Wistar rats (12 - 14 weeks, 220 - 250 g, Charles River Laboratories, Sulzfeld, 
Germany) were kept under standard laboratory conditions (12 h / 12 h light-dark cycle, with 
lights on at 07:00 h; 22 ± 1 °C; 55 ± 5 % relative humidity; free access to water and standard 
rat chow). 
In experiments 1 and 2, half of the rats were kept as virgins, whereas the other half was 
mated with sexually experienced stud Wistar males. Pregnancy was confirmed the next day 
by the presence of sperm in vaginal smears (assigned as PD 1). Rats were kept in mixed 
groups (pregnant/ virgin) of 3 to 4 rats before they were single-housed on PD 18 (or 
equivalent in virgins) to ensure undisturbed parturition. 
For experiments 3 and 4 virgin female Wistar rats were mated as described above. Pregnant 
rats were group-housed up to four rats per cage until surgery on PD 18. After surgery, 
pregnant rats were single-housed in plexiglass observation cages (38 x 22 x 35 cm³) to 
ensure undisturbed parturition. On the day of birth, offspring were culled to eight pups of 
mixed sexes and half of the bedding was replaced by new bedding. Dams were randomly 
assigned to one of the treatment groups on LD 1 and received the same treatment 
throughout the experiment. 
For the maternal defense test, naïve virgin female Wistar rats (10 weeks, 180 - 220 g; Charles 
River) at random stages of their estrous cycle were used as intruders. They were kept group-
housed in a separate room until behavioral testing to avoid olfactory recognition by the 
lactating mothers (for review see Bosch, 2013). 
All experiments were performed in accordance with the European Communities Council 
Directive (86/609/EEC) and were approved by the local government of the Oberpfalz, 
Bavaria, Germany. 
 
4.3.2 Experiment 1: qPCR for V1bR mRNA in the MPOA and BNST 
Non-manipulated, undisturbed rats were sacrificed on LD 4 (or equivalent in virgins at 
random stages of the estrous cycle; n = 3 – 5 per group). Brains were removed, snap-frozen 
in n-methylbutane on dry ice and stored at -80 °C until further processing. Next, brains were 
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cut into 2x 200 µm slices at the regions of interest, which were identified with the aid of a 
rat brain atlas (Paxinos and Watson, 2007). The MPOA and BNST were dissected with a 
puncher (inner diameter: 1 mm) and side-pooled; thus, a total of 4 punches of each brain 
region were taken per rat. Total RNA was extracted using RNeasy Micro Kit (Qiagen, Hilden, 
Germany) in combination with QIAshredder columns (Qiagen) and RNase-Free DNase Set 
(Qiagen) according to the manufacturer’s instructions. RNA content was determined with 
the aid of a NanoDrop photospectrometer. Next, 100 ng of RNA were reverse transcribed 
into cDNA by use of SuperScript III according to manufacturer’s instructions (Invitrogen, 
Darmstadt, Germany). SYBR Green-based (Qiagen) qPCR for V1bR (forward primer: 5’-CAT 
ACC TCC ATC CAC CTT CC-3’; reverse primer: 5’-TCT TCA TCC CTA CCT AGC CA-3’; Metabion, 
Planegg/ Steinkirchen, Germany) relative to ribosomal protein L13A (Rpl13A; NM_173340; 
forward primer: 5’-ACA AGA AAA AGC GGA TGG TG-3’; reverse primer: 5’-TTC CGG TAA TGG 
ATC TTT GC-3’; Metabion) and Tyrosine 3-monooxygenase/ tryptophan 5-monooxygenase 
activation protein, zeta (Ywhaz; NM_013011; forward primer: 5’-TTG AGC AGA AGA CGG 
AAG GT-3’ ; reverse primer: 5’-GAA GCA TTG GGG ATC AAG AA-3’; Metabion) as reference 
genes (Bonefeld et al., 2008) was performed on the 7500 Fast Real Time PCR Systems v2.0.6 
(Applied Biosystems, Darmstadt, Germany) and mRNA levels were quantified with the 
comparative CT method (ΔΔCT). Specificity of the primers was assured by omitting reverse 
transcription and by using ddH2O as template. The PCR protocol consisted of an initial 
denaturation step of 5 min at 95 °C, followed by 40 cycles of denaturation at 95 °C for 10 s, 
and annealing/extension at 60 °C for 45 s. At the end of the protocol a melting curve was 
generated and PCR products were analyzed by agarose gel electrophoresis to confirm the 
specificity of the primers. All samples were run in duplicate. 
 
4.3.3 Experiment 2: Western Blot analysis for V1bR protein in the MPOA and BNST 
Rats were treated and brain punches were taken as described for experiment 1 (n = 3 – 5 per 
group). Proteins were extracted from punches in 50 µl lysis buffer (containing 0.5 mM of 
0.02 % EDTA (Sigma Life Science, Steinheim, Germany), 250 mM of NaCl (powder; VWR 
Chemicals, Leuven, Belgium), 50 mM of 1 M HEPES (Sigma Life Science), 0.5 % of Igepal 
(Sigma-Aldrich, Steinheim, Germany), 10 % of Halt-Protease & Phosphatase Inhibitor 10x 
Cocktail (Thermo Scientific, Rockford, USA)) in which the probes were homogenized with a 
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sterile handheld pestle. After gentle rotation (1 h, 4 °C) and centrifugation (15 min, 13.000 
rpm, 4 °C) the supernatant containing the protein-fraction was collected on ice. The protein 
concentrations were determined using the BCA Protein Assay Kit (Pierce/Thermo Scientific) 
and the Optima plate reader (BMG Labtech GmbH, Ortenberg, Germany). Fifteen µg of each 
protein sample were electrophoretically separated on a 12 % SDS-gel (Criterion TGX Stain 
Free Precast Gel, Bio-Rad, Munich, Germany) and subsequently transferred onto a 0.2 µm 
nitrocellulose membrane (Bio-Rad) by means of the Turbo Trans Blot unit (Bio-Rad). Equal 
loading of protein samples was verified using the stain free technology provided by Bio-Rad, 
which quantifies the amount of total protein loaded in one lane by staining tryptophans, 
instead of using a single band of one reference protein. This technique was preferred over 
traditional methods of loading control, since pregnancy and lactation are known to induce 
substantial changes in protein levels in the brain, which might bias relative gene expression 
(Gilda and Gomes, 2013; Rivero-Gutiérrez et al., 2014). Non-specific binding sites on the 
nitrocellulose membranes were blocked with 5 % milk-powder (Carl Roth GmbH & Co. KG, 
Karlsruhe, Germany) in TBST for 1 h at room temperature and incubated with a specific 
antibody against the rat V1bR (1:5000, Alpha Diagnostic, San Antonio, USA; for verification of 
specificity see Supplementary Information and Figure S2) in TBS-T overnight at 4 °C. Bands 
were visualized by a secondary HRP-conjugated anti-rabbit IgG antibody (1:2000 in 5 % milk-
powder, 1h at room temperature; Cell Signaling Technology) and Clarity Western ECL 
Substrate (Bio-Rad). Images were taken with the ChemiDocTM XRS+ system (Bio-Rad). 
Optical density of the protein bands was measured and related to total protein binding with 
Image Lab 5.1 according to the manufacturer’s protocol (Bio-Rad). 
 
4.3.4 Experiments 3 & 4: Local blockade of V1bR within the MPOA (experiment 3) 
and mpBNST (experiment 4) 
4.3.4.1 Implantation of local guide cannulae.  
On PD 18, rats were implanted bilaterally with two stainless steel guide cannulae (23 G, 12 
mm length) 2 mm above the MPOA (0.4 mm posterior, ±0.8 mm lateral to bregma, 6.8 mm 
ventral) or the mpBNST (0.5 mm posterior, -3.0 mm and +3.1 mm lateral to bregma, 4.9 mm 
ventral, angle 12.5°) (Paxinos and Watson, 2007) under semi-sterile conditions. Briefly, rats 
were anesthetized with the inhalation-narcotic isoflurane (Baxter Germany GmbH, 
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Unterschleißheim, Germany) and placed on a thermo pad (32 °C) to minimize core body 
temperature loss throughout anesthesia. Two stainless steel screws were inserted into the 
skull for better adhesion of the cannulae; the first cannula was fixed with light-hardening 
dental glue (Heraeus Kulzer GmbH, Hanau, Germany) to avoid an unnecessary elongation of 
anesthesia and for better precision while the second cannula was fixed (Kallocryl, Speiko, 
Münster, Germany). The wound was closed with dental cement (Kallocryl). The cannulae 
were closed with stainless steel dummy cannulae of the same length as the guide cannulae. 
At the end of the surgery, rats received 0.12 ml of the antibiotic Enrofloxacin (Baytril 2.5 %, 
Bayer Vital GmbH, Leverkusen, Germany) subcutaneously to prevent inflammation. After 
surgery, rats were placed individually in an observation cage to guarantee undisturbed 
parturition. 
 
4.3.4.2 Infusion of receptor subtype-specific V1bR antagonist.  
Rats were handled twice daily on PD 15 - 17 and 19 - 21 to familiarize them with the local 
infusion procedure and to minimize non-specific stress responses during the experiments 
(Bayerl et al., 2014; Klampfl et al., 2014). Starting on LD 1, lactating dams received on each 
experimental day acute bilateral infusions of VEH (0.5 µl per side; sterile Ringer’s solution + 5 
% dimethyl sulphoxide; pH 7.4; B. Braun Melsungen, Melsungen, Germany) or the receptor 
subtype-specific V1bR antagonist SSR149415 (100 ng / 0.5 µl VEH per side (Serradeil-Le Gal 
et al., 2002)) 10 min prior to the respective test. The concentration was chosen based on 
previous studies (Bayerl et al., 2014; Salomé et al., 2006; Stemmelin et al., 2005); binding of 
the V1bR antagonist to the structurally similar OXT and V1aR is rather unlikely as SSR149415 
binds with high specificity to the rat V1bR (Griebel et al., 2002; Griffante et al., 2005; 
Serradeil-Le Gal et al., 2002). The treatments were administered over 20 s via a 10 µl 
Hamilton syringe connected to an injection system consisting of an infusion cannula (30 G, 
length 14 mm, i.e. 2 mm longer than the guide cannula) on a polyethylene tube of 20 cm 
length. 
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4.3.5 Behavioural tests 
The behavioral tests from experiments 3 and 4 were conducted every other day based on an 
established protocol (Klampfl et al., 2014). Briefly, on LD 1, maternal care was observed in 
the home cage under ‘non-stress’ conditions. We are aware that the infusion per se creates a 
minimal amount of stress, though the term ‘non-stress’ is used here to distinguish maternal 
care without previous exposure to the maternal defense test from maternal care following 
the maternal defense test, which is a strong psychosocial stressor (‘stress’ condition, LD 7, 
see below; Neumann et al., 2001). On LD 3, maternal motivation to retrieve pups in a novel 
environment was assessed in the PRT. On LD 5, anxiety-related behavior was assessed on the 
EPM. For the PRT and EPM test dams were transported to separate rooms 60 min prior to 
the tests to allow for habituation. On LD 7, maternal care was monitored in the home cage 
before and after the maternal defense test, which was also used to measure maternal 
aggression (Bosch et al., 2005; Neumann et al., 2001; for review see Bosch, 2013). 
 
4.3.5.1 Maternal care observation.  
The mother’s behavior was monitored every second minute for approximately 10 s in 30 min 
intervals, leading to a maximum of 15 counts per interval. On LD 1, dams were observed 60 
min before (9:00 – 10:00 a.m.), and two hours immediately after (10:00 a.m. – 12:00 p.m.) 
infusion of V1bR antagonist or VEH (MPOA: n = 11 – 15 per group, mpBNST: n= 18 – 19 per 
group). On LD 7, dams were observed 60 min in the morning (9:00 – 10:00 a.m.) and 
subsequently brought to the maternal defense test room. After infusion and the maternal 
defense test, dams were observed for another 60 min to assess possible behavioral effects 
of stressor exposure. Behaviors were scored according to an established protocol (Bayerl et 
al., 2014; Klampfl et al., 2014) and included nursing, which is comprised of ABN as the only 
active nursing posture of the mother, blanket posture and lying on side or back. All nursing 
postures together with licking / grooming of the pups and carrying the pups were taken as 
mother-pup interactions. Furthermore, we assessed non-maternal behaviors like eating / 
drinking, self-grooming, resting / sleeping away from the offspring, digging and locomotion, 
which were summed up as “off pups” behavior. 
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4.3.5.2 Maternal motivation in the PRT. 
The motivation of the dams to retrieve their pups is very high during the early phase of 
lactation (for review see Numan and Woodside, 2010) and was measured in the PRT. The 
pups were separated from the mothers 60 min prior to the test and kept on a thermo pad 
(32 °C) to maintain body temperature, while at the same time dams were transported to the 
experimental room. Ten minutes before starting the test, dams were infused with either 
V1bR antagonist or VEH; subsequently, pups were brought to the experimental room and 
distributed in the retrieval box (see Figure 22), which was additionally covered with a 
handful of home cage bedding.  
In order to characterize pup retrieval under different challenging conditions, we tested the 
dams in one of two different experimental setups of the PRT (for details see below and 
Figure 22). Half of the dams were tested in the conventional setup of our laboratory (‘no 
house’ condition; MPOA: n = 6 – 7 per group, mpBNST: n = 6 per group; Figure 22A; Bayerl et 
al., 2014; Bosch and Neumann, 2008; Bosch et al., 2010; Klampfl et al., 2014; Neumann et 
al., 2005), the other half in the modified setup (‘house’ condition; MPOA: n = 6 – 8 per 
group, mpBNST: n = 13 – 15 per group; Figure 22B; also see Supplemental Information).  
 
 
Figure 22 Conventional (A) and 
modified (B) pup retrieval test (PRT) 
setup. 
Schematic representation of the 
conventional (‘no house’ condition; A) 
or the modified (‘house’ condition; B) 
PRT and distribution of the pups (grey). 
The dam (white) is placed in the middle 
of the box, facing away from the 
entrance of the house (gray rectangle) 
within the modified PRT setup. 
 
The conventional PRT was performed according to an established protocol using a retrieval 
box made of white plastic (54 x 34 x 32 cm³; Bosch and Neumann, 2008; Neumann et al., 
2005). The dams were placed in the middle of the box (t0) and retrieval behavior (time and 
number of retrieved pups as well as latency to retrieve the first pup) was scored for a 
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maximum of 15 min (t15). After termination of the test, dams were put back into their home 
cages together with their pups. The modified setup consists of a black plastic box (54 x 34 x 
60 cm³), made out of the same material as the home cage floor and an additional red 
Perspex plastic house (13 x 17 x 11 cm³, opening 6 x 8.5 cm²; PLEXIGLAS® GS Rot 3C33, 
ThyssenKrupp Plastics GmbH, Regensburg, Germany; transparency: 13 %); based on our 
preliminary study in lactating HAB and LAB rats. While in HAB dams maternal motivation to 
retrieve pups is high, it is significantly lower in LAB dams when tested in the conventional 
PRT (Figure S3; (Neumann et al., 2005); interestingly, this is also the case in HAB and LAB 
mice (Kessler et al., 2011; for review see Bosch, 2011). Furthermore, especially LAB dams 
often retrieve their pups not to a single place in the conventional retrieval box but into two 
or even more corners (unpublished observation DSB, SMK, BMG, OJB). Therefore, we have 
chosen to provide the mothers with a red house (see above) as potential nesting site, as an 
enclosed dim area is known to be preferred to a light arena, similar to the conditions in the 
light-dark box test (Crawley and Goodwin, 1980). The result was that non-manipulated LAB 
dams retrieved their pups significantly faster as well as more pups during the 15-min test 
(HAB/LAB dams: n = 9 – 10 per group; Figure S3), elevating the LAB dams motivation to 
levels of HAB dams. Therefore, the modified test enables us to increase pup retrieval and, 
conversely, to detect potential impairing effects of any manipulation of the lactating 
mothers on maternal motivation to retrieve pups, which increases the significance of the 
test. For the modified PRT, dams were allowed to explore the house in their home cage for 
150 min to familiarize them with the new object in the afternoon of LD 2. On LD 3, the house 
was re-introduced to the dam’s home cage during the 60 min separation from the pups as 
well as in the PRT arena during the test (Figure 22B). Maternal motivation to retrieve pups 
was measured as described above. 
 
4.3.5.3 Anxiety-related behaviour on the EPM. 
Dams were tested for their anxiety-related behavior on the EPM (Liebsch et al., 1998; Pellow 
et al., 1985) as described before (Bayerl et al., 2014; Bosch et al., 2010; Neumann et al., 
2000). Briefly, the dams were transported to the separate EPM room 60 min prior to the test 
to allow habituation. The substances were infused 10 min before starting the test (MPOA: n 
= 14 – 16 per group, BNST: n = 17 – 19 per group), when the dams were placed in the neutral 
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zone of the EPM (65 lux) facing a closed arm (10 lux) and were allowed to freely explore the 
maze for 5 min. The percentage of time spent on the open arms (90 lux; time on the open 
arms versus all arms) was taken as indicator for anxiety-related behavior whereas the 
number of closed arm entries reflected locomotion (Neumann et al., 2000). 
 
4.3.5.4 Maternal aggression in the maternal defence test.  
The dams were transported to the test room 60 min before testing. The dams (residents) 
received their infusion (MPOA: n = 4 – 7 per group, BNST: n = 18 per group) 10 min prior to 
introducing a virgin female rat (intruder) into their home cage in the presence of the pups 
(Bosch et al., 2005; Neumann et al., 2001; for review see Bosch, 2013). Intruders were used 
only once per day as well as only twice during the experiment with at least one day in 
between for recovery. The behavior during the 10-min testing period was video-taped for 
later analysis by an experienced observer blind to the treatment. The aggressive behaviors 
scored were: number of attacks, latency until first attack, offensive upright (the dam stands 
in an upright position in front of the intruder), keep down (the dam keeps the intruder down 
with her front paws), lateral threat (the dam engages to push the intruder aside by 
approaching laterally with her whole body), and aggressive grooming (for review see Bosch, 
2013). Further, we distinguished between the following non-aggressive behaviors: pup-
directed behavior (direct pup contact including nursing, licking / grooming, carrying), sniffing 
the intruder, exploration of the cage, self-grooming, resting offside the pups as well as 
eating / drinking. After the 10-min test period, the intruders were removed from the 
resident’s home cages.  
 
4.3.6 Verification of cannulae placement 
At the end of the behavioral experiments, rats were sacrificed with CO2 and infused with 0.5 
µl ink with an infusion cannula via the implanted guide cannulae. Brains were taken out and 
snap-frozen in n-methylbutane on dry ice. Brains were cut in 40 µm cryosections, slide 
mounted, and a quick Nissl staining was performed. Correct placement was verified using 
the rat brain atlas (Paxinos and Watson, 2007), and only rats with both cannulae placed 
correctly in the target brain region were included in the statistical analysis (see Figure 23). 
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Figure 23 Verification of cannulae placement sites in the 
MPOA and mpBNST 
Areas of the MPOA and mpBNST (grey shaded areas) in 
which the placement of the guide cannulae were counted 
as successful implantation (modified from Paxinos and 
Watson, 2007); the number indicates the distance in 
millimetres posterior to Bregma. 
Abbreviations: LV, lateral ventricle; ox, optic chiasm. 
 
 
4.3.7 Statistical analysis 
Differences of mRNA and protein levels were statistically evaluated with an independent t-
test for each brain region. Maternal care and maternal motivation to retrieve pups were 
analyzed using two-way ANOVA for repeated measures (factors: time x treatment). The 
ANOVAs were followed by Sidak post-hoc correction if main effects were found. If only a 
time effect was found, additional separate one-way ANOVA for repeated measures (factor: 
time) with subsequent Sidak post-hoc correction was performed for each treatment group. 
Maternal aggression, number of retrieved pups, latency to retrieve the first pup and anxiety-
related behavior was analyzed using independent t-tests. If data were not distributed 
normally (Kolmogorov-Smirnov Test), a Mann-Whitney-U test was performed. A statistical 
significant difference was considered at p ≤ 0.05 and effect size estimations were indicated 
by eta squared values for ANOVAs or Cohens d for independent t-tests. Data are presented 
as mean ± SEM. Statistical analysis was performed using the software SPSS, Version 20 (IBM, 
Ehningen, Germany). 
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4.4 Results 
4.4.1 Experiments 1 & 2: Expression of V1bR in the MPOA and BNST of virgin versus 
lactating rats 
The expression of V1bR as measured at the mRNA and protein level within the MPOA 
(independent t-test; mRNA: t7 = 0.31, p = 0.76, d = 0.21; protein: t7 = -1.49, p = 0.18, d = 1.06) 
or the BNST (mRNA: t5 = 0.75, p = 0.49, d = 0.57; protein: t7 = -0.53, p = 0.61, d = 0.37) did 
not differ between virgin and lactating rats (Table 2). 
 
Table 2 Expression of V1bR mRNA and protein within the MPOA and the BNST  
  MPOA  BNST 
     mRNA Virgin 1.00 ± 0.13  1.00 ± 0.56 
(relative to virgin) lactating 0.87 ± 0.34  0.58 ± 0.25 
     
protein Virgin 1.00 ± 0.11  1.00 ± 0.20 
(relative to total protein) lactating 1.24 ± 0.04  1.17 ± 0.17 
Abbreviations: BNST, bed nucleus of the stria terminalis; MPOA, medial preoptic area; V1bR, V1b receptor. 
Data are presented as mean ± SEM (n = 3-5 per group). 
 
 
4.4.2 Experiment 3: Local blockade of V1bR within the MPOA 
4.4.2.1 Maternal care under non-stress conditions.  
ABN was not affected by the treatment at any time point (Figure 24A). 
Nursing tended to differ depending on time (two-way ANOVA for repeated measures; F4,112 = 
2.42, p = 0.053, η² = 0.05; Figure 24B) but not on treatment; no time x treatment interaction 
was found. Separate one-way ANOVA for repeated measures did not reveal any further 
differences between time-points. 
Mother-pup interaction differed significantly depending on time (F4,112 = 4.45, p = 0.002, η² = 
0.09; Figure 24C) but not on treatment; no time x treatment interaction was found. Separate 
one-way ANOVA for repeated measures did not reveal any further differences between 
time-points. 
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4.4.2.2 Maternal care under stress conditions. 
ABN differed significantly depending on time (two-way ANOVA for repeated measures; F2,46 
= 13.08, p < 0.001, η² = 0.24; Figure 24D) but not on treatment; no time x treatment 
interaction was found. Separate one-way ANOVA for repeated measures revealed a 
significant effect of time (VEH: F2,20 = 4.28, p = 0.028, η² = 0.30; V1bR antagonist: F2,26 = 9.81, 
p = 0.001, η² = 0.43); ABN tended to be decreased at t+30 compared to basal in the V1bR 
antagonist-treated dams only (p = 0.059), whereas at t+60, ABN significantly increased 
compared to t+30 in both groups (VEH: p = 0.015, V1bR antagonist: p < 0.001).  
Nursing differed significantly depending on time (F2,46 = 12.01, p < 0.001, η² = 0.16; Figure 
24E), but not on treatment; no time x treatment interaction was found. Separate one-way 
ANOVA for repeated measures revealed a significant effect of time for V1bR antagonist-
treated dams (F2,26 = 11.18, p < 0.001, η² = 0.46) and an effect by trend for VEH dams (F2,20 = 
3.43, p = 0.052, η² = 0.26). In detail, nursing in the V1bR antagonist-treated dams was 
decreased at t+30 compared to basal (p = 0.003) and increased at t+60 compared to t+30 (p 
= 0.004). 
Mother-pup interaction differed significantly depending on time (F2,46 = 7.17, p = 0.002, η² = 
0.10; Figure 24F), but not on treatment; no time x treatment interaction was found. 
Separate one-way ANOVA for repeated measures revealed a significant effect of time for 
V1bR antagonist-treated (F2,26 = 7.25, p = 0.003, η² = 0.36), but not for VEH-treated, dams; 
mother-pup interaction dropped at t+30 compared to basal (p = 0.002) and increased at t+60 
compared to t+30 (p = 0.037) in the V1bR antagonist-treated dams. 
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Figure 24 Effect of V1bR antagonism within the MPOA on maternal care under non-stress and stress 
conditions. 
Maternal care was monitored before (basal) and after treatment infusion (non-stress condition; A-C) on 
lactation day (LD) 1 or after combined treatment infusion / exposure to the maternal defence test (stress 
condition; D-F) on LD 7. The occurrence of arched back nursing (ABN; A, D), sum of all nursing postures 
(nursing; B, E) and mother-pup interaction (C, F) is presented. Dams were acutely bilaterally infused with 
vehicle (VEH; 0.5 µl Ringer’s solution containing 5 % dimethyl sulphoxide per side) or the V1bR antagonist 
SSR149415 (V1bR-A; 100 ng / 0.5 µl Ringer per side). Data are presented as means + SEM (n = 11 - 15 per 
group). + p ≤ 0.05 versus previous sample of the same group.  
 
 
4.4.2.3 Maternal motivation in the PRT.  
In the conventional PRT (‘no house’ condition), the number of retrieved pups increased over 
the 15-min test (two-way ANOVA for repeated measures; F15,165 = 14.86, p < 0.001, η² = 0.18; 
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Figure 25A), was affected by treatment (F1,11 = 8.19, p = 0.015, η² = 0.27), and showed a time 
x treatment interaction (F15,165 = 4.39, p < 0.001, η² = 0.05); V1bR antagonist-treated dams 
retrieved more pups compared to VEH starting at 4 min (t4: p = 0.05, t5: p = 0.048, t6: p = 
0.023, t7: p = 0.022, t8: p = 0.022, t9: p = 0.013, t10: p = 0.008, t11: p = 0.007, t12: p = 0.002, 
t13: p = 0.01, t14: p = 0.02, t15: p = 0.02). Consequently, the total number of retrieved pups 
was higher in V1bR antagonist-treated dams compared to VEH (independent t-test; t11 = -
2.72, p = 0.02, d = 1.51). Further, the latency to retrieve the first pup was decreased by trend 
in V1bR antagonist-treated dams (t11 = 2.22, p = 0.072, d = 1.33; VEH: 490.0 ± 171.5 s, V1bR 
antagonist: 100.0 ± 37.0 s). 
 
 
Figure 25 Effect of V1bR antagonism 
within the MPOA on maternal 
motivation. 
Maternal motivation was measured 
either in the conventional (‘no house’ 
condition; A) or the modified (‘house’ 
condition; B) pup retrieval test (for 
details, see Section 4.3.5.2). The time 
until retrieval of each pup was 
monitored for 15 min following acute 
bilateral infusion of vehicle (VEH) or the 
V1bR antagonist SSR149415 (V1bR-A; 
for details see Figure 24).  
Data are presented as means + SEM (n = 
6 - 8 per group). * p ≤ 0.05 versus VEH. 
 
 
In the modified PRT (‘house’ condition), the number of retrieved pups increased over the 15-
min test (two-way ANOVA for repeated measures; F15,180 = 30.78, p < 0.001, η² = 0.45; Figure 
25B), was affected by treatment (F1,12 = 14.26, p = 0.003, η² = 0.19) , and showed a time x 
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treatment interaction (F15,180 = 2.10, p = 0.012, η² = 0.03); V1bR antagonist-treated dams 
retrieved more pups compared to VEH starting at 2 min (t2: p = 0.042, t3: p = 0.05, t4: p = 
0.01, t5: p = 0.004, t6: p = 0.019, t7: p = 0.034, t8: p = 0.013, t9: p = 0.017, t10: p = 0.005, t11: 
p = 0.005, t12: p = 0.011, t13: p = 0.031, t14: p = 0.031, t15: p = 0.031). Consequently, the 
total number of retrieved pups was higher in V1bR antagonist-treated dams compared to 
VEH (independent t-test; t12 = -2.45, p = 0.031, d = 1.33). Further, the latency to retrieve the 
first pup was decreased in V1bR antagonist-treated dams (t12 = 2.30, p = 0.041, d = 1.24; 
VEH: 310.0 ± 35.5 s, V1bR antagonist: 153.3 ± 63.6 s). 
Comparing pup retrieval of the VEH groups of both PRT setups confirmed our finding in LAB 
dams (Figure S3); in the modified PRT, mothers retrieved their pups faster compared to the 
conventional PRT (two-way ANOVA for repeated measures; F15,180 = 14.33, p < 0.001, η² = 
0.28); further a time x condition interaction was present (F15,180 = 4.98, p < 0.001, η² = 0.10).  
 
4.4.2.4 Maternal aggression in the maternal defence test.  
The treatment groups did not differ in any aggressive or non-aggressive behaviors in the 
maternal defense test (data not shown). 
 
4.4.2.5 Anxiety-related behaviour on the EPM.  
The treatment groups did not differ in any parameter on the EPM (data not shown). 
 
4.4.3 Experiment 4: Local blockade of V1bR within the mpBNST 
4.4.3.1 Maternal care under non-stress conditions.  
ABN differed significantly depending on time (two-way ANOVA for repeated measures; F4,136 
= 8.50, p < 0.001, η² = 0.13; Figure 26A) but not on treatment; no time x treatment 
interaction was found. Separate one-way ANOVA for repeated measures revealed a 
significant effect of time (VEH: F4,68 = 3.22, p = 0.018, η² = 0.16; V1bR antagonist: F4,68 = 6.19, 
p < 0.001, η² = 0.27); ABN increased at t+60 compared to t+30 in both treatment groups 
(VEH: p = 0.003, V1bR antagonist: p = 0.015).  
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Nursing (F4,136 = 5.12, p = 0.001, η² = 0.09; Figure 26B) and mother-pup interaction (F4,136 = 
4.81, p = 0.001, η² = 0.08; Figure 26C) differed significantly depending on time, but not on 
treatment; no time x treatment interactions were found. Separate one-way ANOVA for 
repeated measures did not reveal any further differences between time-points. 
 
 
Figure 26 Effect of V1bR antagonism within the mpBNST on maternal care under non-stress and stress 
conditions. 
Maternal care was monitored before (basal) and after treatment-infusion (non-stress condition; A-C) on LD 1 
or after combined treatment-infusion / exposure to the maternal defence test (stress condition; D-F) on LD 7. 
The occurrence of arched back nursing (ABN; A, D), sum of all nursing postures (nursing; B, E) and mother-pup 
interaction (C, F) is presented. Dams were acutely bilaterally infused with vehicle (VEH) or the V1bR antagonist 
SSR149415 (V1bR-A; for details see Figure 24). Data are presented as means + SEM (n = 18 - 19 per group). + p 
≤ 0.05 versus previous sample of the same group; * p ≤ 0.05, (*) p = 0.054 versus VEH.  
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4.4.3.2 Maternal care under stress conditions.  
ABN differed significantly depending on time (two-way ANOVA for repeated measures; 
factor time: F2,68 = 16.18, p < 0.001, η² = 0.21; Figure 26D) but not on treatment; a significant 
time x treatment interaction (F2,68 = 3.31, p = 0.042, η² = 0.04) was found. The post-hoc test 
revealed that in the V1bR antagonist group ABN dropped at t+30 compared to basal (p = 
0.002) and increased at t+60 compared to t+30 (p < 0.001). Furthermore, at t+60 V1bR 
antagonist-treated dams showed by trend more ABN compared to VEH dams (p = 0.054). 
Nursing differed significantly depending on time (F2,68 = 14.30, p < 0.001, η² = 0.19; Figure 
26E) but not on treatment; a significant time x treatment interaction (F2,68 = 3.83, p = 0.027, 
η² = 0.05) was found. The post-hoc test revealed a drop in nursing at t+30 compared to basal 
(p = 0.03) and an increase at t +60 compared to t+30 (p < 0.001) in the V1bR antagonist-
treated group, resulting in significantly higher nursing compared to basal (p = 0.025). 
Furthermore, at t+60 V1bR antagonist-treated dams showed significantly more nursing 
compared to VEH dams (p = 0.018). 
Mother-pup interaction differed significantly depending on time (F2,68 = 12.20, p < 0.001, η² = 
0.16; Figure 26F) but not on treatment; no time x treatment interaction was found. Separate 
one-way ANOVA for repeated measures revealed a significant effect of time within the 
antagonist-treated dams only (F2,34 = 11.80, p < 0.001, η² = 0.41); mother-pup interaction 
increased at t+60 compared to t+30 (p < 0.001), resulting in significantly higher mother-pup 
interaction compared to basal (p = 0.016). 
 
4.4.3.3 Maternal motivation in the PRT.  
The treatment groups did not differ in any parameter, neither in the conventional nor the 
modified PRT (data not shown). 
 
4.4.3.4 Maternal aggression in the maternal defence test.  
During the maternal defense test, aggressive behavior towards the female virgin intruder 
was not different between the groups. Pup-directed behavior was decreased in the V1bR 
antagonist-treated group compared to VEH (independent t-test; t34 = 2.15, p = 0.045, d = 
0.72; Table 3). In detail, licking / grooming of the pups (t34 = 2.34, p = 0.031, d = 0.78), but no 
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other maternal parameter, was lower in the V1bR antagonist-treated dams compared to 
VEH. No other non-aggressive behavior was affected by any treatment. 
 
4.4.3.5 Anxiety-related behaviour on the EPM.  
The treatment groups did not differ in any parameter on the EPM (data not shown). 
 
Table 3 Effect of V1bR blockade within the mpBNST on maternal aggression on LD 7  
        VEH V1bR antagonist 
   
aggressive behaviour   
number of attacks      5.2 ± 1.0     5.9 ± 1.0 
attack duration     3.5 ± 0.7 s     3.6 ± 0.6 s 
attack latency 181.0 ± 41.0 s 156.8 ± 38.0 s 
keep down   13.0 ± 4.7 s   24.6 ± 6.9 s 
lateral threat     7.2 ± 3.2 s     7.7 ± 2.1 s 
offensive upright     2.3 ± 0.8 s     3.9 ± 1.6 s 
aggressive grooming   24.3 ± 4.6 s   27.6 ± 5.2 s 
sum aggressive 228.0 ± 31.0 s 279.5 ± 22.3 s 
   
non-aggressive behaviour   
pup-directed behaviour   58.8 ± 18.8 s   17.4 ± 4.4 s * 
direct contact   25.2 ± 12.3 s     8.0 ± 3.4 s 
licking / grooming   33.2 ± 10.7 s     7.7 ± 2.1 s * 
carrying     0.4 ± 0.2 s     1.7 ± 1.4 s 
Sniffing   64.8 ± 7.7 s   58.0 ± 4.4 s 
Exploration 136.2 ± 18.6 s   96.7 ± 14.3 s 
self-grooming   75.8 ± 7.7 s   81.3 ± 12.9 s 
Resting   14.5 ± 4.1 s   30.9 ± 8.7 s 
Other   17.8 ± 5.0 s   23.1 ± 8.3 s 
sum non-aggressive 367.9 ± 30.8 s 307.4 ± 23.7 s 
Abbreviations: mpBNST, medial-posterior part of the bed nucleus of the stria terminalis; V1bR, V1b receptor; 
VEH, vehicle. 
Data are presented as mean ± SEM (n = 18 per group). * p ≤ 0.05 versus VEH.  
C h a p t e r  4  94 
4.5 Discussion 
In the present study we show that, although neither V1bR mRNA or protein levels in the 
MPOA or the BNST of lactating rats undergo peripartum-associated changes, V1bR play a 
role in mediating various aspects of maternal behavior in a brain region-specific manner. 
Within the MPOA, V1bR blockade increased pup retrieval, whereas in the mpBNST the same 
treatment reduced pup-directed behavior during the maternal defense test. 
V1bR are distributed across numerous areas of the rat brain as demonstrated in male 
rodents (Hernando et al., 2001), where they are implicated in mediating social behaviors 
(Caldwell et al., 2008) like social recognition and memory, social motivation and inter-male 
aggression (Pagani et al., 2015; Wersinger et al., 2008, 2004, 2002; for review see Stevenson 
and Caldwell, 2012). Importantly, V1bR are also expressed in brain areas known to be 
involved in the regulation of maternal behavior, i.e. the MPOA and BNST (for reviews see 
Bosch and Neumann, 2012; Numan and Insel, 2003). Here, V1aR binding is up-regulated 
during lactation as part of peripartum adaptations (Bosch and Neumann, 2008; Bosch et al., 
2010; for review see Bosch and Neumann, 2012). Our current study reveals that neither 
V1bR mRNA nor protein levels differed within the MPOA or the BNST between lactating and 
virgin rats. Here, the use of virgins at random estrous stages is a limitation of the study, since 
the estrous stage can affect gene expression (Nakamura et al., 2010). Hence, a potential 
variability in virgins’ V1bR expression may mask differences between virgin and lactating 
rats. However, the current data suggest that any involvement of V1bR in maternal behavior 
is not regulated at the gene expression or protein synthesis level, but rather relies on a 
preexisting pool of V1bR or changes in receptor binding as described for V1aR (Bosch and 
Neumann, 2008; Bosch et al., 2010).  
Investigations of the impact of V1bR on maternal behavior started a few years ago and are 
still sparse to date. Wersinger et al. (2007) were the first to demonstrate that the lack of 
V1bR lowers maternal aggression in lactating V1bR knockout mice compared to wildtype 
mice. Recently, we showed that acute central infusion of the V1bR antagonist SSR149415 
impairs mother-pup interaction in lactating Wistar rats (Bayerl et al., 2014). Due to this 
central approach, reflecting a global rather than a site-specific manipulation, we now aimed 
to investigate the behavioral role of V1bR within the MPOA and mpBNST. 
The importance of the MPOA in maternal behavior has been shown in various studies 
starting in the 1950s; Fisher described that intracranial chemical stimulation of the MPOA 
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induces maternal behavior (Fisher, 1956). Later, Numan and colleagues demonstrated that 
knife cuts of the lateral projections of the MPOA disrupt maternal behavior (Numan and 
Callahan, 1980; Numan, 1990). With respect to the AVP system in the MPOA, V1aR have 
been shown to facilitate the onset (Pedersen et al., 1994) as well as the maintenance of 
established maternal care in lactating rats (Bosch and Neumann, 2008). Furthermore, 
depending on the interaction with the offspring, AVP is locally released within the MPOA 
(Bosch et al., 2010) and, thus, binding to both the V1aR and the V1bR. In the present study, 
local infusion of the V1bR antagonist into the MPOA decreased maternal care under stress, 
but not under non-stress conditions. This is partly in line with our results on central V1bR 
antagonism and stressor exposure where especially nursing and mother pup-interaction 
were reduced (Bayerl et al., 2014). Hence, our study suggests that V1bR activation within the 
MPOA seems to be beneficial in order to reinstate adequate maternal care after exposure to 
an acute stressor. 
In addition to maternal care, the MPOA is highly important for mediating maternal 
motivation to retrieve pups (for reviews see Numan and Insel, 2003; Olazábal et al., 2013). 
For example, excitotoxic or electrical lesions of the MPOA, as well as knife cuts that sever the 
dorsolateral connections of the MPOA impair pup retrieval (Franz et al., 1986; Kalinichev et 
al., 2000; Lee et al., 2000; Numan and Corodimas, 1985; for review see Numan, 1988). This 
maternal behavior has been attributed to the activity of the AVP system within the MPOA; 
preventing V1aR activation significantly reduces pup retrieval in lactating rats (Bosch and 
Neumann, 2008; Pedersen et al., 1994). In contrast, blocking V1bR facilitated pup retrieval 
independent of the PRT setup (Figure 25). Thus, it is feasible that the behavioral outcome of 
parallel activation of V1aR and V1bR within the MPOA reflects the integration of facilitating 
and impairing maternal motivation to retrieve pups, respectively. Notably, as non-
manipulated lactating rats show high levels of motivation to retrieve pups, it can be assumed 
that V1aR is the predominant receptor subtype in this brain region. In this context it would 
be interesting to determine the ratio of V1aR / V1bR expression in the MPOA of lactating 
rats. Based on the fact that within the MPOA V1aR binding is increased in lactation (Bosch 
and Neumann, 2008) whereas V1bR expression is unchanged compared to virgin rats (this 
study), we speculate that in lactating rats activation of V1aR overrule V1bR, thereby 
facilitating pup retrieval. This might also be the cause for higher pup retrieval in lactating 
HAB dams (for review see Bosch, 2011); the higher AVP synthesis and release due to a single 
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nucleotide polymorphism in the promotor region of the gene might result in excessive 
activation of V1aR over V1bR. Conversely, in virgin rats V1aR binding is lower than in 
lactation, which would increase the power of V1bR activation thereby potentially causing 
avoidance to retrieve pups in virgin rats (Rosenblatt, 1975). Future studies investigating 
V1bR binding could serve to clarify this hypothesis. 
In addition to the MPOA, the BNST is also involved in the regulation of maternal behavior 
(for reviews see Bosch and Neumann, 2012; Bosch, 2011; Numan and Insel, 2003). For 
example, bilateral knife-cuts disrupting the dorsolateral connections of the MPOA/BNST 
region (Numan and Callahan, 1980) as well as excitotoxic lesions of the BNST (Numan and 
Numan, 1996) impair aspects of maternal care in lactating rats. Regarding the AVP system in 
the BNST, V1aR do not mediate maternal care or pup retrieval as demonstrated by local 
V1aR blockade (Bosch et al., 2010). In the present study, we extend these findings by 
showing that V1bR in the mpBNST are not involved in those behaviors either, at least under 
non-stress conditions (Figure 3). However, under stress condition, a preceding intra-mpBNST 
infusion of the V1bR antagonist, but not VEH, resulted in decreased ABN and nursing during 
the 30 min immediately after termination of the maternal defense test. This is in line with 
our previous study, thereby strengthening our hypothesis that V1bR might be involved in 
adequate stress coping (Bayerl et al., 2014). 
The BNST is also involved in maternal aggression (Bosch et al., 2010; Consiglio et al., 2005; 
Klampfl et al., 2014; for review see Bosch, 2011). For example, injections of OXT in the 
anterior part of the BNST (Consiglio et al., 2005) as well as V1aR antagonism in the posterior 
BNST significantly decreases maternal aggression towards the female virgin intruder rat 
(Bosch et al., 2010). Interestingly, as OXT receptor and V1aR binding in the BNST are 
unchanged in response to the maternal defense test (Caughey et al., 2011) it is suggested 
that local neuropeptide release rather than changes on the receptor level modify the extent 
of maternal aggression, as described for the CeA (Bosch et al., 2005). However, since local 
infusion of the V1bR antagonist in the mpBNST did not alter maternal aggressive behavior 
(Table 3 top) we assume that only V1aR in this region are involved in mediating maternal 
aggression itself. Interestingly, during the maternal defense test dams treated with the V1bR 
antagonist displayed less pup-directed behavior (Table 3 bottom), which is not apparent in 
V1aR antagonist-treated dams (Bosch et al., 2010). These findings suggest a V1 receptor 
subtype-specific role, at least during the maternal defense test; AVP released within the 
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mpBNST facilitates aggressive behavior towards the intruder via V1aR, whereas activation of 
V1bR during maternal aggression induces pup-directed behavior to protect the offspring 
from threats by the intruder and, thus, to provide maternal care even under stressful 
situations.  
Treatment with the V1bR antagonist in the MPOA or the mpBNST did not alter anxiety-
related behavior. While the MPOA has not been related to anxiety, a role of the BNST has 
been described in various studies in virgin (female and male; Pezuk et al., 2008; Sahuque et 
al., 2006; Walker et al., 2003) and lactating rats (Klampfl et al., 2014; for review see Lonstein, 
2007) independent of the AVP system. However, V1 receptors in the mpBNST are seemingly 
not involved in anxiety-related behavior given local inhibition of V1bR (this study) or V1aR 
(Bosch et al., 2010) did not affect this behavior. 
In conclusion, our data demonstrate that preventing AVP to bind to V1bR in the MPOA 
promotes maternal motivation to retrieve pups, suggesting an opposing role compared to 
V1aR (Bosch and Neumann, 2008). Furthermore, within the mpBNST both V1aR (Bosch et al., 
2010) and V1bR (this study) complement each other, as receptor blockade impairs defense 
and protection of the offspring, respectively. Hence, we provide strong evidence for a brain-
site specific involvement of V1bR in the MPOA and mpBNST for various aspects of maternal 
behavior in lactating rats. These peripartum functions seem to be essential for the proper 
display of maternal behavior, thereby further advancing our knowledge of the involvement 
of the AVP system in maternal brain and consequently on potential adaptations during the 
postpartum period. 
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Chapter 5 
Vasopressin V1a, but not V1b, receptors within the PVN of  
lactating rats mediate maternal care and anxiety-related behaviour 
 
Authors’ contribution: 
Doris Bayerl: experimental design, performance of experiments, data analysis, first 
draft of manuscript 
Jennifer Hönig: performance of experiments 
Oliver Bosch: experimental design, performance of experiments, revision of 
manuscript 
 
[in preparation to be submitted to Behavioural Brain Research as Short Communication] 
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5.1 Abstract 
The brain neuropeptide AVP mediates a wide range of social behaviours via its V1a (V1aR) 
but also its V1bR.With respect to maternal behaviour, V1bR are still less investigated, 
whereas V1aR have been shown repeatedly to trigger maternal behaviour, depending on the 
brain region. Here, we aimed to study the role of both V1aR and V1bR within the PVN, a 
major source of AVP, in maternal care (LD 1), maternal motivation in the PRT (LD 3) and 
anxiety-related behaviour on the EPM (LD 5) by acute local infusion of receptor subtype-
specific antagonists for V1aR (d(CH2)5Tyr(Me)
2AVP) or V1bR (SSR149415). Furthermore, we 
compared V1bR expression in the PVN of virgin versus lactating rats (LD 4). 
Our results demonstrate that intra-PVN V1bR mRNA (qPCR) or protein (Western Blot) 
content did not differ between virgin and lactating rats. Furthermore, antagonism of V1aR, 
but not of V1bR, decreased nursing and anxiety-related behaviour. Maternal motivation was 
not affected by any treatment. 
In summary, we demonstrate subtype-specific involvement of V1 receptors within the PVN 
in various parameters of maternal behaviour and anxiety. The lack of effects after V1bR 
blockade demonstrates that AVP acts mainly via V1aR in the PVN, at least in lactating rats, to 
mediate maternal care and anxiety. 
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5.2 Introduction 
The brain neuropeptides AVP and OXT are synthesized and released within the PVN (for 
review see Landgraf and Neumann, 2004; Veenema and Neumann, 2008), and facilitate 
maternal behaviour in lactating rats (for reviews see Bosch and Neumann, 2012, 2008). 
Central AVP acts on maternal care, maternal motivation and maternal aggression via two 
receptor subtypes in the brain, namely V1aR and V1bR (Bayerl et al., 2014; Bosch and 
Neumann, 2008; Nephew and Bridges, 2008a). Furthermore, the AVP system is upregulated 
around parturition and during lactation (Caldwell et al., 1987), as indicated by higher V1aR 
binding and increased AVP release during mother-pup interaction in the MPOA and the BNST 
(for review see Bosch and Neumann, 2012) as well as increased AVP mRNA expression within 
the PVN (Bosch et al., 2007; Walker et al., 2001). Interestingly, the PVN is also involved in the 
expression of maternal behaviour as shown by lesion studies (Insel and Harbaugh, 1989; 
Numan and Corodimas, 1985). Furthermore, pup-presentation increases c-fos expression 
only within the anterior magnocellular part of the PVN (amPVN) but not the parvocellular 
subdivision of the PVN (pPVN) in maternal rats (for review see Numan and Insel, 2003). We 
now aimed to study the impact of the AVP system in the PVN on maternal and anxiety-
related behaviour by receptor subtype-specific antagonism of V1aR and V1bR in lactating 
rats. 
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5.3 Material and Methods 
5.3.1 Animals 
In all experiments, female Wistar rats (12 - 14 weeks, 220 - 250 g, Charles River, Sulzfeld, 
Germany) were kept under standard laboratory conditions (12 h / 12 h light-dark cycle, with 
lights on at 07:00 h; 22 ± 1 °C; 55 ± 5 % relative humidity; free access to water and standard 
rat chow). For the lactating groups, virgin females were mated with stud males and 
pregnancy was confirmed the next day by the presence of sperm in vaginal smears (assigned 
as PD 1). Rats were kept in groups of 3 to 4 rats before they were single-housed on PD 18 (or 
equivalent in virgins) to ensure undisturbed parturition. All experiments were performed in 
accordance with the European Communities Council Directive (86/609/EEC) and were 
approved by the local government of the Oberpfalz, Bavaria, Germany. 
 
5.3.2 V1bR mRNA and protein in the PVN 
To determine V1bR mRNA and protein content within the PVN, lactating rats were sacrificed 
on LD 4 (or equivalent in virgins at random stages of the oestrous cycle), brains were 
removed, snap-frozen in n-methylbutane on dry ice and stored at -80 °C until punches from 
the PVN were taken to measure mRNA via qPCR and protein content via Western Blot 
analysis as described previously (Bayerl et al., 2016).  
 
5.3.3 Local blockade of V1aR and V1bR within the PVN 
5.3.3.1 Implantation of local guide cannulae.  
For behavioural analysis, on PD 18 females were implanted bilaterally with stainless steel 
guide cannulae (23 G, 12 mm length) 2 mm above the PVN (1.4 mm posterior, 1.8 / 2.1 mm 
lateral to bregma, 6.0 mm ventral, angle 10°; (Paxinos and Watson, 2007)) under inhalation 
anaesthesia and semi-sterile conditions as described before (Bayerl et al., 2014; Bosch and 
Neumann, 2008). At the end of the surgery, rats received 0.12 ml of the antibiotic 
Enrofloxacin (Baytril 2.5 %, Bayer Vital GmbH, Leverkusen, Germany) subcutaneously to 
prevent inflammation. Afterwards, pregnant rats were single housed and treated as 
described previously (Bayerl et al., 2016, 2014). 
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5.3.3.2 Infusion of receptor subtype-specific V1aR or V1bR antagonist.  
On experimental days, dams received acute bilateral infusion of V1aR antagonist 
d(CH2)5Tyr(Me)
2AVP (100 ng / 0.5 µl VEH / side (Kruszynski et al., 1980)), V1bR antagonist 
SS149415 (100 ng / 0.5 µl VEH / side (Serradeil-Le Gal et al., 2002)) or respective VEH (0.5 µl 
/ side; V1aR: sterile Ringer’s solution; V1bR: sterile Ringer’s solution + 5 % dimethyl 
sulphoxide; pH 7.4; B. Braun Melsungen, Melsungen, Germany) 10 min prior to the test via 
an infusion cannula (27 G, length 14 mm, i.e. 2 mm longer than the guide cannula) as 
described previously (Bayerl et al., 2016). All behavioural experiments were conducted 
between 9:00 A.M. and 1:00 P.M. 
 
5.3.4 Behavioural tests 
5.3.4.1 Maternal care observation.  
On LD 1, maternal care was observed 60 min before treatment infusion at 10:00 A.M. and 
two hours immediately afterwards for approximately 10 s every second minute in 60 min 
intervals according to an established protocol (Bayerl et al., 2014; Bosch and Neumann, 
2008). The quality of nursing was reflected by the amount of ABN, the only active nursing 
posture in which the dam is engaged in a quiescent kyphosis (for review see Bosch and 
Neumann, 2012). Other parameters scored were nursing, in which all nursing positions (ABN, 
blanket posture and lying on side or back) are summed up. On LD 2, maternal care was 
observed one additional hour in the morning from 9:00 – 10:00 A.M. to control for potential 
long-term effects of the antagonists. 
 
5.3.4.2 Maternal motivation to retrieve pups in the PRT. 
On LD3, the motivation of the dams to retrieve their pups after a 60-min separation period 
was measured in the conventional PRT as described previously (Bayerl et al., 2014). Ten 
minutes before the test, dams were infused with their respective treatment, pups were 
brought to the experimental room and distributed in a white plastic box (54 x 34 x 32 cm³) 
covered with home-cage bedding. Subsequently, the dams were placed in the middle of the 
box and the number of retrieved pups was scored for a maximum of 15 min. 
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5.3.4.3 Anxiety-related behaviour on the EPM. 
On LD 5 dams were tested for their anxiety-related behaviour on the EPM as described 
previously (Bosch and Neumann, 2008; Pellow et al., 1985). The EPM consists of two open 
arms (50 x 10 cm²; 90 lux) and two closed arms (50 x 10 cm²; height of walls: 30 cm; 10 lux) 
connected by a neutral zone (10 x 10 cm²; 65 lux) and is elevated 80 cm over the floor. Dams 
were infused with their respective treatment 10 minutes before testing, placed subsequently 
in the neutral zone facing a closed arm and allowed to freely explore the maze for 5 min. The 
percentage of time spent on the open arms (versus all arms) and the percentage of open 
arm entries (versus all arm entries) is indicative for anxiety-related behaviour; the number of 
closed arm entries is a measure for locomotion (Bosch and Neumann, 2008). 
 
5.3.5 Verification of cannulae placement 
At the end of the behavioural experiments, rats were sacrificed and blue ink was infused via 
the implanted cannulae. Brains were removed, snap-frozen in n-methylbutane on dry ice, 
cut into 40 µm coronal sections, slide mounted, and stained via quick Nissl staining. Correct 
placement was considered using the rat brain atlas (Paxinos and Watson, 2007); only rats 
with both cannulae placed correctly were included in the statistical analysis (see Figure 27). 
 
 
Figure 27 Verification of cannulae placement 
sites in the PVN 
Areas of the PVN (grey shaded areas) in which 
the placement of the guide cannulae were 
counted as successful implantation (modified 
from Paxinos and Watson, 2007); the number 
indicates the distance in millimetres posterior to 
Bregma. 
Abbreviations: LV, lateral ventricle; ox, optic 
chiasm. 
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5.3.6 Statistical analysis 
Maternal care and maternal motivation was analyzed using two-way ANOVA for repeated 
measures (factors: time x treatment). The ANOVAs were followed by Sidak post-hoc 
correction if main effects were found. When only a time effect was found, an additional 
separate one-way ANOVA for repeated measures (factor: time) with subsequent Sidak post-
hoc correction was performed for each treatment group. Anxiety-related behaviour as well 
as V1bR mRNA and protein content were analyzed using independent t-test, after testing for 
normal distribution (Kolmogorov-Smirnov test). Data are presented as mean + SEM, and 
significance was considered at p ≤ 0.05. For all analysis the software package SPSS, Version 
20 (IBM, Ehningen, Germany) was used. 
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5.4 Results 
5.4.1 Expression of V1bR in the PVN of virgin versus lactating rats 
V1bR mRNA as well as protein expression were similar between the groups (independent t-
test; mRNA: t7 = 2.048, p = 0.08, protein: t7 = -1.399, p = 0.204; Table 4). 
 
Table 4 Expression of V1b receptor mRNA and protein within the PVN 
  expression values 
   mRNA virgin 1.00 ± 0.38 
(relative to virgin) lactating 0.28 ± 0.10 
   
protein virgin 1.00 ± 0.14 
(relative to total protein) lactating 1.34 ± 0.20 
Data are presented as mean ± SEM (n = 3-6).  
 
 
5.4.2 Local blockade of V1aR or V1bR within the PVN 
5.4.2.1 Maternal care under non-stress conditions 
Nursing was altered depending on time (V1aR antagonist: F2,18 = 4.313, p = 0.029; V1bR 
antagonist: F2,36 = 4.554, p = 0.017; Figure 28), but not on treatment; no time x treatment 
interaction was detected. Separate one-way ANOVA showed a significant time effect for 
both antagonist-treated groups (V1aR antagonist: F2,10 = 9.18, p = 0.005; V1bR antagonist: 
F2,16 = 3.962, p = 0.04), but not for VEH-treated dams. In detail, the post hoc test revealed for 
V1aR antagonist-treated dams a decrease in the 60 min after infusion compared to basal (p = 
0.043). No further differences in V1bR antagonist-treated dams were found. 
Maternal care was not affected by treatment on LD 2. 
 
5.4.2.2 Maternal motivation in the PRT 
Maternal motivation was not affected by antagonism of any V1 receptor (not shown). 
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Figure 28 Effect of V1aR or V1bR antagonism within 
the PVN on nursing 
The mean occurrence of nursing before (basal) and in 
the two hours after treatment infusion (+60min and 
+120 min) is presented. Dams were bilaterally infused 
with the V1aR antagonist d(CH2)5Tyr(Me)
2
AVP (100 
ng/0.5 µl vehicle per side), the V1bR antagonist 
SSR149415 (100 ng/0.5 µl Ringer per side) or the 
respective vehicle (VEH; V1aR: 0.5 µl Ringer’s solution 
per side; V1bR: 0.5 µl Ringer’s solution containing 5 % 
dimethyl sulphoxide per side).  
Data are presented as means + SEM (V1aR antagonist 
= 5 – 6; V1bR antagonist = 9 - 11).  
# p ≤ 0.05 versus previous sample of the same group. 
 
 
5.4.2.3 Anxiety-related behaviour on the EPM. 
Anxiety-related behaviour on the EPM was decreased after blocking V1aR in the PVN (% time 
on the open arms: t9 = -2.681, p = 0.025; % open arm entries: t9 = -2.399, p= 0.04; Figure 29), 
whereas locomotion was unchanged (data not shown). Blockade of V1bR did not affect 
anxiety-related behaviour (not shown). 
 
 
Figure 29 Effect of V1aR antagonism within the 
PVN on anxiety-related behaviour on the EPM 
The percentage of time spent in (left) and 
percentage of entries into (right) the open arms of 
the EPM after V1aR antagonist infusion (for details 
see Figure 28) as assessed 10 min after treatment 
infusion on LD 5 are presented.  
Data are presented as means + SEM (n = 5 - 6).  
* p ≤ 0.05 versus VEH. 
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5.5 Discussion 
In the present study we demonstrate that intra-PVN V1aR modulate maternal care and 
anxiety-related behaviour whereas V1bR were not found to modulate any maternal 
behaviour. In line, V1bR mRNA and protein expression within the PVN do not adapt due to 
lactation. 
Similar to unchanged AVP mRNA expression and V1aR binding within the PVN of lactating 
versus virgin rats (Bosch and Neumann, 2010), V1bR mRNA as well as protein expression 
were similar between virgin and lactating rats. Thus, both receptors are seemingly not 
adapted during the peripartum period within the PVN as seen, for example, in the MPOA or 
BNST (Bosch and Neumann, 2008; Bosch et al., 2010). These findings indicate that a putative 
role of intra-PVN V1 receptors in maternal behaviour is probably based on changes in their 
activation via local AVP release or in the receptor signalling cascades, which should be 
addressed in future studies. 
In the behavioural assessment of V1 subtype-specific manipulation within the PVN, we found 
that nursing on LD 1 was decreased only after infusion of the V1aR antagonist. This might 
indicate a specific role of local V1aR activation for the adequate expression of maternal care, 
e.g. after experiencing a mild stressor such as the infusion procedure (Klampfl et al., 2013). 
However, exposure to a stronger stressors like the maternal defence test (Neumann et al., 
2001) could further highlight the involvement of the V1 receptor subtypes in maternal 
behaviour, as intra-PVN AVP release is elevated during the maternal defence test in lactating 
females (Bosch, O.J. & Meddle, S.L., unpublished data). Since none of the behaviours 
differed on LD 2 in any group, a long-term effect of either V1 antagonist can be excluded, 
which is in accordance with previous studies (Bayerl et al., 2016, 2014; Bosch and Neumann, 
2008). 
None of the antagonists affected maternal motivation to retrieve pups in the PRT. These 
results were somewhat predicted since lesion of the PVN before - but not after - delivery 
impair pup retrieval (Insel and Harbaugh, 1989) and in the present study the V1 receptors 
were antagonised postpartum immediately before performing the test. Furthermore, pup 
retrieval is mainly mediated via the MPOA (for review see Numan and Insel, 2003), where 
they, indeed, depend upon the simultaneous local activation and deactivation of V1aR 
(Bosch and Neumann, 2008) and V1bR (Bayerl et al., 2016), respectively.  
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Anxiety-related behaviour on the EPM was decreased after blocking V1aR in the PVN. This is 
in line with an earlier study on HAB males, where intra-PVN V1aR antagonist tended to act 
anxiolytic (Wigger et al., 2004). In contrast, blockade of V1bR did not affect anxiety-related 
behaviour, similar to central (Bayerl et al., 2014) as well as local infusion of the V1bR 
antagonist into the BNST and the MPOA of lactating rats (Bayerl et al., 2016). The current 
findings are in contrast to studies in male rats where orally administered V1bR antagonist 
acts anxiolytic (Serradeil-Le Gal et al., 2002). However, both the administration route and the 
gender differences might underlie the differences in the findings. Hence, in lactating females 
the anxiolytic effect of AVP is rather mediated via V1aR than V1bR. 
Interestingly, lactating mothers of the HAB breeding line are characterized by an increased 
synthesis of AVP, which is positively correlated to the high levels of maternal care (for review 
see Bosch, 2011). Central blockade of V1aR within HAB dams decreased ABN and anxiety-
related behaviour, whereas synthetic AVP in LAB dams increased these behaviours. In our 
Wistar rats, we found decreased nursing and anxiety-related behaviour after V1aR 
antagonism. The different outcomes of V1aR blockade demonstrate the brain region specific 
involvement in the regulation of distinct aspects of maternal behaviour. In addition, 
breeding line differences might be responsible for opposing outcomes. 
Interestingly, the subregions of the PVN are activated differently, depending on the stimulus. 
While the amPVN is activated by pup presentation, the pPVN is linked to activation of CRF 
and AVP neurons resulting of HPA axis activation (for review see Numan and Insel, 2003). As 
we cannot distinguish between the subdivisions with our intra-PVN infusions, the different 
results might be obtained by activation/blockade of both PVN subdivisions in parallel. 
Taken together, our data provide further insight in the complex, brain region-specific 
regulation of different aspects of maternal behaviour via V1 receptor subtypes. As 
uncovered in this study, only one of the two V1 receptors might play a role for a certain 
behaviour within a specific brain area, whereas in other regions both V1aR and V1bR may 
act in a similar manner or even counteract each other. Our data advances the understanding 
of postpartum adaptations and, therefore, of possible maladaptations with severe 
consequences for the offspring. 
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Chapter 6 
More than reproduction - central blockade of GnRH and kisspeptin 
decrease maternal behaviour in lactating rats 
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6.1 Abstract 
GnRH is a major regulator and activator of the HPG axis. Many studies proofed the 
importance of GnRH in reproduction and sexual behaviour. However, to date only one study 
shows an involvement of GnRH in maternal behaviour; 30% reduction of GnRH neurons 
abolishes the mother’s motivation to retrieve pups. On this basis, we aimed to investigate 
the effects of central GnRH receptor blockade on maternal care under non-stress and stress 
conditions, maternal motivation in the PRT and maternal aggression in the maternal defence 
test in lactating rats. We found reduced maternal aggression in dams infused with the GnRH 
antagonist (luteneizing hormone-releasing hormone antagonist); no other behaviour was 
affected. Due to the fact that GnRH also binds to the kisspeptin receptor GPR54, and 
behavioural effects may be mediated via kisspeptin, a second set of lactating rats were 
centrally infused with three doses of the GPR54 antagonist kisspeptin-234 (0.002 µg/ µl; 0.02 
µg/ µl; 0.2 µg/ µl) followed by observation of maternal care under non-stress and stress 
conditions, as well as maternal aggression. While maternal care under non-stress conditions 
was decreased by the low dose of GPR54 antagonist, maternal care under stress conditions 
was decreased by the medium dose. Maternal aggression was not affected by any dose. 
Taken together we extend the knowledge on GnRH modulating maternal behaviour; GnRH 
receptor activation is necessary for protection of the offspring. Further, we demonstrate for 
the first time that maternal care is lowered by antagonism of GPR54. These findings shed 
new light on two hormones of the reproductive axis, extending their functions to the 
maternal behaviour. 
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6.2 Introduction 
Throughout all mammalian species, the hormones of the HPG-axis play a distinct role in the 
endocrine control of reproduction. The HPG-axis is triggered by GnRH, which is synthesized 
from neurons in the hypothalamus and released at the median eminence into the 
hypophyseal portal system. At the pituitary level, GnRH facilitates the release of LH and FSH 
(for review see Ellis, 2013). Thus, GnRH in the brain acts as a neurohormone, important for 
the release of steroids into the bloodstream, which in turn facilitate sexual behaviour. GnRH 
neurons are also found in brain areas like the amygdala, the MPOA and ARC (Moss and 
Foreman, 1976; Yoon et al., 2005), where GnRH is thought to process information about 
olfactory cues and circadian rhythm (Wen et al., 2011), to facilitate puberty and mating 
behaviour (Yoon et al., 2005). The GnRH system consists of the hormone itself, from which 
more than 20 isoforms are known to date (Millar, 2005), and two GPCR subtypes: GnRH-I 
and GnRH-II, with only GnRH-I being active in rats and humans (Millar, 2005). GnRH is 
released in pulses (Millar, 2005) and follows a similar circadian rhythm as AVP (Funabashi et 
al., 2000). Further, in vivo studies showed that the release of AVP into the hypothalamo-
neurohypophysial system of rats can be stimulated by icv infusion of a GnRH agonist 
(Boczek-Leszczyk et al., 2010). Interestingly, both GnRH and AVP can modulate the 
expression of maternal behaviour; transgenic lactating mice with systemically 30% less GnRH 
neuron show decreased pup retrieval (Brooks et al., 2012), and AVP and its V1 receptors 
directly impact on the various components of maternal behaviour (Bayerl et al., 2016, 2014; 
Bosch and Neumann, 2008; Nephew and Bridges, 2008a; Pedersen et al., 1994, 1982; for 
review see Bosch, 2013, 2011; Bosch and Neumann, 2012). 
GnRH neurons also innervate kisspeptin neurons (Kalló et al., 2013) as well as kisspeptin can 
activate GnRH neurons (Han et al., 2005; Liu et al., 2008), thereby triggering the release of 
GnRH (Guerriero et al., 2012; for review see d’Anglemont de Tassigny and Colledge, 2010). 
Kisspeptin is secreted from neurons of the anteroventral periventricular nucleus (AVPV) and 
the ARC (Clarkson and Herbison, 2006; Han et al., 2005) and mediates its action via binding 
to GPR54 (also known as KISS1 receptor or AXOR12; Lee et al., 1999), a member of the Gq11 
family of GPCRs (Kotani et al., 2001; Muir et al., 2001). In most studies the kisspeptin system 
is linked to sexual and reproductive behaviour (de Roux et al., 2003; Funes et al., 2003; 
Seminara et al., 2003), in which the neuropeptides AVP and OXT are also involved (for review 
see Bosch and Neumann, 2012). Interestingly, both neuropeptides not only modulate 
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maternal behaviour (for review see Bosch and Neumann, 2012) but, moreover, can be 
stimulated by kisspeptin (Rao et al., 2011; Scott and Brown, 2013). 
In confirmation, a pilot study showed co-expression of AVP and GnRH after immuno-
fluorescent staining of slices containing the OVLT of lactating eGFP rats (unpublished data, 
Ueta Y., Grinevich V.; also see Section 1.4). The OVLT is part of the anterioventral third 
ventricle (AV3V) region, which is known to be responsible for a balanced AVP secretion 
(McKinley et al., 2004). Furthermore, it is interconnected with the median preoptic nucleus, 
which is located near the MPOA, known to be involved in maternal behaviour (for review see 
Numan and Insel, 2003). 
Due to those complex interactions as described above as well as the evidence that the GnRH 
system affects pup retrieval we aimed to further investigate the role of kisspeptin and GnRH 
in maternal behaviour. In two independent experiments, early lactating rats were acutely 
infused icv with either a GnRH receptor antagonist (Experiment 1) or a GPR54 antagonist 
(Experiment 2), followed by obseravtions of maternal care, maternal motivation in the PRT 
and maternal aggression. 
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6.3 Material & Methods 
6.3.1 Animals 
Rats were kept under standard laboratory conditions (12 h / 12 h light-dark cycle, with lights 
on at 07:00 h; 22 - 25 °C; 55 ± 5 % relative humidity; free access to water and standard rat 
chow). Virgin female Wistar rats (12 - 14 weeks, 220 - 250 g, Charles River, Sulzfeld, 
Germany) were mated with sexually experienced stud Wistar males. Pregnancy was 
confirmed the next day by the presence of sperm in vaginal smears (assigned as PD 1). Rats 
were kept in groups of 3 to 4 rats until PD 18, after which rats were single housed in 
plexiglass observation cages (38 x 22 x 35 cm³) to ensure undisturbed parturition. The 
following days until PD 21, rats were handled twice daily to avoid unspecific stress responses 
during the experiments. On the day of birth offspring were culled to eight pups of mixed 
sexes and half of the bedding was replaced by new one. 
Naive virgin female Wistar rats (10 weeks, 180 - 220 g; Charles River) at random stages of 
their oestrous cycle were used as intruders in the maternal defence test. They were kept 
group-housed up to 4 rats in a separate room until the behavioural testing to avoid olfactory 
recognition by the lactating mothers (for review see Bosch, 2013). 
All experiments were performed in accordance with the European Communities Council 
Directive (86/609/EEC) and were approved by the local government of the Oberpfalz, 
Bavaria, Germany. 
 
6.3.2 Experimental schedule 
On PD 18, females were implanted with a stainless steel guide cannula (21 G, 12 mm length) 
2 mm above the right lateral ventricle (1.0 mm posterior, 1.6 mm lateral to bregma, 2.0 mm 
ventral; Paxinos and Watson, 2007) under inhalation anaesthesia (Isoflurane; Baxter 
Germany GmbH, Unterschleißheim, Germany) and semi-sterile conditions as described 
before (Bayerl et al., 2014; Bosch et al., 2010). At the end of the surgery, rats received 0.12 
ml of the antibiotic Enrofloxacin (Baytril 2.5 %, Bayer Vital GmbH, Leverkusen, Germany) 
subcutaneously to prevent inflammation. 
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6.3.2.1 Experiment 1: Icv infusion of GnRH antagonist 
Starting on LD 1, lactating dams received daily an acute infusion of 5 µl VEH (sterile Ringer’s 
solution; pH 7.4; B. Braun Melsungen AG, Melsungen, Germany) or GnRH antagonist (10-6 M; 
Luteneizing Hormone-Releasing Hormone Antagonist, Trifluoroacetate, Bachem, Bubendorf, 
Switzerland). The dose was chosen based on previous studies (Csabafi et al., 2013) and 
infused with an infusion cannula (25 G, length 14 mm, i.e. 2 mm longer than the guide 
cannula) as described previously (Neumann et al., 2000). Maternal care of lactating dams 
was observed on LD 1 under non-stress conditions, followed by assessment of maternal 
motivation in the PRT on LD 2. On LD 4, maternal care was monitored under stress 
conditions, i.e. directly after the maternal defence test, which itself was used to assess 
maternal aggression (see below). The dams received the same respective treatment 
throughout the experiment. 
 
6.3.2.2 Experiment 2: Icv infusion of different doses of GPR54 antagonist 
Starting on LD1, dams received a single infusion of either 5 µl VEH (Aqua ad iniectabilia, B. 
Braun Melsungen AG, Melsungen, Germany) or GPR54 antagonist (Kisspeptin 234; Tocris 
bioscience, Bristol, UK) on testing days. Due to the lack of behavioural data on the 
substance, a dose-response study with three different doses was performed (0.002 µg/ µl 
(low dose), 0.02 µg/ µl (middle dose), 0.2 µg/ µl (high dose)).  
On LD1 we observed maternal care under non-stress conditions, followed by maternal care 
observations under stress conditions, i.e. the maternal defence test on LD 3, which was also 
used to assess maternal aggression. The dams received the same respective treatment on 
both testing days. 
 
6.3.3 Behavioural tests 
6.3.3.1 Maternal care observation. 
Maternal care was observed in the home cage of the dams before and after treatment 
infusion under “non-stress” conditions. Additionally, we observed maternal care before and 
after treatment infusion followed by the maternal defence test (stress conditions; Bosch et 
al., 2005; Neumann et al., 2001; for review see Bosch, 2013). We use the term “non-stress” 
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as we want to distinguish between observations after infusion alone on LD 1 (non-stress 
condition) or infusions followed by the maternal defence test, which is a strong psychosocial 
stressor (Neumann et al., 2001), on LD 4 (stress condition). However, we are aware that the 
infusion procedure per se creates a limited amount of stress (Bayerl et al., 2014; Klampfl et 
al., 2014). 
Under non-stress conditions, dams were observed 60 min before treatment infusion (9:00 – 
10:00 A.M.) and two hours immediately after treatment infusion. Observations under stress 
conditions took place 60 min under basal conditions in the morning (9:00 – 10:00 A.M.), 
before dams were subsequently brought to the maternal defence test room. After the test 
for maternal aggression another 60 min observation period was assessed to rule out possible 
behavioural effects of stressor exposure. 
The behaviour of the mother was monitored by an experienced observer blind to the 
treatment for approximately 10 s every second minute in 30 min intervals according to an 
established protocol (Bayerl et al., 2014; Bosch and Neumann, 2008; Klampfl et al., 2013). 
ABN was used as a measure for the quality of nursing, as it reflects the only active nursing 
posture in which the dam is engaged in a quiescent kyphosis (Stern and Johnson, 1990). 
Other parameters counted were “total nursing”, in which the different nursing postures 
ABN, blanket posture and lying on side or back are summed up. All nursing postures 
including licking / grooming the pups and carrying the pups is reflected by the occurrence of 
mother-pup interaction. 
 
6.3.3.2 Maternal motivation in the PRT 
The modified PRT was performed as described earlier (Bayerl et al., 2016). Briefly, dams 
were separated from their pups 60 min prior to testing. At the same time, a red plastic house 
(13 x 17 x 11 cm³, entrance 6 x 8.5 cm²), providing a potential nesting site, was introduced, 
which the dams were allowed to explore for 150 min the day before. Ten minutes before the 
test, dams were infused with their respective treatment. The pups were brought to the 
experimental room and distributed in a black plastic box (54 x 34 x 60 cm³) covered with 
bedding. After placing the red house on one side of the box, the dams were put in the 
middle of the box (t0) and retrieval behaviour (time and number of retrieved pups) was 
scored for a maximum of 15 min (t15) by an experienced observer blind to the treatment. 
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6.3.3.3 Maternal aggression in the maternal defence test.  
Lactating mothers (residents) received their respective treatment infusion 10 min prior to 
introducing a smaller virgin female rat (intruder) into their home cage in the presence of the 
pups (Bosch et al., 2005; Neumann et al., 2001; for review see Bosch, 2013). The behaviour 
during the 10-min testing period was video-taped for later analysis by an experienced 
observer blind to the treatment. The following behaviours were scored: number of attacks, 
latency until first attack, offensive upright (the dam stands in an upright position in front of 
the intruder), keep down (the mother keeping the intruder down with her front paws), 
lateral threat (the mother engages to push the intruder aside by approaching laterally with 
her whole body), aggressive grooming (for review see Bosch, 2013) and non-aggressive 
behaviour. At the end of the test the intruder was removed from the residents’ home cage 
and maternal care was observed for another hour as described above. Intruders were used 
only once per day as well as only twice during the experiment with at least one day in-
between for recovery. 
 
6.3.4 Verification of guide cannula placement 
At the end of experiments, rats were euthanized via CO2 asphyxiation and infused with 5 µl 
ink with an infusion cannula via the implanted guide cannula. Brains were removed and cut 
with a razor blade at the implantation site of the cannula. Correct placement was considered 
if ventricles were coloured blue. Only rats with cannula placed correctly were included in the 
statistical analysis. 
 
6.3.5 Statistical analysis 
Maternal care and pup retrieval were analyzed using two-way ANOVA for repeated 
measures (factors: time x treatment). The ANOVAs were followed by Sidak post-hoc 
correction if main effects were found. If only a time effect was found, separate one-way 
ANOVA for repeated measures was performed for detailed description of the time 
differences within the treatment groups.  
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Maternal aggression, number of retrieved pups and house entrance latency was analyzed 
using independent t-test after testing for normal distribution (Kolmogorov-Smirnov Test). If 
data were not distributed normally, Mann-Whitney-U test was performed. A statistically 
significant difference was considered at p ≤ 0.05. Data are presented as means + SEM. 
Statistical analysis was performed using the software SPSS, Version 20 (IBM, Ehningen, 
Germany). 
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6.4 Results 
6.4.1 Experiment 1: Icv infusion of GnRH antagonist 
6.4.1.1 Maternal care under non-stress conditions  
ABN, blanket and total nursing were not affected by the treatment at any time point 
(Supplementary Table S4). Mother-pup interaction differed significantly depending on time 
(F4,48 = 3.02, p = 0.027), but not on treatment; no time x treatment interaction was found. 
Separate one-way ANOVA for repeated measures revealed a significant effect of time in the 
VEH-treated dams only (F4,28 = 4.19, p = 0.009). The post-hoc test did not give any further 
differences. 
 
6.4.1.2 Maternal care under stress conditions  
None of the observed behaviours differed at any time point (not shown). 
 
6.4.1.3 Maternal motivation in the PRT. 
Pup retrieval increased over time (F15,180 = 25.90, p < 0.001), but not depending on 
treatment; no time x treatment interaction was found. Number of retrieved pups and house 
entrance latency was not affected by any treatment (not shown). 
 
6.4.1.4 Maternal aggression in the maternal defence test.  
During the maternal defence test, GnRH antagonist-treated dams were less aggressive than 
VEH-treated dams (Figure 30). In detail, the number (independent t-test; t12 = 2.54, p = 
0.026; Figure 30A) and duration (t12 = 2.44, p = 0.031; Figure 30B) of attacks as well as 
offensive upright (t12 = 2.85, p = 0.023; 30C) were reduced in the GnRH antagonist-treated 
dams; although the sum of all aggressive behaviours did not differ between treatment 
groups (Figure 30D). None of the other aggressive or none-aggressive behaviours were 
altered (Supplementary Table S5).  
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Figure 30 Effect of central GnRH antagonism on maternal aggression 
The number (A) and duration of attacks (B), offensive upright (C) and the sum of aggressive behaviour (D) were 
measured on lactation day (LD) 4 in the maternal defence test 10 min after infusion of 5 µl vehicle (VEH; sterile 
Ringer’s solution; pH 7.4) or GnRH antagonist (10
-6
 M; Luteneizing hormone-releasing hormone antagonist, 
Trifluoroacetate). Data are presented as mean + SEM, n = 6 - 8 per group. * p ≤ 0.05 versus VEH. 
 
 
6.4.2 Experiment 2: Icv infusion of different doses of GPR54 antagonist 
6.4.2.1 Maternal care under non-stress conditions  
ABN differed significantly depending on time (F4,72 = 7.20, p < 0.001; Figure 31A), but not on 
treatment; no time x treatment interaction was found. Separate one-way ANOVA for 
repeated measures revealed a significant effect of time for the low (F4,20 = 6.07, p = 0.002) 
and medium dose (F4,16 = 3.31, p = 0.037), but not for the high dose. The post-hoc test did 
not show any further difference.  
Nursing differed significantly depending on time (F4,72 = 5.24, p = 0.001; Figure 31B), but not 
on treatment; no time x treatment interaction was found. Separate one-way ANOVA for 
repeated measures revealed a significant effect of time for the low dose only (F4,20 = 4.84, p 
= 0.007). Post-hoc test did not show any further difference. 
Mother-pup interaction differed significantly depending on time (F4,72 = 10.15, p = 0.005), 
but not on treatment; no time x treatment interaction was found. Separate one-way ANOVA 
for repeated measures revealed a significant effect of time for the low dose only (F4,20 = 4.62, 
p = 0.008). Post-hoc test did not show any further difference. 
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Figure 31 Effect of different doses of central kisspeptin antagonist on maternal care 
Maternal care was monitored 60 min before (basal) and 120 min after treatment infusion on lactation day (LD) 
1 (A, B) as well as 60 min before (basal) and 60 min immediately after treatment infusion in combination with 
the maternal defence test (C, D) on LD 3. The mean occurrence of arched back nursing (ABN; A, C) and all 
nursing postures (B, D) is presented. Dams were infused with 5 µl vehicle (VEH; Aqua ad iniectabilia) or 0.002 
µg/ µl (low dose), 0.02 µg/ µl (medium dose) or 0.2 µg/ µl (high dose) of a kisspeptin antagonist (Kisspeptin 
234). Data are presented as mean + SEM, n = 5 – 6 per group. # p ≤ 0.05 versus previous sample of the same 
group (separate statistics). 
 
 
6.4.2.2 Maternal care under stress condition 
ABN differed significantly depending on time (F2,36 = 13.29, p < 0.001; Figure 31C), but not on 
treatment; a significant time x treatment interaction was found (F6,36 = 3.08, p = 0.015). 
When treated with the medium dose, ABN dropped in the first 30 min after the maternal 
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defence test (p = 0.019) and increased at t +60 (p < 0.001) compared to the previous time 
point, respectively. No effects for any other dose were found. 
Nursing differed significantly depending on time (F2,36 = 12.47, p < 0.001; Figure 31D), but 
not on treatment; no time x treatment interaction was found. Separate one-way ANOVA for 
repeated measures revealed a significant effect of time for the medium dose (F2,8 = 22.27, p 
= 0.001). Nursing decreased at t +30 compared to basal (p = 0.023), whereas it increased at t 
+60 compared to the previous time point (p = 0.024). No effects for any other dose were 
found. 
Mother-pup interaction differed significantly depending on time (F2,36 = 13.659, p < 0.001), 
but not on treatment; no time x treatment interaction was found. Separate one-way ANOVA 
for repeated measures revealed a significant effect of time for the medium dose (F2,8 = 
12.01, p = 0.004). Mother-pup interaction tended to increase at t +60 compared to the 
previous time point (p = 0.052). No effects for any other dose were found. 
 
6.4.2.3 Maternal aggression in the maternal defence test 
None of the observed behaviours differed at any time point (not shown). 
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6.5 Discussion 
This study is the first approach to assess maternal behaviour in the context of the GnRH and 
kisspeptin system using receptor antagonists in lactating rats. We demonstrate that central 
GnRH receptor antagonism decreases attacks and one aspect of threat behaviour, i.e. 
offensive upright, during maternal aggression testing, whereas central GPR54 antagonist 
affects maternal care under non-stress and stress conditions in a dose-dependent manner. 
Thus, the GnRH and kisspeptin system seem to be play different roles in virgin versus 
lactating rats, mediating a bunch of reproductive functions especially in virgin rats but also 
influencing different aspects of maternal behaviour in dams. 
So far, there is only one study providing evidence of the involvement of GnRH in maternal 
behaviour. This initial study used transgenic mice, which had systemically 30% less GnRH 
neurons (Brooks et al., 2012). Although these mice did not have a total depletion of GnRH 
neurons, maternal behaviour is significantly impaired, i.e. dams leave their pups scattered in 
the cage and need longer to retrieve them into the nest compared with non-transgenic 
control mothers (Brooks et al., 2012). The reduction of GnRH neurons could result in 
decreased binding of GnRH receptors, but also in decreased GnRH release, both potentially 
having negative effects on maternal motivation to retrieve pups. 
In accordance, mice dams with a Gq/11 fore-brain knockout failed to retrieve their pups and 
had no pups that survived to weaning age (Wettschureck et al., 2004). As the GnRH-I 
receptor subtype present in rats, but also in humans, is a GPCR mediating its action through 
Gq/11 pathway (Millar, 2005), the appropriate functioning of the receptor seems to be 
necessary for adequate maternal behaviour, i.e. protection of the offspring. 
In our study, central GnRH antagonism resulted in reduced aggression. Although we do not 
see changes in maternal motivation to retrieve the pups, both, pup retrieval and aggression, 
serve to protect the pups from threat, i.e. hypothermia because of laying outside the nest or 
infanticide/injuries by a conspecific during the maternal defence paradigm. One has also to 
take in account that our central approach may overcome brain region specific effects, as i.e. 
the MPOA is importantly involved in pup retrieval (Kalinichev et al., 2000; Numan, 1990) and 
is further known to express GnRH neurons (Caligioni et al., 2007). 
Interestingly, GnRH neurons within the MPOA have been shown to co-express OXT receptors 
(Caligioni et al., 2007). As both, the MPOA itself as well as the neurotransmitter are known 
to be involved in the regulation of maternal behaviour (for reviews see Bosch and Neumann, 
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2012; Numan and Insel, 2003), a disruption of proper signalling within this area could lead to 
disrupted maternal behaviour. Future studies directly targeting the MPOA may help to 
specify the role of GnRH in the regulation of the different maternal behaviour aspects.  
As maternal aggression was affected in our study, an additional involvement of the BNST is 
likely. The BNST was linked to maternal aggression in various studies before (Bosch et al., 
2010; Caughey et al., 2011; Consiglio et al., 2005) and is known to be innervated by GnRH 
neurons (Boehm et al., 2005). Further studies are necessary, i.e. by targeting the BNST 
directly with the GnRH antagonist, to rule out the effects on maternal aggression more 
specifically. 
In the past years, the GnRH system was also found to be closely linked to the kisspeptin 
system. Studies have shown that neurons of one system innervate neurons of the other 
system and vice versa (Han et al., 2005; Kalló et al., 2013; Liu et al., 2008). In addition, GPR54 
receptors were found on GnRH neurons (for review see Roseweir and Millar, 2013). Thus we 
hypothesized a negative influence of a GPR54 antagonist on maternal behaviour in lactating 
rats. To date, most studies on the kisspeptin system were investigated in the context of 
puberty, reproduction and metabolism (Han et al., 2005; Pineda et al., 2010; Stengel et al., 
2011; Tolson et al., 2014; for review see Reynolds et al., 2009). In our initial study, we found 
a decrease in ABN under non-stress conditions directly after infusion of the low GPR54 
antagonist dose. Earlier studies have shown that intravenous administration of a kisspeptin 
agonist increases OXT plasma levels in female rats (Kotani et al., 2001). Further, an icv 
infusion of kisspeptin increased the firing rate of OXT neurons in the SON in late pregnant 
and early lactating rats (Scott and Brown, 2013). As OXT is known to mediate maternal care 
(for review see Bosch and Neumann, 2012), a blockade of kisspeptin receptors which may 
negatively influence the firing of OXT neurons could lead to the observed decrease in ABN. 
Further studies have shown, that the activity of kisspeptin neurons within the MPOA of mice 
is mediated by AVP (Piet et al., 2015). In general, icv administered kisspeptin agonist 
increases AVP plasma concentration (Ten et al., 2010). As not only OXT, but also AVP is 
known to mediate maternal behaviour (for review see Bosch and Neumann, 2012), further 
studies unravelling a connection between kisspeptin, OXT and AVP, maybe also in relation to 
the GnRH system, are necessary. 
Given the fact that under non-stress conditions the low dose, whereas under stress-
conditions the medium dose shows effects, a direct proportional effect of the dose to the 
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type of stressor seems likely. Future studies unravelling an intermittent dose of our low and 
medium values could be useful in further investigating the role of the kisspeptin system in 
maternal behaviour of lactating rats. The lack of effect with the high dose might be due to 
compensatory mechanisms occurring in lactating rats. During lactation, females normally do 
not show an estrous cycle in order to protect themselves of another pregnancy, since this 
might endanger the female itself but also the offspring (Ohkura et al., 2009). The absence of 
the estrous cycle during lactation is considered to be due to inhibited pulse mode of GnRH 
and LH secretion. In detail, the LH surge in lactating females is hypothesized to be 
suppressed due to neural inputs associated with the suckling stimulus which inhibit the 
activity of kisspeptin neurons in the ARC and in turn may control pulsatile GnRH and LH 
release (Ohkura et al., 2009; Tsukamura et al., 1988). In addition to physiological suppression 
of kisspeptin release, maybe also decreased receptor sensitivity may occur in lactation, 
which has not been investigated so far. 
Another fact one must consider is the complexity of adaptations occurring in lactating 
rodents (Neumann, 2001; Neumann et al., 1998a, 1998b; for review see Russell et al., 2001) 
and also kisspeptin and GnRH seem to adapt with the reproductive status. A study 
conducted in rhesus monkeys showed a switch from an ovarian steroid-independent 
mechanism in prepubertal to an ovarian steroid-dependent mechanism in pubertal 
individuals in the response of GnRH to kisspeptin (Guerriero et al., 2012). So far, nothing is 
known about this mechanism in lactation, implicating the necessity of further studies. 
In summary, we provide evidence that a GnRH receptor antagonist impairs the protection of 
the offspring by reducing attacks and threat behaviour of the mother towards an intruder, 
whereas a GPR54 antagonist impairs ABN under non-stress and stress conditions in a dose-
dependent manner. 
In conclusion, blockade of GnRH as well as of kisspeptin receptors impairs maternal 
behaviour, thereby indicating a complex role in aspects of reproduction and maternal 
behaviour. 
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Chapter 7 
General Discussion 
 
7.1 Summary of results 
The overall aim of my thesis was to provide further insight in the involvement of the AVP 
system, especially of V1bR, in hypothalamic and limbic brain regions in the different aspects 
of maternal behaviour in lactating rats. 
In an initial approach I manipulated Wistar dams centrally with a specific V1bR agonist or 
antagonist to investigate the impact of the AVP receptor subtype in different aspects of 
maternal behaviour (Chapter 2). I could show that blocking V1bR centrally in the brain 
impaired maternal care directly after infusion under non-stress as well as under stress 
conditions. There were no effects of V1bR manipulation found in maternal motivation to 
retrieve pups, maternal aggression or maternal anxiety. Taken together, these results 
indicate a role of central V1bR in the modulation of certain aspects of maternal behaviour. 
However, local approaches are requested to reveal the specific location of the effects (see 
below). 
In order to determine the role of V1bR manipulation in an animal model for extremes in 
anxiety and nursing behaviour, I repeated the experiment in HAB and LAB dams (Chapter 3). 
Due to the increased AVP expression and release in HAB dams, I hypothesised an influence 
of central V1bR antagonism especially in HAB dams, and the other way round, of central 
V1bR agonism in LAB dams on maternal care. Surprisingly, neither treatment had any effect. 
Instead, both breeding lines showed a stable phenotype regarding maternal care, maternal 
motivation and maternal anxiety as described before. Analysis of the maternal defence test 
showed for the first time a shift of increased maternal aggression from HAB dams to LAB 
dams. Non-manipulated LAB dams showed increased aggression compared to HAB dams in 
the maternal defence test, which was confirmed in subsequent generations. This change 
might have occurred due to breeding over many years, although sibling pairing was strictly 
avoided. An analysis of changes in neuropeptide and hormonal systems could contribute to 
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clarify the shift of a single parameter of maternal behaviour without changes in other 
aspects of the phenotype. 
Due to the fact that opposing mechanisms mediated via single brain regions might be 
overruled by the central manipulation of V1bR, I elucidated the involvement of the V1 
receptor subtypes specifically within distinct brain regions, i.e. the MPOA, the BNST (Chapter 
4) and the PVN (Chapter 5), all known to be involved in the regulation of maternal 
behaviour. First, I investigated potential lactation-induced changes in V1bR mRNA and 
protein expression; I did not find any difference within any brain region. However, as central 
manipulation of V1bR indicated a behavioural relevance of the receptor subtype in maternal 
behaviour I continued with acute local infusion of V1bR antagonist. My findings are 
summarized in Figure 32 and Figure 33.  
 
 
Figure 32 Graphical summary of local V1bR antagonism within the MPOA and the BNST 
Local infusion of V1bR antagonist within the MPOA increased the motivation of the dams to retrieve their 
pups in a novel environment, whereas within the BNST decreased pup-directed behaviour during the maternal 
defence test was found. 
 
In detail, I found increased maternal motivation to retrieve pups in a novel environment 
after V1bR antagonism within the MPOA. Within the mpBNST, V1bR blockade impaired pup-
directed behaviour during the maternal defence test, with dams showing less licking and 
grooming of the pups in the presence of the intruder. Furthermore, V1bR antagonism 
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decreased maternal care under stress conditions in both brain regions. In the PVN, V1bR 
blockade had no effect on any maternal parameter, implicating its minor role in maternal 
behaviour within this brain region. In contrast, V1aR blockade decreased nursing under non-
stress conditions and anxiety-related behaviour on the EPM, without affecting pup retrieval. 
In summary, V1R mediate different aspects of maternal behaviour in a brain region 
dependent manner. 
 
   
Figure 33 Graphical summary of local V1aR or V1bR antagonism within the PVN 
Local infusion of V1aR antagonist (orange) within the PVN decreased maternal care and anxiety-related 
behaviour on the EPM, whereas local V1bR antagonist infusion (blue) had no effect on maternal behaviour. 
 
During research on the source of AVP within the “maternal super-region” I could detect, in 
collaboration with Dr. Ueta (Kitakyushu, Japan) and Dr. Grinevich (Heidelberg, Germany), co-
expression of AVP-GnRH in the OVLT of lactating, but not virgin, AVP eGFP rats. On the basis 
of this pilot study, I investigated the involvement of GnRH in the regulation of maternal 
behaviour in lactating rats (Chapter 6). Central antagonism of GnRH decreased aggression in 
the maternal defence test but did not affect any other maternal parameter. As GnRH 
neurons are closely linked to the kisspeptin system, I further blocked central GPR54 in 
another cohort of lactating dams (Chapter 6). As this is the first study investigating kisspeptin 
in the context of maternal behaviour, I performed a dose-response study with a GPR54 
antagonist. Indeed, the blockade with the low dose of 0.002 µg/µl decreased maternal care 
under non-stress conditions, whereas the medium dose of 0.02 µg/µl kisspeptin antagonist 
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decreased maternal care under stress conditions. No further changes were detected on any 
other maternal parameter. These observations provide evidence of two further 
neuropeptide systems involved in the regulation of maternal behaviour. 
 
 
7.2 Involvement of the brain AVP system, especially of V1bR, in maternal care 
In most mammals, mothers take care of the offspring and provide them with the essential 
nutrition which guarantees their survival and growth. Various neurotransmitter systems are 
described to promote nursing behaviour, with OXT and AVP being among the most studied 
(for review see Bosch and Neumann, 2012). 
An involvement of AVP was already suggested in the 1980s by Pedersen et al., who found 
that central AVP administration leads to an promotion of crouching over and 
licking/grooming of pups in ovariectomized, hormone-primed virgin female rats (Pedersen et 
al., 1982). In line with this finding, repeated central infusion of AVP in lactating rats 
increased ABN, whereas central V1aR blockade decreased ABN and mother-pup interaction 
(Bosch and Neumann, 2008). Also central V1bR antagonism decreased mother-pup 
interaction besides nursing (Chapter 2). These observations suggest a crucial role for both 
V1R subtypes in maternal care under non-stress condition. In addition, V1bR antagonism 
under stress conditions leads to similar findings of impaired nursing and mother-pup 
interaction (Chapter 2). This brings up the hypothesis that V1bR are necessary to provide 
adequate maternal care after disruption of the homeostasis by the infusion procedure per se 
or in combination with the strong stressor of the maternal defence test. 
The effects can be clearly linked to V1bR, as the antagonist used is highly selective for the rat 
V1bR (Griebel et al., 2002; Serradeil-Le Gal et al., 2002). Thus, parallel inactivation of V1aR or 
OXT receptors is unlikely. Although, a compensatory effect of the OXT system might 
contribute to the behavioural outcome; studies in V1bR knockout mice have shown that OXT 
can act on V1bR (Koshimizu et al., 2012), thereby promoting maternal care. In confirmation, 
OXT receptors have been found to partly take over the stress-induced ACTH release in these 
mice (Nakamura et al., 2008). Nevertheless the antagonist provides a highly selective 
pharmacological tool to investigate the effects of V1bR in the different aspects of maternal 
behaviour.  
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Due to the fact that central manipulation of V1R might be too unspecific for distinct effects 
of brain regions known to be involved in maternal care, or to reflect the integration of 
various effects, region-specific antagonism was used to further elucidate potential effects of 
V1R subtypes. 
Here, the MPOA is one of the brain regions of major interest, known to facilitate maternal 
care after chemical stimulation (Fisher, 1956). Lesion studies of the dorsolateral connections 
of the MPOA which disrupt maternal care in lactating rats underline the importance of the 
brain region (Numan and Callahan, 1980; Numan, 1990). Focussing on the AVP receptor 
subtypes, V1aR antagonism or down-regulation via antisense oligodeoxynucleotides in this 
brain region has an impairing effect on maternal care by delaying the onset in parturient rats 
(Pedersen et al., 1994) and decreased ABN as well as mother-pup interaction in lactating rats 
(Bosch and Neumann, 2008). In contrast, intra-MPOA up-regulation of V1aR via an adeno-
associated viral vector improved maternal care (Bosch and Neumann, 2008). In addition, AVP 
is released in response to mother-pup interaction (Bosch et al., 2010) and thus, it binds to 
both AVP receptor subtypes. Under stress conditions, V1bR antagonism within the MPOA 
decreased ABN, total nursing and mother-pup interaction (Chapter 4), similar to central 
blockade. This underlines the suggested role of V1bR to reinstate adequate maternal care 
after exposure to a stressor, i.e. after disruption of the homeostasis in order to provide 
sufficient care for the offspring. 
The mpBNST, which is inter-connected with the MPOA, is also involved in the regulation of 
maternal care, as initially shown by lesion studies (Numan and Numan, 1996). In contrast to 
the MPOA, intra-mpBNST V1aR blockade does not disrupt maternal care under non-stress 
conditions (Bosch et al., 2010), suggesting the involvement of another AVP receptor or 
neuropeptide system in the regulation of this behaviour. Indeed, antagonism of V1bR within 
the mpBNST only decreased ABN and total nursing after the maternal defence test, but not 
under non-stress conditions (Chapter 4). This confirms the importance of V1bR in maternal 
brain regions ensuring the ability of adequate stress coping in dams. Further it implies a 
region-specific involvement based on experimental conditions, i.e. the role of the mpBNST 
during stress. This was also shown to be the case regarding another neuropeptide system, 
i.e. CRF (Klampfl et al., 2015, 2014). Blockade of both CRF receptors (CRF-R), CRF-R1 and 
CRF-R2, improves nursing, specifically ABN, under stress conditions in the mpBNST. In 
contrast, only CRF-R1 blockade tended to increase ABN in the adBNST. Future studies 
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elucidating the role of V1bR within the adBNST could provide further insight in the specific 
involvement of the AVP system in the regulation of maternal behaviour aspects in the 
subnuclei of the BNST. 
Besides the maternal super-region, also the PVN is implicated in mediating maternal care. In 
addition to lesion studies showing the involvement of the PVN in maternal care (Insel and 
Harbaugh, 1989; Numan and Corodimas, 1985), the presence of the pups was found to 
increase c-fos expression in the amPVN of dams (for review see Numan and Insel, 2003). 
After antagonism of V1aR within the PVN we found a decrease in maternal care under non-
stress conditions, whereas V1bR antagonism had no effect. This might indicate that V1aR 
within the PVN are important in the adequate expression of maternal care under basal 
conditions.  
Thereby, a brain-region dependent but also behaviour-specific and context-dependent 
mechanism seems to regulate central V1R: they either modulate maternal behaviour alone 
(V1aR, but not V1bR, blockade within the PVN impairs nursing under non-stress conditions), 
as counterparts (V1aR blockade within the MPOA impairs/ V1bR blockade improves pup 
retrieval within the MPOA) or in complement (blockade of both receptor subtypes within the 
mpBNST impairs pup defence/protection).  
One also must not forget the potential influence of the closely related OXT in all these brain 
regions. Besides AVP, OXT is known to positively correlate with maternal behaviour (for 
review see Bosch and Neumann, 2012). Thereby, the dorso-medial BNST projects to the PVN 
and the SON, by targeting regions with a high density of oxytocinergic and vasopressinergic 
cell bodies, respectively (Dong and Swanson, 2006). Thus, manipulation of receptors within 
the mpBNST could also affect the projections to the PVN and mediate the neuropeptide 
signalling in this target region.  
These distinct roles of the V1aR and V1bR on maternal behaviour in different brain regions 
might also be linked to the distribution of the receptor subtypes (see Figure 5). Whereas the 
MPOA is dominated by V1bR, the PVN mostly expresses V1aR. Within the BNST both 
receptor subtypes can be found (Griebel et al., 2005). Thus, the lack of behavioural effect 
after V1bR blockade within the PVN might be due to the very low amount of receptors in this 
brain region. In contrast, manipulation of both V1aR and V1bR in the mpBNST resulted in 
alterations of maternal behaviour. Within the MPOA V1bR are expressed in a higher amount 
than V1aR, suggesting additional mechanisms leading to the behavioural outcome. As the 
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distribution of receptors (see Figure 5) was investigated in male rats (Griebel et al., 2005; 
Hernando et al., 2001; Orcel et al., 2002), gender or lactation specific adaptations may occur, 
which has to be determined more specifically in future studies. Interestingly, in a first 
cellular approach, I did not find alterations of V1bR mRNA or protein expression within the 
MPOA, BNST and PVN in lactating rats compared to virgins. This suggests adaptations in the 
signal transduction or sensitivity to the agonist in lactation. Since V1bR are internalized after 
agonist binding in a higher amount than V1aR, also this internalization process might be 
adapted in lactation and/or under stress conditions (Kashiwazaki et al., 2015). In addition, an 
increased sensitivity of V1bR in lactation might be responsible. It is known that high levels of 
AVP binding to V1bR stimulate not only the IP3 pathway (Gq/G11), but also cyclic adenosine 
monophosphate (Gs) signalling (Orcel et al., 2009). Studies in cell culture have described, 
that a drug increasing the sensitivity of the V1bR, decreases the amount of AVP which is 
necessary to stimulate both signalling cascades (Orcel et al., 2009). Since the release of AVP 
is known to be increased in lactation (for review see Bosch and Neumann, 2012), additional 
mechanisms increasing the sensitivity of V1bR might lead to simultaneous activation of the 
Gq11 and Gs, i.e. IP3 and cyclic adenosine monophosphate pathway. Future studies are 
necessary to confirm this suggestion and the resulting behavioural consequences. 
However, changes in maternal behaviour after V1bR manipulation occur without adaptation 
on mRNA or protein expression, a distinct role of V1bR in lactation can be suggested. This is 
supported by the fact, that virgin rats are not maternal. Future studies investigating if V1bR 
manipulation accelerates pup sensitisation in virgins could further help to understand the 
role of the AVP system in maternal behaviour. 
Taken together, brain region specific blockade of V1R shows a pivotal role of V1aR within the 
PVN under non-stress conditions, and V1bR within the MPOA and the mpBNST under stress-
conditions. Therefore, both V1R subtypes seem to be important for homeostasis, adequate 
stress-coping and thus adequate maternal care. 
Regarding V1bR manipulation within HAB and LAB dams no differences due to treatment 
could be found (Chapter 3). In line with previous studies, HAB dams were highly maternal 
compared to less maternal LAB dams. Interestingly, among generation #51, a shift regarding 
the different nursing positions was observed. So far, HAB dams are described to be more 
engaged in ABN, i.e. showing more high and low crouch, as well as higher amount of nursing 
in general compared to LAB dams, with blanket position being equally provided in both 
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breeding lines. HAB dams of generation #51 still show increased high crouch than LAB dams, 
but low crouch position was equally shown in both breeding lines. Consequently, this 
diminishes the difference of ABN, which is also about the same value in HAB and LAB dams 
of this generation. In contrast, LAB dams show more blanket position compared to HAB 
dams, also adjusting the values of total nursing to the same level in both breeding lines. 
Taken together, LAB dams of generation #51 seem to show increased low crouch and 
blanket nursing compared to LAB dams of foregoing generations. Acoustic disturbances in 
the observation rooms (Lauer et al., 2009; Milligan et al., 1993), which might have impaired 
low crouch position in HAB dams thereby mimicking an increase in low crouch of LAB dams 
are unlikely, as low crouch and blanket levels in LAB dams seem to have increased between 
generation #50 and #51. As several other factors, like smell irritation (due to several 
unknown students) could be the reason for this change in maternal care, observations in 
dams of new pairings are necessary. Additionally, as maternal care is highly variable, V1bR 
manipulations should be repeated, to rule out receptor-subtype specific effects on this 
aspect of maternal behaviour. 
 
 
7.3 Involvement of the brain AVP system, especially of V1bR, in maternal 
motivation 
Maternal motivation reflects “the investment of time and resources to seek and maintain 
contact with the young” (Olazábal et al., 2013). This behaviour is measured in the laboratory 
in the PRT, where it reflects the dams’ motivation to retrieve her pups in a novel 
environment (Neumann et al., 2005; van Leengoed et al., 1987). In this test the dams’ drive 
to protect their pups by retrieving them to one place, which is in most cases the nest, has to 
overcome the fear of the unknown arena (for reviews see Numan and Insel, 2003; Olazábal 
et al., 2013). Maternal motivation was found to be mediated by the MPOA in rats, with 
lesions of the dorsolateral connections disrupting the behaviour (Franz et al., 1986; 
Kalinichev et al., 2000; Numan and Corodimas, 1985). Further, during pup retrieval the 
release of AVP within the MPOA is increased (Bosch et al., 2010). Thus, central manipulation 
of V1bR might be insufficient or lead to a minor effect, which behavioural outcome is not 
visible. 
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This is supported by our local blockade of V1bR restricted to the MPOA, which led to 
increased pup retrieval. In contrast, pup retrieval is decreased by blocking V1aR within the 
same region (Bosch and Neumann, 2008; Pedersen et al., 1994), proposing an opposing role 
of both V1R subtypes within the MPOA on maternal motivation. Further, V1aR activation, 
but simultaneous decreased V1bR signalling within the MPOA seems to be important for the 
adequate behaviour. Due to unchanged V1bR mRNA and protein expression (Chapter 4) but 
increased V1aR signalling (Bosch and Neumann, 2008) a dominance of V1aR within the 
MPOA can be suggested. Focussing on the AVP system, this V1aR dominance provides the 
basis of proper maternal motivation to retrieve pups in lactating rats. An increased 
activation of V1aR might also be the reason for increased pup retrieval in HAB dams 
compared to LAB dams. Due to their SNP in the AVP promoter region, elevated levels of AVP 
can bind to V1aR and results in the high motivational state of HAB dams. However, as the 
neuropeptide can also bind to the V1bR, the adaptations of the receptor subtypes in 
lactation and their involvement in the regulation of maternal motivation needs to be 
reconfirmed, e.g. by manipulation of V1bR within the MPOA.  
However, pup retrieval behaviour of LAB dams could be improved by providing them a 
familiar nest site during the PRT (Chapter 3 and 4). LAB dams retrieve their pups very poorly 
in the conventional PRT (Neumann et al., 2005). Although retrieval behaviour is known to be 
very high in early lactation (for review see Bosch, 2011), the reason for the low number of 
pups retrieved by LAB dams might be due to a lack in social investigation. This hypothesis is 
supported by findings in the modified hole board test although performed in males; LAB rats 
prefer to halt social contact in order to investigate a novel environment, whereas HAB rats 
prefer to stay in contact with cage mates (Ohl et al., 2001). Importantly this study was 
performed in males and needs to be repeated in females to verify the hypothesis of a lack in 
social abilities. Indeed, first indices of differences in sociability between HAB and LAB dams 
were observed in the conventional PRT. HAB rats retrieved their pups quickly to a single nest 
and stayed in close contact to the young independent of the novel environment. In contrast, 
LAB dams retrieved their pups only poorly and spent more time sniffing and rearing in the 
box. Although their motivation should be high during this early phase of lactation (for review 
see Bosch, 2011), they preferentially investigate the novel environment instead of keeping 
contact to their offspring and protecting them of potential threats (reflected by decreased 
pup retrieval compared to HABs). Personal observations (DSB, SMK, OJB) show that LAB 
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dams even try to escape from the box (not as a flight reflex rather than being interested in 
the surrounding), which is in accordance to the observation of the modified hole board test 
in males (Ohl et al., 2001). Thus, LAB dams seem to be in a conflict: on the one hand they 
want to leave the pups in order to investigate the environment, which can be referred to 
their lack of sociality. On the other hand, they want to stay with their pups and retrieve 
them to a single nesting site, which is due to their maternal status. With the modified PRT, 
which consists of a box with higher walls, escape got impossible. In addition, the house 
provides a safe place for the pups and the dam, thus shifting the “interest”, especially from 
LAB dams, to pup retrieval. Since pup retrieval is already very high in HAB dams, further 
improvement is hardly possible. Nevertheless, comparing the retrieval behaviour of VEH 
dams in the conventional PRT to the modified PRT (Chapter 4) an improvement in the 
number of pups retrieved can be observed, confirming the improvement not only of LAB, but 
also of NAB dams. Since these NAB dams were manipulated, confirmation of the PRT setup 
in non-manipulated lactating Wistar rats is warranted. 
Blockade of V1bR within either the BNST (Chapter 4) or the PVN (Chapter 5) did not affect 
maternal motivation, similar to previous studies showing no effect on maternal motivation 
after V1aR blockade within the BSNT (Bosch et al., 2010). Although both brain regions have 
been shown to be involved in the regulation of maternal behaviour, pup retrieval seems to 
rely mainly on the MPOA. Further, the time-point of manipulation plays a role; lesions of the 
PVN before giving birth, but not postpartum, are known to disrupt maternal care and pup 
retrieval (Insel and Harbaugh, 1989). Thus, our infusions start in lactation, the results are in 
line with the previous studies. Future studies blocking V1R within the PVN at different time-
points may strengthen the role of the AVP system in accordance to previous findings. 
 
 
7.4 Involvement of the brain AVP system, especially of V1bR, in maternal 
aggression 
Maternal aggression is an essential behaviour to protect the offspring from any potential 
threat (for review see Bosch, 2013). Under laboratory conditions, the threat is mimicked by 
an unfamiliar intruder, in my case a virgin female, about 10 % smaller than the resident. The 
opponents are not equal in size/body weight, as I want to stress the mother and evoke 
maternal aggression, but prohibit pup killing by the intruder. Nevertheless, the dams 
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respond with a repertoire of attack and threat behaviours, which can be manipulated by 
substance infusion. 
Central agonism and antagonism of V1bR did not affect aggressive behaviour of the NAB 
dams (Chapter 2) nor in HAB and LAB dams (Chapter 3) during the maternal defence test. 
Brain region specific blockade of V1bR elucidated a V1R-subtype specific implication in 
maternal aggression within the mpBNST. While V1aR blockade reduced attacks and threat 
behaviour towards the intruder (Bosch et al., 2010), V1bR blockade reduced pup directed 
behaviour during the aggressive encounter, especially licking and grooming (Chapter 4). 
Studies on both the AVP (Bosch et al., 2010) and the CRF-system (Klampfl et al., 2014) show 
a specific implication of the mpBNST in maternal aggression. Interestingly, and in contrast to 
the other studies, V1bR blockade led to changes in non-aggressive behaviour, i.e. pup-
directed behaviour. This could hint to the specific role of V1bR by mediating the caretaking 
of the offspring during stressful situations. Thus, in order to get the required balance 
between attacking the intruder and taking care of the offspring, both V1R subtypes need to 
be activated concomitantly. Only if both receptors are activated under stressful conditions, 
adequate defence and protection of the young is possible. 
In contrast, a misbalance of adequate attacking of the intruder and protection of the 
offspring could lead to excessive forms of aggression, which was found with subsequent 
breeding in LAB dams (Chapter 3). Surprisingly, the LAB dams, which have low levels of 
anxiety and display lower levels of maternal care, reflected by decreased ABN and 
aggression during the maternal defence test (Bosch and Neumann, 2008; Bosch et al., 2010, 
2006, 2005; Neumann et al., 2005; for review see Bosch, 2011), appeared to turn into 
abnormally aggressive dams (Chapter 3). During the maternal defence test they attacked the 
head, nose and belly of the intruders and injured the defensively behaving counterparts 
seriously, similar to observations in LAB males (Beiderbeck et al., 2012; Neumann et al., 
2010). This behaviour already fulfils two out of three criteria for abnormal aggression (for 
review see Haller and Kruk, 2006): (1) disregarding species-specific rules by attacking 
vulnerable body parts and (2) insensitivity towards social signals of the opponent, by 
ignoring the submissive behaviour of the intruder and continuing attacking. The last criteria, 
(3) mismatch between provocation and response, is hard to distinguish in maternal defence 
test. Any other rat, although slightly smaller than the dam, is a potential risk for the 
offspring, thus, a dam aggressively defending her offspring is quite normal. In case of 
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maternal aggression, the other two criteria seem to be more important than the third one, 
as maternal aggression is triggered by different cues than other types of aggressive 
encounters like intermale or territory aggression (Wersinger et al., 2007). In addition, 
aggression was negatively correlated with AVP release within the LS in males (Everts et al., 
1997). The AVP system, in detail V1aR, within the LS is also linked to social memory in male 
rats (Everts and Koolhaas, 1997). Infusion of a V1aR antagonist impairs social memory, which 
is not confirmed in lactating rats so far. If so, decreased AVP within the LS of LAB dams and 
consequently less binding of V1R, leading to decreased sociability might be an explanation 
for elevated aggression within these dams. Thus, measurement of AVP release within the LS 
during the maternal defence test might rule out differences in HAB/LAB dams, which micht 
be linked to inter-LS AVP levels. Importantly, this might not be true in lactating females, as 
maternal aggression has different triggers compared to intermale aggression (Wersinger et 
al., 2007). Another important factor seems the decreased sniffing in LAB dams compared to 
HAB dams of generation #50 during the maternal defence test. As anogenital sniffing is part 
of the social investigation pattern in rats, the decreased sniffing hints to an impairment of 
social abilities in LAB rats, as described before (Ohl et al., 2001). Nevertheless, the reason of 
the changing aggressive phenotype in LAB rats still remains unknown. Studies in male V1bR 
knockout mice found decreased social memory in these mice, compared to wildtype 
(Wersinger et al., 2002). Interestingly, a lack of social memory was also recognized in 
pregnant female V1bR knockout mice; these mice failed to terminate their pregnancy when 
they or cohabituated with an unfamiliar novel male (Bruce effect) (Wersinger et al., 2008; for 
review see Stevenson and Caldwell, 2012). In male rats, antagonism of V1aR impairs 
maternal memory, indicating the importance of V1aR in social behaviour and the proper 
receiving of pup cues (Nephew and Bridges, 2008b). Therefore, the lack of social abilities 
observed in LAB rats might also rely on changes in the AVP system, more specifically, in the 
V1R. Besides the AVP system, also dopamine, serotonin, and glucocorticoids have been 
found to be involved in the regulation of high levels of aggression (Ferris, 2005; Miczek et al., 
2002; Neumann et al., 2010; for reviews see Haller and Kruk, 2006; Haller, 2013). Studies in 
LAB males have confirmed the role of dopamine and the reward system in the regulation of 
aggression (Couppis and Kennedy, 2008; Ferrari et al., 2003); the high levels of aggression in 
LAB males could be decreased by local infusion of a dopamine D2 receptor antagonist within 
the NAc (Beiderbeck et al., 2012). The NAc has been closely related to the dopaminergic 
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reward system, which is known to be hyper-active not only in rats, but also in psychopathic 
patients (Buckholtz et al., 2010). Thus, high levels of aggression could have a rewarding 
effect in LAB dams, which needs further investigation. Besides the dopamine system also the 
serotonin system has been shown to be linked to aggression. Thereby, systemic 
administration of serotonin or a specific serotonin receptor agonist (either for 5-HT1A or 5-
HT1B) reduce maternal aggression in an unspecific manner (since also general activity can be 
reduced) (Olivier et al., 1995; for review see Lonstein and Gammie, 2002). Due to the fact 
that breeding over years might have changed the AVP system further, but also several 
petidergic and non-peptidergic systems in LAB rats, a genetic screening may outline these 
adaptations. Understanding the potential changes in these systems could help to understand 
the neurobiological mechanisms behind abnormal levels of aggression in lactating LAB dams. 
 
 
7.5 Involvement of the brain AVP system, especially of V1bR, in maternal 
anxiety 
In order to provide adequate maternal care for the young anxiety-related behaviour in 
lactating rats has to be reduced (Hansen et al., 1985; Lightman and Young, 1989; Neumann 
et al., 1998a; Windle et al., 1997). This adaptation occurs due to facilitation of the PRL, OXT 
and CRF-system during lactation (Klampfl et al., 2015, 2014; Neumann et al., 2000; Torner et 
al., 2001). Further, AVP is implicated in the regulation of anxiety related behaviour, by 
exhibiting an anxiogenic effect in male and virgin female rats (Landgraf et al., 1995; Wigger 
et al., 2004; for review see Ring, 2005) as well as in mice (Bunck et al., 2009). Also in lactating 
rats central chronic synthetic AVP infusion increased whereas repeated central V1aR 
antagonist infusion decreased anxiety-related behaviour on the EPM (Bosch and Neumann, 
2008). This is similar to findings in male V1aR knockout mice, which show decreased anxiety 
on the EPM, in the light-dark box and the open field (Bielsky et al., 2004). In contrast, male 
V1bR knockout mice do not differ in anxiety related behaviour from wild-type controls 
(Wersinger et al., 2002). However, no data on anxiety-related behaviour of female virgin and 
lactating V1bR knockout mice are available to date, which remains to be investigated. In 
more natural animal models, intraperitoneally or orally administered V1bR antagonist was 
shown to act anxiolytic on the EPM, the open field (Amikishieva et al., 2011; Griebel et al., 
2002) but also in a social defeat paradigm (Litvin et al., 2011) in male rodents. 
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Central blockade of V1bR in lactating rats did not affect anxiety-related behaviour (Chapter 
2), suggesting that differences in administration route but also gender can influence the 
behavioural outcome. Further, a brain-region specific effect is likely, which may be masked 
by the central approach. Lonstein (for review see Lonstein, 2007) suggested an involvement 
of the BNST in the regulation of postpartum anxiety. In detail, pup contact may decrease 
noradrenaline release in the ventral BNST (vBNST) when dams experience an anxiogenic 
situation. Consequently, GABAergic projections from the vBNST to brain regions like the 
PVN, amygdala and the ventrocaudal PAG are decreased. Potentially excitatory projections 
from the PVN and the amygdala to the ventrocaudal PAG are also inhibited. The release of 
OXT and PRL within and from the PVN may also be induced by vBNST disinhibition to exert 
anxiolytic properties in the lactating dam. 
This hypothesis is strengthened by the results of intra-BNST blockade of V1aR, which tends 
to decrease anxiety-related behaviour in lactating rats (Bosch et al., 2010). In contrast, no 
changes were observed after blocking V1bR within the mpBNST or within the MPOA. In case 
of the latter, this is not surprising, as the MPOA has not been referred to mediate anxiety in 
rats (Bosch et al., 2010). However, the role of the BNST, more specific the subnuclei of the 
BNST, in the modulation of maternal anxiety is not fully understood yet; the obtained effects 
are thought to be mediated by activation of inhibitory projections from the BNST to 
subnuclei of the amygdala (Walker et al., 2003), leading to suppressed anxiety in lactation 
(for review see Lonstein, 2007). Therefore, investigation of V1bR blockade within the 
subnuclei of the amygdala may help to understand the involvement of the receptor subtype 
in the regulation of anxiety-related behaviour in lactating dams. 
Local V1aR, but not V1bR, blockade within the PVN of Wistar rats decreased anxiety-related 
behaviour on the EPM. This is in line with studies in hyper-anxious HAB males and, more 
importantly, dams; the increased anxiety due to elevated AVP expression and release within 
the PVN can be reversed by repeated central infusion of a specific V1aR antagonist (Bosch 
and Neumann, 2008; Wigger et al., 2004). Thus, although the V1R within the BNST seem not 
to be main regulators of maternal anxiety, projections from the BNST to the PVN might be 
involved in the regulation of anxiety of V1aR within the PVN. 
In addition, due to diffusion of the antagonist, all subdivisions of the PVN might have been 
targeted. As the pPVN and the amPVN are known to be activated by different neuropeptide 
systems, i.e. the AVP and CRF system, respectively (for review see Numan and Insel, 2003), 
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their concomitant activation might have decreased maternal anxiety. Indeed there has been 
evidence, that V1bR and CRF-R1, both GPCRs, can build heterodimers (Milligan et al., 2006). 
These heterodimers can show synergistic action, e.g. on catecholamine release of bovine 
chromaffin cells or trigger ACTH release from corticotroph cells in the pituitary (Murat et al., 
2012). As CRF may also potentiate the AVP-induced signalling pathway by increased IP3 
production, the behavioural effects may reflect down-stream adaptations of V1bR/CRF-R1 
heterodimers. In addition, CRF neurons within the pPVN and amPVN are known to express 
V1bR (Dabrowska et al., 2013). Thus, they could respond to local AVP release via activation 
of V1bR. As a simultaneous activation of AVP and CRF neurons within the PVN in lactation 
my blunt behavioural outcomes, future studies targeting the V1bR and the CRF system, e.g. 
by targeting CRF-R1, in parallel may shed further insight in the complex network of maternal 
circuits. 
Intriguingly, an initial study investigated the involvement of the V1bR in context of 
antidepressant treatment on anxiolytic actions of the drug. In detail, V1bR knockout mice 
chronically infused intraperitoneally with a selective serotonine-noradrenaline-reuptake 
inhibitor spent more time on the open arm of the EPM compared to V1bR knockout mice 
infused with VEH (Ishizuka et al., 2010). Notably, these studies have been conducted in 
males. Nevertheless, anxiety-related behaviour seems to be regulated by a variety of 
synergistic neuropeptid systems. Since a decrease in anxiety-related behaviour on the EPM is 
only visible in V1bR knockout-, but not wildtype mice, treated with a SNRI, blockade of V1bR 
alone, seems not efficient enough to create a visible behavioural effect. In addition, as non-
peptidergic and peptidergic systems are adapted in lactation, a potential effect of V1bR 
blockade might be overruled by effects of other systems, e.g. decreased noradrenergic input 
from the PVN during early lactation (for reviews see Lonstein, 2007; Slattery and Neumann, 
2008). 
Thus, future studies investigating the role of V1bR more specifically in anxiety-related but 
also in depressive-like behaviour in lactating females could further help to clarify the 
subsequent roles of the V1R subtypes. Taken together, I provide evidence that the 
regulation of anxiety-related behaviour on the level of the hypothalamus, exactly within the 
PVN, in lactating rats seems to be mediated rather by V1aR than V1bR. Importantly, 
synergistic effects of the AVP system with other neuropeptide systems are likely and can 
affect the behavioural outcome. 
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7.6 Correlation of the AVP, GnRH and kisspeptin system in the view of 
maternal behaviour 
On the basis of the co-expression of AVP and GnRH neurons within the OVLT of lactating 
rats, I further investigated the role of GnRH in maternal behaviour. Due to an initial study in 
mice with a 30% reduction of GnRH neurons, leading to impaired maternal behaviour 
(Brooks et al., 2012), I assessed the GnRH system in a more natural animal model. Indeed, 
antagonism of GnRH decreased maternal aggression in the maternal defence test. In 
contrast to the study by Brooks et al., I did not find changes in maternal care or maternal 
motivation to retrieve pups. As the study was conducted in genetically modified mice 
whereas I used Wistar rats, the differences of the target organisms may explain the different 
outcomes. However, blockade of GnRH receptors leads to decreased activity of GnRH 
neurons as GnRH binding is prohibited. This is similar to a decrease in GnRH neurons, which 
leads to a decrease in GnRH release and following decreased receptor stimulation (Brooks et 
al., 2012). Thus, the different effects of decreased GnRH signalling on maternal behaviour 
might also be due to the central/systemic approaches, reflecting a downstream effect of 
stopping the activity of the GnRH neurons on projection sites. In addition, the behavioural 
outcome could also hint to a local effect, e.g. of the MPOA; the MPOA is known to be 
critically involved in maternal behaviour and represents the predominant area of GnRH 
neuron expression (Brooks et al., 2012; for review see Numan and Insel, 2003). Future 
studies investigating the role of GnRH within the MPOA might provide further insight in the 
complex regulation of different aspects of maternal behaviour. In addition, GnRH neurons 
also have been found to express dopamine, serotonin and OXT receptors (Li and Pelletier, 
1995; for review see Numan and Stolzenberg, 2009), which are known to mediate maternal 
behaviour. This leads to the suggestion, that GnRH within the MPOA acts as a 
neuromodulator on maternal circuits (Brooks et al., 2012). 
Regarding the comprised amount of GnRH neurons in the study of Brooks et al. (Brooks et 
al., 2012), another reason for the behavioural outcome could be the decreased stimulation 
of GPR54, known to be co-expressed on GnRH neurons (Irwig et al., 2004). This in turn would 
lead to altered activation of kisspeptin neurons (Han et al., 2005; Liu et al., 2008). So far, the 
involvement of the kisspeptin system in maternal behaviour was not investigated. In my 
initial approach I found an influence of kisspeptin receptor blockade on maternal care. In 
detail, central kisspeptin receptor antagonism decreased ABN and nursing under non-stress 
G e n e r a l  Discussion  141 
and stress conditions. Due to unchanged maternal care after GnRH blockade (see above), the 
involvement of other neuropeptide systems facilitating maternal care concomitant with 
kisspeptin is likely. Indeed, centrally administered kisspeptin or kisspeptin agonist has been 
shown to trigger the firing of OXT neurons within the SON of lactating rats (Scott and Brown, 
2013) and to increase AVP plasma concentrations (Ten et al., 2010), respectively. As both 
neuropeptides are critically involved in the regulation of maternal care (for review see Bosch 
and Neumann, 2012), a cross-link between the kisspeptin and OXT or/and AVP system is 
hypothesised. Future studies are necessary to address the relationship of kisspeptin with 
these systems and their influence in maternal behaviour. Importantly, the obtained effects 
after kisspeptin receptor antagonism seem to be dose-dependent; whereas the low dose 
was effective under non-stress conditions (referring to the mild stress of infusion), the 
medium dose showed effects under stress-conditions (referring to the strong psychosocial 
stressor of maternal defence testing). Consequently, kisspeptin receptor antagonist exerts 
its effect in a dose-dependent way in response to the stress type in the experiments. It has 
been shown before that different doses of a specific drug affect different behavioural 
parameters, e.g. grooming and crouching in male prairie voles appears dependent on 
different intra-LS AVP doses (Wang et al., 1994). 
Taken together I could provide important insights into the involvement of the GnRH and 
kisspeptin system in the regulation of maternal behaviour. Future studies are warranted to 
investigate in brain regions involved in the regulation of different maternal aspects by both 
neuropeptide systems. 
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7.7 Conclusions, translational aspects and outlook 
In my thesis I could reveal for the first time a role of the V1bR in the regulation of maternal 
behaviour in lactating Wistar rats. V1bR mediate specific maternal aspects depending on the 
brain-region. Thereby, the V1bR subtype exerts its action alone, in a concomitant or an 
opponent manner to V1aR in the modulation of maternal behaviour, also depending on the 
brain region. 
Whereas V1bR have a minor/unknown role within the PVN, they interfere with appetitive 
maternal behaviour within the MPOA. Due to the fact that the MPOA is a rely station of the 
behavioural responses to pup stimuli and exerts a variety of efferent projections to other 
brain regions, the behavioural outcome may include downstream effects as well. Within the 
mpBNST, V1bR modulate pup-directed behaviour during stressful conditions, i.e. the 
maternal defence test. This indicates a role of V1bR within the mpBNST in modulating social 
interactions. With the pups being the social counterpart for interaction, the activation of 
intra-mpBNST V1bR seem to be important to provide adequate maternal care also in 
stressful situations. Within the mpBNST, V1bR seem to complement V1aR, as blockade of 
each receptor subtype impairs defence and protection of the offspring. Regarding the PVN, 
V1aR seem to dominate over V1bR. Since the AVP system is also known to be implicated in 
maternal aggression within the PVN, future studies investigating the effects of V1R 
antagonism after maternal defence testing are warranted. Results seem promising, as 
studies in males prove evidence of a stress induced increase of AVP release within the PVN 
in response to social defeat (Wotjak et al., 1996). 
Another aspect which is worth to be investigated in future studies is the effect of chronic 
V1bR manipulation in maternal behaviour. Studies in virgin male and female V1bR knockout 
mice as well as AVP-deficient Brattleboro rats showed a stressor dependent involvement of 
the V1bR in normal ACTH and CORT responses (Lolait et al., 2007; Zelena et al., 2004). These 
findings suggest a different involvement of V1bR in behavioural outcomes dependent on 
acute or chronic manipulation of the receptor. 
Importantly, all these behavioural adaptations within the distinct brain regions (MPOA, BNST 
and PVN) occur although mRNA and protein expression of V1bR are not altered in lactation 
compared to virgins, proposing alterations in receptor density or binding as well as in 
signalling pathways. Additionally, lactation induced changes in the recycling of V1bR from 
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the cytoplasm back to the membrane are likely. To test this hypothesis, highly specific 
antibodies are needed, to guarantee reliable results. Future studies approaching the binding 
or the recycling pathway of V1bR within lactating rats could further elucidate its role in the 
different aspects of maternal behaviour. In contrast, V1aR binding seems to adapt in 
lactation, showing increased levels compared to virgins (Bosch and Neumann, 2008; Bosch et 
al., 2010). This leads to the conclusion that both V1R subtypes are adapted in lactation to 
contribute to the modulation of maternal behaviour in lactation, but on the basis of different 
regulatory mechanisms. Future studies on adaptations of receptor density in the cytoplasm, 
receptor recycling or signalling transduction may outline potential adaptions, especially of 
V1bR. 
Due to the expression pattern of V1bR throughout the brain, other brain regions implicated 
in distinct maternal aspects like the CeA, the PAG and the LS could further clarify the role of 
V1bR within the mediation of maternal behaviour. During maternal aggression increased 
AVP release in CeA was measured in HAB, but not in LAB, dams (Bosch and Neumann, 2010). 
In this line, V1aR antagonism reduces aggression in resident HAB dams, whereas synthetic 
AVP increases the attack and threat behaviour in low aggressive LAB dams (Bosch and 
Neumann, 2010; for review see Bosch, 2013). According to this knowledge of the 
involvement of AVP and its V1aR in the animal model of extremes in anxiety, further 
investigations of the V1bR in NAB rats would shed light on the link between receptor 
subtypes and the behavioural outcome. 
A further brain region expressing V1bR is the SCN, which is known to be responsible for 
circadian rhythm of diverse hormonal fluctuation, like AVP, melatonin, and growth hormone 
(for reviews see Challet, 2015; Kalsbeek et al., 2010; Kim et al., 2015; Moore, 2013), as well 
as of motivated behaviours like maternal behaviour, eating, and exercise (Antle and Silver, 
2015; for review see Johnston, 2014). Further, AVP neurons from the SCN project to the 
MPOA but also to the BNST and PVN (Kalsbeek and Buijs, 2002), known to mediate maternal 
care. Interestingly, also maternal care shows a rhythmic pattern over 24 hours (Antle and 
Silver, 2015), which might be due to different release pattern of AVP within the SCN and 
projections to the maternal brain regions. In order to approach this hypothesis activation 
and inactivation of the SCN with subsequent observation of maternal care could help to 
understand this correlation.  
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So far, these findings help to increase our understanding of the complex changes and 
systems that are involved in the maintenance and control of appropriate maternal care. 
Initial studies in humans showed a link between a polymorphism in the V1aR gene, 
specifically on the RS3 allel, and decreased maternal structuring and supportive behaviour 
during a free-play session with their children (Avinun et al., 2012). In more detail, mothers 
with two copies of the RS3 “risk” allel were less sensitive in perceiving and responding to the 
infants’ cues promptly and appropriatly than mothers with one or zero copies of the allele 
(Bisceglia et al., 2012). Thus, genetic identification could identify mothers which are carrier 
of a “risk” allele. Depending on the individual personality and the severity of insensitivity of 
the mother towards her child, child abuse or maternal neglect might be prevented in time. 
Future studies on other potential alleles, maybe on the V1bR gene, may help to understand 
genetic modifications which lead to pathological phenotypes in maternal behaviour. 
In addition to the AVP system, also the GnRH as well as the kisspeptin systems are involved 
in the modulation of maternal behaviour in the postpartum period. Both systems have 
mainly been attributed to reproduction, except one single study; genetically modified mice 
with a partial reduction in GnRH neurons have been found to show impairments in pup 
retrieval. Thus, I could provide the first insight in two further hormonal systems implicated in 
the regulation of maternal behaviour of lactating Wistar rats.  
Due to the fact that the co-expression of GnRH and AVP-ir was found within the OVLT, 
further investigation of this specific brain region in the modulation of maternal behaviour by 
administration of selective GnRH or/and AVP (receptor) antagonists could be a future step.  
In humans, GnRH is already used to treat reproductive diseases, e.g. hypogonadotropic 
hypogonadism (Maggi et al., 2015). Similar to the closely linked kisspeptin system, the GnRH 
system has not been related to maternal behaviour in humans to date. Nevertheless, studies 
on plasma kisspeptin in pregnant women provide a link between kisspeptin mRNA 
expression and labour. Kisspeptin mRNA is decreased in women with in term vaginal delivery 
compared to women receiving a cesarean section. In addition, the expression is dramatically 
increased when delivery occurs preterm (Torricelli et al., 2008). Furthermore, studies during 
pregnancy indicated a link between low kisspeptin-levels and preeclampsia, pregestational 
insulin-dependent diabetes mellitus (type 1) and gestational diabetes (Cetković et al., 2012). 
In addition decreased levels of kisspeptin indicate placental dysfunction, often followed by 
adverse perinatal outcome. Future studies investigating plasma kisspeptin levels during 
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mother-child interaction could help to understand the wide range of physiological actions of 
the kisspeptin system. Nevertheless, these studies in pregnant women and my studies in 
lactating rats show evidence for the importance of the GnRH- and kisspeptin system not only 
in reproduction and pregnancy, but also in lactation. Therefore both systems may provide 
potential targets in treatment of reproductive, as well as maternal behaviour deficits. 
 
Thus, in my thesis I showed a crucial involvement of V1bR in the regulation of maternal 
behaviour. Thereby, V1R subtypes act in a brain region dependent manner, including 
hypothalamic and limbic areas, on distinct aspects of the maternal repertoire. This provides 
evidence for a central effect of V1bR in the complex regulation of maternal behaviour. 
In addition, I showed a GnRH-AVP co-expression within the OVLT of lactating rats and an 
influence of the GnRH- and kisspeptin system on the regulation of maternal aggression and 
maternal care, respectively. This suggests an interaction between the neuropeptide systems, 
which has to be confirmed in future studies. 
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Abbreviations 
ABN  arched back nursing  
ACTH  adrenocorticotropic hormone  
amPVN anterior magnocellular part of the paraventricular nucleus of the hypothalamus 
ANOVA  analysis of variance  
ARC arcuate nucleus 
AVP  arginine-vasopressin  
BNST  bed nucleus of the stria terminalis  
CeA  central amygdala  
CREB cyclic adenosine monophosphate response element binding protein 
CRF  corticotropin-releasing factor  
eGFP enhanced green fluorescent protein 
EPM  elevated plus-maze  
FSH follicle stimulating hormone 
GABA  γ-amino butyric acid  
GnRH gonadotropin-releasing hormone 
GPCR  G-protein coupled receptor  
GPR54 kisspeptin receptor 
HAB  high anxiety-related behaviour  
HPA axis  hypothalamo-pituitary-adrenal axis  
HPG axis hypothalamo-pituitary-gonadal axis 
icv intracerebroventricular  
IP3 inositol triphosphate 
ir immunoreactivity 
LAB  low anxiety-related behaviour  
LD  lactation day  
LH luteineizing hormone 
LS  lateral septum  
mpBNST  medial-posterior bed nucleus of the stria terminalis  
MPOA  medial preoptic area  
mRNA messenger ribonucleic acid 
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NAB  non-selected for anxiety-related behaviour  
NAc nucleus accumbens 
OVLT organum vasculosum of the lamina terminalis 
OXT  oxytocin  
PD  pregnancy day  
pPVN parvocellular part of the paraventricular nucleus  
PRL prolactin  
PRT pup retrieval test  
PVN paraventricular nucleus of the hypothalamus 
qPCR quantitative real-time polymerase chain reaction 
SCN suprachiasmatic nucleus 
SON  supraoptic nucleus  
V1aR V1a receptor 
V1bR V1b receptor 
vBNST  ventral bed nucleus of the stria terminalis  
VEH  Vehicle 
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Supplementary 
Chapter 3 
Comparison of breeding EPM to experimental EPM of HAB and LAB rats of generation #51 
 
Figure S1 Anxiety-related behaviour of HAB 
and LAB rats of generation #51 as virgins on 
the breeding EPM and as lactating dams on 
the experimental EPM 
Time spent on the open arms of HAB and LAB 
dams under two different reproductive 
conditions. 
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Chapter 4 
Supplementary Information: Verification of V1bR antibody specificity in Western Blot 
analysis 
Material & Methods 
To verify the specificity of the antibody against the rat V1bR (1:5000, Alpha Diagnostic, San Antonio, 
USA), we tested maternal (cortex) and embryonic (day (d)12 and d16) brain tissue for V1bR protein 
expression. AVP receptors are not expressed in neonates before embryonic d16 (Tribollet et al., 
1991); hence, we predicted a protein band at 55 KDa in both maternal brain tissue and embryonic 
d16, but not in d12, tissue. 
At day 12 or 16 of pregnancy, dams were deeply anesthesized, decapitated, and the embryos were 
removed. Tissue was taken from the head of the embryos and proteins were isolated according to the 
protocol for adult brain regions (for details see main manuscript). Western Blot analysis was 
performed as described in the main manuscript. Loading was controlled by staining for ß-tubulin 
(1:1000). 
 
Results 
Our results show a clear negative result for d12 fetal tissue but a positive V1bR protein band in d16 
embryonic and maternal tissue (Figure S2) thereby proofing the specificity of the V1bR antibody. 
 
 
Figure S2 V1bR antibody specificity in 
protein analysis 
Representative Western Blot for V1bR 
protein of adult (maternal brain cortex, 
lactation day 4; column 1) and embryonic 
(days d12 and d16; columns 2 - 4) brain tissue 
to verify the specificity of the antibody for rat 
V1bR. ß-tubulin from adult and embryonic 
(d12) tissue was used as loading control. 
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Supplementary Information: Verification of a modified setup in the PRT 
Material & Methods 
Animals. Female HAB and LAB rats (12 - 14 weeks, 220 - 250 g) were used (Landgraf and 
Wigger, 2002; Liebsch et al., 1998; Mathys et al., 2004; Neumann et al., 2005a; Neumann et 
al., 2005b; for review see Bosch, 2011). Rats were mated with sexually experienced stud 
Wistar males and pregnancy was confirmed the next day by the presence of sperm in vaginal 
smears. Pregnant females were kept in groups of 3 to 4 rats before they were single-housed 
in plexiglass observation cages (38 x 22 x 35 cm³) on PD 18 to ensure undisturbed 
parturition. On the day of birth, offspring were culled to eight pups of mixed sexes and half 
of the bedding was replaced by new bedding. 
Rats were kept under standard laboratory conditions (12 h / 12 h light-dark cycle, with lights 
on at 07:00 h; 22 ± 1 °C; 55 ± 5 % relative humidity; free access to water and standard rat 
chow). 
All experiments were performed in accordance with the European Communities Council 
Directive (86/609/EEC) and were approved by the local government of the Oberpfalz, 
Bavaria, Germany. 
 
Maternal motivation in the PRT. On LD 3, HAB and LAB dams were tested on their motivation 
to retrieve their pups in a novel environment. Lactating dams were moved to the test room 
60 min prior to the test, pups were removed from the home cage and kept on a thermo pad 
(32 °C) in another room to avoid auditory recognition. To characterize retrieval behavior 
under different challenging conditions, two different PRT setups were used (see Figure 21, 
Chapter 4). Females of both breeding lines were tested either in the conventional setup of 
our laboratory (‘no house’ condition; Figure 21A; Bayerl et al., 2014; Bosch and Neumann, 
2008; Bosch et al., 2010; Neumann et al., 2005a), or in the modified setup (‘house’ 
condition; Figure 21B).  
 For details on the PRT setups please see Material and Methods of Chapter 4. 
 
Statistical analysis. Maternal motivation was analyzed using three-way ANOVA for repeated 
measures (factors: time x condition x breeding line). The number of retrieved pups as well as 
the latency to retrieve the first pup was analyzed using two-way ANOVA (factors: condition x 
breeding line). The ANOVA was followed by Sidak post-hoc correction if main effects were 
S u p p l e m e n t a r y   185 
found. A statistical significant difference was considered at p ≤ 0.05 and effect size 
estimations were indicated by eta squared values. Data are presented as mean + SEM. 
Statistical analysis was performed using the software SPSS, Version 20 (IBM, Ehningen, 
Germany). 
 
Results 
Pup retrieval in HAB and LAB dams significantly differed over the 15-min test (three-way 
ANOVA for repeated measures; F15,510 = 124.50, p < 0.001, η² = 0.32; Figure S3), between the 
breeding lines (F1,34 = 31.55, p < 0.001, η² = 0.16) as well as between the PRT setups (F1,34 = 
24.60, p < 0.001, η² = 0.13). A significant time x breeding line x setup interaction was found 
(F15,510 = 3.93, p < 0.001, η² = 0.10). The post-hoc test revealed that in the conventional PRT 
HAB dams retrieved their pups faster than LAB dams from t1 on (p < 0.001 in each case). In 
the modified PRT, HAB and LAB dams only differed in the first 2 min (t1: p = 0.006, t2: p = 
0.009). Moreover, when comparing only the LAB groups, it becomes evident that LAB dams 
retrieved their pups faster in the modified compared to the conventional PRT from t3 on (p ≤ 
0.001 in each case).  
 
 
Figure S3 Maternal motivation of lactating rats bred for high (HAB) and low (LAB) anxiety-related behaviour 
in two different pup retrieval test (PRT) setups. 
Maternal motivation was tested in HAB and LAB dams either in the conventional (‘no house’ condition; -h) or 
the modified (‘house’ condition; +h) PRT. The time until retrieval of each pup was monitored for 15 min. Data 
are presented as means + SEM (n = 9 - 10 per group). * p ≤ 0.05 versus same breeding line with house; # p ≤ 
0.05 versus equivalent in HAB group. 
S u p p l e m e n t a r y   186 
Consequently, the total number of retrieved pups at t15 differed significantly between HAB 
and LAB (two-way ANOVA; F1,37 = 13.34, p = 0.001, η² = 0.18), depending on the PRT setup 
(F1,37 = 18.07, p < 0.001, η² = 0.24); additionally a breeding line x setup interaction was found 
(F1,37 = 9.94, p = 0.003, η² = 0.13). The post-hoc test revealed that LAB dams retrieved the 
least number of pups in the conventional PRT compared to all other groups (p < 0.001 in 
each case) and, importantly, LAB dams in the modified PRT did not differ from HAB dams in 
any PRT setup making these LABs indistinguishable from HABs. 
Further, the latency to retrieve the first pup differed significantly between HAB and LAB 
mothers (two-way ANOVA; F1,37 = 9.89, p = 0.003, η² = 0.19), depending by trend on the PRT 
setup (F1,37 = 3.92, p = 0.056, η² = 0.07); additionally a breeding line x setup interaction was 
found (F1,37 = 5.59, p = 0.024, η² = 0.11). The post-hoc test revealed that in LAB dams the 
latency to retrieve the first pup is higher in the conventional PRT compared to the modified 
PRT (p = 0.004) and that in the conventional PRT LAB dams show a higher latency to retrieve 
their first pup compared to HAB dams (p < 0.001). 
 For discussion of the results please see Discussion Chapter 4. 
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Chapter 6 
Table S4 Maternal care under non-stress conditions before and after central GnRH antagonist 
infusion on LD 1 
  Occurrence [n] 
Behaviour Treatment basal t +30 t +60 t +90 t +120 
ABN VEH   3.4 ± 0.9   3.4 ± 1.1   3.6 ± 0.8   2.0 ± 1.0   2.8 ± 0.6 
 GnRH ant   4.0 ± 1.1   3.7 ± 1.8   3.2 ± 1.0   4.3 ± 1.3   2.2 ± 0.9 
       
Blanket VEH   9.9 ± 0.9   8.0 ± 1.3 10.0 ± 0.8 12.1 ± 1.2 11.9 ± 0.7 
 GnRH ant   8.2 ± 0.7   9.0 ± 1.9 10.7 ± 0.9   9.0 ± 1.3 10.3 ± 0.9 
       
Nursing VEH 13.3 ± 0.5 11.4 ± 1.1 13.8 ± 0.5 14.1 ± 0.4 14.6 ± 0.2 
 GnRH ant 12.2 ± 0.7 12.7 ± 0.8 13.8 ± 0.7 13.3 ± 1.1 12.5 ± 1.4 
       
Mother-pup 
interaction 
VEH 14.3 ± 0.6 12.0 ± 1.1 14.6 ± 0.2 14.5 ± 0.3 15.0 ±0.0 
GnRH ant 13.8 ± 0.6 13.5 ± 0.8 15.0 ± 0.0 14.5 ± 0.3 13.5 ± 1.1 
       
Off pups VEH   0.8 ± 0.6   3.0 ± 1.1   0.4 ± 0.2   0.5 ± 0.3   0.0 ± 0.0 
 GnRH ant   1.2 ± 0.6   1.5 ± 0.8   0.0 ± 0.0   0.5 ± 0.3   1.5 ± 1.1 
Abbreviations: VEH, vehicle; ant, antagonist; ABN, arched back nursing. 
Data are presented as mean ± SEM (n = 6 - 8 per group). 
  
S u p p l e m e n t a r y   188 
Table S5 Aggressive and non-aggressive behaviours during the maternal defence test after central 
GnRH antagonist infusion on LD 4 
 VEH GnRH antagonist 
   
aggressive behaviour   
   
number of attacks  14.4 ± 3.5   3.7 ± 1.1 * 
attack duration      9.5 ± 2.4 s      2.5 ± 0.7 s * 
attack latency      76.3 ± 21.8 s 132.3 ± 46.7 s 
keep down      35.6 ± 16.3 s 16.2 ± 9.0 s 
lateral threat      39.5 ± 13.5 s   20.4 ± 11.0 s 
offensive upright    26.1 ± 7.9 s      3.2 ± 1.4 s * 
aggressive grooming    19.4 ± 2.9 s 21.9 ± 9.7 s 
other aggressive    268.4 ± 29.1 s 231.6 ± 24.8 s 
sum aggressive    398.6 ± 39.1 s 295.8 ± 32.7 s 
   
non-aggressive behaviour   
   
pup-directed 
behaviour 
     32.1 ± 22.6 s   39.8 ± 23.2 s 
sniffing    46.1 ± 5.8 s   70.5 ± 16.1 s 
exploration      72.0 ± 10.2 s   79.6 ± 17.1 s 
self-grooming      36.0 ± 11.0 s   99.8 ± 27.9 s 
resting      5.9 ± 3.0 s 11.6 ± 3.6 s 
other      8.0 ± 6.9 s   2.0 ± 2.0 s 
sum non-aggressive    200.2 ± 38.7 s 303.2 ± 32.6 s 
Abbreviations: VEH, vehicle. 
Data are presented as mean ± SEM (n = 6 - 8 per group). * p ≤ 0.05 versus VEH. 
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